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Abstract

Orientia tsutsugamushi secretes two ankyrin repeat-containing effectors via a Type-1
secretion system to inhibit host NF-κB function
By Sean M. Evans, B.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2017
Director: Jason A. Carlyon, Ph.D.
Professor
Microbiology and Immunology

Scrub typhus is a potentially fatal infection that threatens one billion persons in the AsiaPacific region and is caused by the obligate intracellular bacterium, Orientia
tsutsugamushi. How this organism facilitates its intracellular survival and pathogenesis is
poorly understood. Intracellular bacterial pathogens utilize the Type 1 (T1SS) or Type 4
secretion system (T4SS) to translocate ankyrin repeat-containing proteins (Anks) into the
host cell to modulate host cell processes. The O. tsutsugamushi genome encodes one of
the largest known bacterial Ank libraries as well as Type 1 and Type 4 secretion systems
(T1SS and T4SS), which are expressed during infection. In silico analyses of the Anks’
C-termini revealed that they possess characteristics of T1SS secretion signals.
Escherichia coli expressing a functional T1SS was able to secrete chimeric hemolysin
proteins bearing the C-termini of 19 of 20 O. tsutsugamushi Anks. In addition to infecting
endothelial cells, O. tsutsugamushi infects professional phagocytes. To better understand
why these innate immune cells are unable to eliminate O. tsutsugamushi, we addressed
the activity of host NF-κB proinflammatory transcription factor. Screening of O.
tsutsugamushi infected cells at an MOI of 1 revealed inhibition of NF-κB nuclear

xviii

accumulation as early as 8 hours in HeLa and bone-marrow derived macrophage cells.
When stimulating infected cells with TNF-α, IκBα degradation still occurs, however NFκB dependent gene transcription remains downregulated. Immunofluorescence
microscopic analysis of TNF-α treated cells ectopically expressing all O. tsutsugamushi
Anks revealed that two nuclear trafficking Anks, Ank1 and Ank6, result in a significant
decrease in NF-κB nuclear accumulation. Additionally, these Anks also significantly
inhibited NF-κB dependent gene transcription. Co-immunoprecipitation experiments
revealed that both Anks interact with importin-β1, exportin-1, and the p65 NF-κB subunit.
Treating cells with importazole significantly reduces the nuclear accumulation of Ank1
and Ank6. Finally, treating infected cells or cells ectopically expressing Ank1 or Ank6 with
leptomycin B resulted in restoration of NF-κB nuclear accumulation. With these data, we
propose that O. tsutsugamushi secretes Ank1 and Ank6 to initially interact with importinβ1, which permits their nuclear entry where they then interact with NF-κB and
subsequently exportin-1 to prevent NF-κB nuclear accumulation.

xix

Chapter 1

Introduction and Literature Review

1

1.1 Orientia tsutsugamushi background
Taxonomy
Orientia tsutsugamushi is a Gram-negative obligate intracellular bacterial species in the
order Rickettsiales and the family Rickettsiaceae that is known to be the causative agent
of the human disease scrub typhus. Other genera that are classified in this order are
obligate intracellular bacteria such as Ehrlichia, Anaplasma, Rickettsia, Wolbachia, and
Neorickettsia that are classified into two main families: Anaplasmataceae and
Rickettsiaceae. Bacterial species of the Anaplasmataceae family form replicative
vacuoles where as those of the Rickettsiaceae escape quickly from the phagosome and
replicate freely in the host cytosol. A unique characteristic of Rickettsia is that they have
a unique lifestyle of transitioning from invertebrate (ticks, lice, and mites) to vertebrate
hosts (deer, rodents, and humans) and vice versa. O. tsutsugamushi was originally
termed Rickettsia tsutsugamushi but was later removed from this genus in 1995 due to
phylogenetic differences, genome size, biochemical properties and the 16s rRNA gene
sequences.2 Some of these major biochemical property differences between Rickettsia
and Orientia is that Orientia lacks LPS and possibly peptidoglycan. The latter is currently
under investigation based on recent experiments done by Salje, et al.3

Discovery
O. tsutsugamushi was first described in Chinese texts dating as far back as 313 A.D. and
1810 in Japanese literature. It was described in 1878 as a disease that affected a vast
population of farmers near river valley locations in the summer time which is the peak
2

season for acquiring scrub typhus. This documentation by the Japanese is the original
source of the name “tsutsugamushi” which translates to noxious or dangerous mite.4 This
pathogen was originally isolated and researched in 1906.5 The source of scrub typhus
was hypothesized to be a protozoan but later was concluded to be a bacterium in 1929
and named Rickettsia tsutsugamushi due to its indistinguishable disease characteristics
of murine typhus (Rickettsia typhi).6, 7 After its reclassification into a new genus, a new
species annotated as Orientia chuto was discovered in a febrile patient in the United Arab
Emirates as well as a 3rd possible species from a patient in Chile.8, 9

Morphology
O. tsutsugamushi is a Gram-negative bacterium, which appears as paired pleomorphic
coccobacillus with larger dimensions than those of the Rickettsia genus with a width of
approximately 0.3 µm-0.5 µm and a length of 1.2 µm-3.0 µm (Figure 1A).10, 11 It is currently
documented that this bacterium lacks a peptidoglycan due to its resistance to all β-lactam
antibiotics and the fact that it lacks many genes for peptidoglycan synthesis. 12 On the
contrary, recent studies have confirmed that a fluorescent derivative of the amino acid Dalanine (a component of peptidoglycan) known as HCC-amino-D-alanine can be used to
image live O. tsutsugamushi.3 Within the host cell, the bacteria traffic by microtubules and
form a microcolony at the perinuclear microtubule-organizing center (MTOC).13 The lack
in cell wall rigidity makes these bacteria extremely fragile and unable to live outside the
host cell. One component that protects the bacteria for a period of time is the host
membrane itself. As O. tsutsugamushi exits the cell, it envelops itself in the host
membrane in a manner that is similar to the budding of virus particles (Figure 1B) but will
3

B

A

Figure 1. O. tsutsugamushi is pleomorphic and possesses a fraction of host cell
membrane. A. Transmission electron microscopy of one O. tsutsugamushi bacterium at
33,000x magnification. Modified from: Ewing, E.P., Jr., Takeuchi, A., Shirai, A. &
Osterman, J.V. Experimental infection of mouse peritoneal mesothelium with scrub
typhus rickettsiae: an ultrastructural study. Infect Immun 19, 1068-75 (1978). B. Scanning
electron micrograph of budding O. tsutsugamushi seen on the surface of an L929
fibroblast cell at 72 h of infection. Modified from: Seong, S.Y. et al., 2001. Orientia
tsutsugamushi infection: overview and immune responses. Microbes Infect 3:11-21.
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remove this host cell membrane once safely inside the next host cell. 11, 14, 15 The most
prevalent protein on the bacterial membrane is the strain variable 56-kDa antigen, typespecific antigen (TSA56), which is the most heavily studied protein for vaccine
purposes.16 The presence of a polysaccharide electron dense coat has been reported
that allows biofilm like formations within the host cell and is hypothesized to stimulate
inflammation in the host.16

1.2 Environmental life cycle and epidemiology
Epidemiology
O. tsutsugamushi is maintained in nature by transovarial transmission by trombiculid
mites of the genus Leptotrombidium which are defined as the vector as well as the
reservoir.17 Normally these mites acquire serous tissue components from small
mammals, commonly mice and rats, and ground feeding birds that are commonly found
in scrub vegetation hence the disease name.18, 19 Scrub typhus is contained to where the
population of these mites live. This region, termed the “tsutsugamushi triangle” (Figure
2), encompasses the majority of Asia, Northern Australia, and the islands that intercede
between the two continents. Due to the vast majority of ecological conditions seen in this
highlighted region, O. tsutsugamushi can be carried by many Leptotrombidium species.20
Of the mite species, the top three vectors documented are L. deliense, L. akamushi, and
L. scutellare. Other vectors are listed in Table 1.

5

Figure 2. Scrub typhus endemic area. Map of the Asia-Pacific region of the world with
the highlighted region marking where scrub typhus is prevalent.
Modified from: Kelly, D.J. et al., Scrub typhus: the geographic distribution of phenotypic
and genotypic variants of Orientia tsutsugamushi. Clinical infectious diseases: an official
publication of the Infectious Diseases Society of America. 2009;48 Suppl 3:S203-230.
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Table 1. List of the main vectors in scrub typhus rich countries. Leptotrombidium
mite species that carry O. tsutsugamushi are prevalent in certain countries and country
regions. Modified from: Kelly, D.J. et al., Scrub typhus: the geographic distribution of
phenotypic and genotypic variants of Orientia tsutsugamushi. Clinical infectious diseases:
an official publication of the Infectious Diseases Society of America. 2009;48 Suppl
3:S203-230.
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Life cycle of the trombiculid mite and transmission
Humans acquire scrub typhus when they are bitten by an infected trombiculid
(Leptotrombidium spp.) larva (chigger). This mite has a four-stage life cycle: egg, sixlegged chigger, eight-legged nymph, and adult.21 This cycle occurs year-round in warm
tropical regions but occurs in a two-to-eight month time span in temperate regions.22 For
example, the peak occurrence of scrub typhus in Korea normally occurs between October
and November but in Southern India can range from October to February.22,

23

The

chigger feeds once on a vertebrate host once during their life where it will bite and feed
on lymph and dermal tissue of their host for three-to-five days.24, 25 O. tsutsugamushi
resides in the salivary gland cells of the mite, which during the mite’s feeding will secrete
saliva as well as O. tsutsugamushi.26 The escape of the bacteria from the salivary gland
is a slow process due to the fact that at least six hours of mite feeding must occur in order
for the vertebrate host to become infected.26 Following the mite’s engorgement, it will
continue to mature as a nymph and subsequently into an adult where it will live in the
soil.25 When infected adult female mites lay eggs where the bacteria have potential to be
transmitted to the oocytes and thus the offspring where the infection is maintained
throughout all of its life stages.12 Filial infection of O. tsutsugamushi is not 100% since the
bacteria in an infected female do not infect every oocyte and will cause a decrease in the
percentage of infected offspring overtime if the mite does not feed on an infected
vertebrate.27

Humans are incidental hosts where they acquire scrub typhus through occupational or

8

recreational activity and therefore play no role in the maintenance of O. tsutsugamushi in
nature.25

1.3 Scrub typhus
Clinical manifestations and disease
Scrub typhus is an acute febrile zoonosis that affects all organs and the central nervous
system in the patient. Approximately 10-12 days on average after the bite of an infected
chigger, signs and symptoms will manifest.14 The patient will initially present with malaise,
fever, lymphadenopathy, maculopapular rash, gastrointestinal disturbances, and
myalgia.28 A hallmark feature of scrub typhus is the eschar, which is defined as a focal
necrotic lesion (Figure 3) where the chigger bit the patient.25 Eschars are documented in
60-100% of patients and are most frequently found around the waist, neck, axilla, groin,
and inguinal area.29 Patients that are East Asian or Caucasian will present this sign more
often than those of dark skinned color in the South Asia region.22, 30, 31 If the patient has
not cleared the infection or is not treated with the proper antibiotics, the disease becomes
systemic and potentially fatal. Meningoencephalitis, systemic vascular collapse, and loss
of organ function may lead to patient expiration.19, 25, 32 Depending on the age and immune
system susceptibility of the patient in addition to the strain of O. tsutsugamushi acquired
the disease can range from mild to fatal.14, 33 An analysis of 76 studies with a total of
19,644 patients revealed a median of 6% mortality, but patient series were seen to have
as high as 70% especially in the pre-antibiotic era.34

9

Figure 3. Eschar. Formation of necrotized tissue at the location of chigger feeding.
Modified from: Sudhakar, M.K., and Amarabalan, R. Scrub typhus in adults - a case series
from a tertiary care hospital. Int. J. Med. Public health 1, 34-36 (2011).
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Incidence
Scrub typhus is the leading cause of rickettsioses (bacteria that cause scrub typhus,
spotted fever, typhus, and ehrlichioses).20 It is endemic to the Asia-Pacific region of the
world which contains China, India, Afghanistan, Russia, Northern Australia, and the
Pacific Islands (Figure 2).20 Within the tsutsugamushi triangle contains approximately
one-third of the world’s human population where over one billion people are at risk.35 It
was commonly documented that scrub typhus occurs in rural regions such as small
villages and heavily vegetated areas but sub-urban areas are becoming affected also
resulting in over one million reported cases annually.32,

36

Where documentation is

possible, scrub typhus is reported to cause 20% of acute undifferentiated febrile
hospitalizations in rural communities.36, 37

Military conflict in the Asia-Pacific region has resulted in allied forces to succumb to
infection. During World War II, troops often acquired scrub typhus resulting in mortality as
high as 37.5% with up to three month recovery periods.38, 39 During the Vietnam conflict,
scrub typhus was reported to be second to malaria for causing febrile illness among active
troops.4,

20

Reinfection can occur due to the great antigenic variation among the O.

tsutsugamushi strains. As of 2009, there are over 20 antigenically distinct strains (Table
2).20

11

Table 2. List of O. tsutsugamushi strains as determined by antigenicity. Kelly, D.J.
et al., Scrub typhus: the geographic distribution of phenotypic and genotypic variants of
Orientia tsutsugamushi. Clinical infectious diseases: an official publication of the
Infectious Diseases Society of America. 2009;48 Suppl 3:S203-230.
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Diagnosis and treatment
Diagnosing scrub typhus tends to be difficult due to the fact that a great area of the
tsutsugamushi triangle consists of developing countries that lack sophisticated diagnostic
labs and hospitals. Being that scrub typhus is prevalent in tropical regions, the nonspecific symptoms of fever, malaise, and muscle pains can be confused with other tropical
illnesses such as dengue, typhoid, malaria, and leptospirosis.14 If an eschar is present, it
makes the diagnosis more definitive since the other diseases do not show this sign.
Incorrect diagnosing often leads to the use of ineffective β-lactam-based regimens.40 The
main method of scrub typhus confirmation is dependent on serology, which can lack
specificity, lack sensitivity, and can take two to three days to confirm. The most common
test is the Weil-Felix OX-K agglutination reaction because it is easy to use and is
inexpensive.40 Indirect fluorescent antibody (IFA) test has greater sensitivity but
fluorophore conjugated antibodies are expensive and the technique requires proper
training.40 The challenge with using serum based testing is that for single acute patient
samples there needs to be a cut-off antibody titer. This is in relation to the general
population that live in the scrub typhus-endemic region that possess IgG antibodies to O.
tsutsugamushi. Other diagnostic methods used to avoid this challenge is at the genetic
level by using nested polymerase chain reaction (PCR), quantitative PCR (qPCR), or loop
isothermal amplification (LAMP) with blood buffy coats or eschar biopsies as the source
of sample. Common genes used for these tests are those that encode TSA56, 47-kDa
outer membrane protein (OMP), and the GroEL heat shock protein.41-44 The challenges
once again come from the difficulty to obtain the expensive instruments and equipment
to perform these tests. Recently, a LAMP diagnostic tool was designed; the most ideal
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test in that it utilizes DNA and does not require expensive items such as thermocyclers.
LAMP PCR does not require a DNA extraction procedure, only requires one incubation
temperature to perform the test, is sensitive enough to detect 14 copies of O.
tsutsugamushi DNA (TSA56 gene target) per reaction, and is able to be confirmed by the
naked eye.40, 45

Scrub typhus is commonly treated with broad spectrum tetracyclines (most commonly
doxycycline) or chloramphenicol.46 Since tetracyclines lead to teratogenicity in fetuses as
well as permanent brown staining of teeth in children, an alternative treatment is
azithromycin.46, 47 O. tsutsugamushi possesses an amino acid mutation of Ser-83-Leu in
the DNA gyrase gene, gyrA, making fluoroquinolones ineffective.48 O. tsutsugamushi is
not susceptible to β-lactam antibiotics due to a lack of a peptidoglycan wall. There have
been documented cases of antibiotic resistance in scrub typhus patients. 49 Due to high
antigenic variation of O. tsutsugamushi, it has been difficult to create a highly effective
vaccine. There is promising research for potential vaccine candidates for scrub typhus
such as the ScaA autotransporter adhesin protein in combination with TSA56.50

1.4 O. tsutsugamushi genomics
Genome
The first two published genome sequences of O. tsutsugamushi were of the strains
Boryong and Ikeda in 2007 and 2008, respectively.51, 52 O. tsutsugamushi possesses a
single circular chromosome of 2,127,051 and 2,008,987 basepairs (bp) encoding 2,179
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and 1,967 protein coding sequences (CDSs) in Boryong and Ikeda, respectively.51, 53 The
Boryong strain was isolated from a patient in Korea and the Ikeda strain from a patient in
Japan. Alignment of the two sequences revealed a 97.5% sequence conservation where
several genes for surface proteins had variations consistent with its constant alteration of
antigenicity.51 Despite its high conservation Ikeda is classified as a high-virulence group
strain whereas Boryong is considered a low-virulence strain.54 Although O. tsutsugamushi
encodes approximately ~2,000 CDSs, there is a high degree of pseudogenization (~50%)
from deletions, transposon integrations, and duplications.53 The Boryong strain revealed
the most repetitive bacterial genome sequence known to date being 200-fold higher in
repetitive sequences than its relative Rickettsia prowazekii (epidemic typhus).53 The
genomes of both strains possess a low guanine-cytosine content of 30.5%.51, 53 Recently
a draft genome of 2,022,909 bp was generated of the highly virulent Karp strain, which
showed that 1,604 and 1,951 genes of Boryong and Ikeda, respectively, were found in
the Karp sequence.55 Additional strains sequenced, but currently not published, are
Gilliam, UT144, Sido, TA716, Kato, and AFSC4.56

Genome analysis
Although O. tsutsugamushi strains possess the largest genomes among the Rickettsiales,
they lack an unusual amount of components needed for essential biosynthetic pathways.
They exhibit poor collinearity with any other sequenced Rickettsia genomes, which
supports previous observations of heavy genomic rearrangement of the O. tsutsugamushi
genome most likely from the heavily amplified repetitive sequences it encodes. 51 These
repetitive sequences have been categorized into three types: O. tsutsugamushi amplified
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genetic element (OtAGE), transposable elements, and others. The OtAGE is a member
of the integrative and conjugative element (ICE) group and is approximately 33 kbp. This
element has been amplified a total of 185 times with each copy showing signs of deletions
and insertions. These OtAGEs constitute over one third of the entire genome. The ability
for these genetic elements to become incorporated into the chromosome is heavily relied
on an integrase gene (int) that is contained in the beginning of an OtAGE. Genes that
follow int are similar to those facilitated in conjugative transfer of F plasmids. Further
analysis of the int genes give evidence that they have originated from multiple sources as
they the sequence identity is only 36-38%. 51

There have been 5 types of insertion sequence (IS) elements, four types of miniature
inverted repeat transposable elements, and a group II intron confirmed in O.
tsutsugamushi, all which are not conserved in any other sequenced Rickettsia. The
amplification of these transposable elements is common in intracellular bacterial
genomes. However, the number of copies that O. tsutsugamushi possesses is ten times
higher than those. Among the five IS elements two are often found in the genomes of
chiggers and not bacteria, which implies that there is a chance that they were transferred
from the chigger vector.51

A genomic comparison of O. tsutsugamushi to R. prowazekii revealed that these two
species contain 542 genes in which 519 of these are conserved in all other sequenced
Rickettsia suggesting that these genes are the core gene set for survival. These genes
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are classified as housekeeping and secretion system genes. This comparison also
revealed 195 genes that only O. tsutsugamushi possesses and are absent in R.
prowazekii. Of the 195, 161 are not found in other Rickettsia species and are deemed
unique O. tsutsugamushi genes. These unique genes are often clustered in the genome
and are suggested to be from foreign origins that were brought into O. tsutsugamushi as
segments.51

Housekeeping genes in O. tsutsugamushi and other Rickettsia are unique in that they
possess a portion of genes for cell maintenance pathways (energy metabolism,
nucleotide metabolism, cell envelope formation, and DNA recombination and repair) but
are absent in others making these bacteria dependent on the host cell to complete the
necessary steps in cellular processes. An essential gene that O. tsutsugamushi lacks is
pyruvate dehydrogenase, which is responsible for converting pyruvate into acetyl-CoA for
entry into the tricarboxylic acid cycle (TCA). This has been linked to a frame shift mutation
that has led to inactivation of genes necessary for TCA metabolism. For fatty-acid
biosynthesis, the initial step of generating acetoacetyl-CoA (made by reacting acetyl-CoA
with malonyl-ACP) gene is absent but the genes necessary for further steps are present
suggesting O. tsutsugamushi uses host-derived acetyl-CoA.51,

57

Although O.

tsutsugamushi lacks genes for the TCA cycle, it does possess the majority of the
components needed for oxidative phosphorylation, which include proton pumps,
succinate dehydrogenase complex, and the ATP synthase complex. O. tsutsugamushi
possess five copies of an ATP/ADP translocase that allows the bacterium to harvest host
cell sources of ATP. These translocases also provide the bacterium with a source of
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nucleotides since it lacks the ability to interconvert adenine and guanine and most likely
rely on the host cell for a source of purine nucleotides. O. tsutsugamushi is also
dependent upon the host for obtaining aromatic amino acids (Trp, Tyr, and Phe) and His.

A major reason that led to the reclassification of O. tsutsugamushi from R. tsutsugamushi
is the absence of genes utilized for synthesizing peptidoglycan and LPS. O.
tsutsugamushi does not encode an alanine racemase gene, which is essential for
converting L-alanine to D-alanine, a major constituent of peptidoglycan.58 To fully
generate LPS in Gram negative bacteria, an O-antigen export system is needed, which
is present in Rickettsia species but not O. tsutsugamushi. 12

O. tsutsugamushi is ranked fifth highest among prokaryotes for the number ankyrin
repeat-containing protein genes.59 The Ikeda strain encodes 47 open reading frames
(ORFs), which 9 are pseudogenes and the remainder are identical or replicates.51, 53, 59
Obligate intracellulars secrete Ank effectors and utilize them to facilitate protein-protein
interactions that modulate host cell functions to promote growth of the pathogen.60-63

1.5 O. tsutsugamushi invasion and intracellular development
Adhesion and invasion
O. tsutsugamushi primarily infects dendritic cells, polymorphonuclear leukocytes,
macrophages, and endothelial cells.64-66 In vitro, O. tsutsugamushi is capable of infecting
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numerous cell lines such as L929 fibroblasts, HeLa cervical epithelial cells, human
mammary epithelial cells-1, RAW 264.7 macrophages and mouse bone marrow-derived
macrophages. All O. tsutsugamushi cultures must be maintained in a Biosafety Level-3
(BSL-3) laboratory.66

Bacterial entry into host cells is dependent upon two steps: adherence and invasion.
Without these initial steps, obligate intracellulars do not have the capacity to survive or
replicate. Rickettsial cellular invasion occurs in sequential manner by first allowing
bacterial adhesins and host receptors to interact, second signaling downstream pathways
in the host cell, and third activation of invasion known as induced phagocytosis. An O.
tsutsugamushi actively membrane expressed autotransporter protein annotated as ScaC
has been linked to facilitate adhesion to non-phagocytic cells (endothelial cells and
fibroblasts).67 Autotransporter proteins are defined as possessing an N-terminal signal
sequence that allows it to transport to the periplasm, subsequently allowing the C-terminal
autotransporter domain to insert itself into the bacterial outer membrane where this
domain forms a β-barrel pore.67-69 Within autotransporter proteins are surface-localized
passenger domains. These domains are transported and exposed to the extracellular
surface.70 Autotransporters are commonly found in Gram negative bacteria and are linked
to virulence functions.67, 68 The ScaC protein promotes adherence of O. tsutsugamushi to
the host cell but does not promote its uptake as it does not promote host actin cytoskeletal
rearrangement. This adherence is caused by the interaction of ScaC to host fibronectin. 67
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Fibronectin is considered the most essential extracellular matrix protein to support
bacterial adherence and entry into host cells. This protein is characterized as being a
glycoprotein approximately 250 kDa in size in which its mature form is a homodimer joined
by two C-terminal disulfide bonds.71 Fibronectin possesses an RGD motif that is required
for the interaction with integrins on cell surfaces, particularly α5β1 integrin.71,

72

O.

tsutsugamushi TSA56 protein is used to directly interact with fibronectin to promote
contact with α5β1 integrin.73 This is similar to R. conorii outer membrane B protein that
interacts with fibronectin to subsequently bind to Ku70, a protein that shares high
homology with integrin A.74 The TSA56 protein is the most abundant protein on the O.
tsutsugamushi membrane surface and is confirmed to enhance internalization of O.
tsutsugamushi into host cells.73 Antibodies against TSA56 have been confirmed to
prevent in vitro infection in L929 cells, further supporting the necessity of TSA56
interaction with host cells to promote its uptake and has led to further research in its
candidacy as a therapeutic vaccine.75

The binding of TSA56 indirectly to α5β1 integrin stimulates the host integrin signaling
pathway. This results in rapid actin cytoskeleton rearrangement to ruffle the host cell
membrane around the bacterium. This rearrangement is caused by the recruitment of
signaling adaptor molecules talin and paxillin that then lead to the activation of focal
adhesion kinase (FAK), RhoA GTPase and Src tyrosine kinase (Figure 4).76

O. tsutsugamushi utilizes other host glycoproteins to mediate invasion of human host
cells. One of these is syndecan-4, a ubiquitous component of heparin sulfate
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Figure 4. Binding and internalization of O. tsutsugamushi. The bacterium facilitates
binding to the host by outer surface proteins TSA56 and ScaC to host surface proteins
such as syndecan-4 and fibronectin. These interactions lead to signaling cascade most
likely focal adhesion kinase, Src kinase, and RhoAGTPase. These leads to recruitment
of talin and paxillin which then leads to clathrin-mediated endocytosis. It is hypothesized
that the bacterium escapes the phagosome by secretion of hemolysin and
phospholipase D. The bacteria are then trafficked to the MTOC by microtubules.
Modified from: Ge, Y. & Rikihisa, Y. Subversion of host cell signaling by Orientia
tsutsugamushi. Microbes Infect 13, 638-48 (2011).
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Proteoglycans are defined as a molecule that possesses a protein core and covalently
linked glycosaminoglycan chains. Syndecans are commonly known as surface adhesion
and internalization receptors for intracellular bacteria.66 Syndecan-4 is the only syndecan
found on the majority of mammalian cell surfaces and is considered to be a bridging factor
for extracellular ligands and signaling for actin cytoskeleton rearrangement, a common
mechanism for bacterial host entry.77 It was confirmed that the intracellular invasion of O.
tsutsugamushi had a dose dependent effect with the addition of recombinant syndecan4. Decreasing host cell expression of syndecan-4 also caused a markedly decrease of
>50% invasion.66 Although it is confirmed that O. tsutsugamushi utilizes syndecan-4 for
host cell entry, the bacterial protein for facilitating this interaction is still not known.

Intracellular development
As O. tsutsugamushi is bound to its respective host receptor proteins, signaling events
must occur to stimulate its uptake into the cell. The two major pathways that are most
identified with non-phagocytic host cell internalization of bacteria is the clathrin- and
caveolae-mediated mechanisms.78 Treating cells with multiple clathrin-endocytosis
inhibitors such as monodansylcadaverine, chloropromazine hydrochloride, or sucrose
results in O. tsutsugamushi entry inhibition whereas caveolae-endocytosis inhibitor filipin
III does not. Furthermore, O. tsutsugamushi cells colocalize with host cell clathrin on the
plasma membrane, further confirming that this pathogen is dependent upon clathrin
mediated endocytosis. On the contrary, treating macrophages with these four inhibitors
does not prevent O. tsutsugamushi internalization in macrophages further suggesting that
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professional phagocytic cells rely on induced phagocytosis and non-phagocytic cells
depend on clathrin-mediated endocytosis.79

Following entry into the cell, O. tsutsugamushi is held within an endosome between the
first ten to thirty minutes post-infection where it is confirmed by IFA to colocalize with early
endosomal antigen 1 (EEA1). At one hour post-infection, O. tsutsugamushi is then
present in the late endosome/lysosome stage where the bacteria are confirmed to
colocalize with lysosome-associated membrane protein 2 (LAMP2). The LAMP2
colocalization ceases by two hours post-infection. Although these bacteria are only
present in an acidified compartment for a brief moment, it is essential for O.
tsutsugamushi survival and replication. Treating the infected host cells with vacuole
ATPase proton pumps with ammonium chloride or bafilomycin A results in a complete
protein synthesis inhibition in the pathogen and halts its progression in its life cycle.79 The
strategy of O. tsutsugamushi escaping the lysosome is currently unknown, but based on
genomic analysis it is hypothesized that this bacterium expresses a hemolysin-like
protein, tlyC, that may possess phospholipase D function. This enzyme may be a factor
for disrupting the phagosome/lysosome membrane to allow O. tsutsugamushi to reside
freely in host cytoplasm.53, 80

As O. tsutsugamushi is free from containment in host-derived vacuoles, it utilizes host
dynein, the minus-end directed microtubule motor protein, to facilitate its localization to
the MTOC and does not rely upon actin (Figure 4).13 This is unlike its relative R. rickettsia,
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which uses actin-based motility to transition cell-to-cell.81 Movement to the MTOC puts
O. tsutsugamushi into a glycogen-rich locale of the cell devoid of lysosomes.82 Replication
occurs by binary fission in an eight-to-nine hour time period. These bacteria depart the
host cell in a budding manner similar to viruses where they continue to infect additional
host cells.11, 13

1.6 Human innate and adaptive immune response to O. tsutsugamushi
O. tsutsugamushi induces a prominent T-helper cell 1 (TH1) host immune response,
meaning that elimination of O. tsutsugamushi is dependent upon cell mediated immunity
as opposed to antibody mediated immunity. Cell mediated response is the best T cell
response against this pathogen since antibody bound O. tsutsugamushi phagocytosed
by professional phagocytes is able to escape the phagosome and continue propagation.83
Antibodies bound to O. tsutsugamushi restrict the bacteria of cytoplasmic trafficking such
as localization to glycogen rich regions of the cell.83 Antibody longevity is very short in
scrub typhus patients. Approximately 49 weeks after infection antibody titers are seen to
be at 1:50.84 Infected humans and mice present with increased amounts of TH1 cytokines
IL-1β (interleukin-1β), TNF-α, IL-12, IL-6, IL-10, and IFN-γ and chemokines CXCL9,
CXCL10, and CXCL11 (all three are chemotactic for activated T-cells).85, 86 As expected,
there is neither a decrease nor an increase in TH2 cytokines or chemokines: IL-7, IL-4,
IL-13, and CXCL12.86 This is also confirmed with silencing of TH2 and TH-17 transcription
factors GATA3 and ROR-γt, respectively. Scrub typhus, in severe cases, can manifest
acute respiratory distress syndrome and multiple organ dysfunction syndrome, which is
caused by a cytokine storm (a strong uncontrolled inflammatory response). 87 One of the
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key factors of the cytokine storm is TNF-α, a proinflammatory cytokine, which causes cell
injury by caspase and JNK-MAP kinase cascades.88 O. tsutsugamushi attempts to
regulate this cytokine storm by promoting IL-10 secretion and micro-RNA-155 (miR-155).
Low dose infection of macrophages results in a high amount of secreted IL-10 which
inhibits proinflammatory cytokine production and promotes pathogen replication in a nonstressful environment. Both IL-10 and miR-155 are utilized to inhibit the NF-κB
proinflammatory response.89

One of the initial cell types that O. tsutsugamushi infects are dendritic cells at the mite
feeding site. Dendritic cells, once activated, must undergo maturation. This is
characteristic of high expression of major histocompatibility complexes I or II (MHC-I,
MHC-II) and their co-stimulatory molecules such as CD40 CD80, CD83, and CD86.
Quickly after dendritic cell infection, expression of CD80, CD83, CD86, and MHC-I occur
confirming that O. tsutsugamushi induces dendritic cell activation. These cells are a great
source of IL-6, IL-8, IL-12p70, and TNF-α.85 IL-6 and IL-8 are well known for their ability
to activate lymphocytes and promote neutrophil migration. 90,
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Allowing neutrophil

migration to the initial source of the infection allows the bacteria to pass from the dermal
dendritic cells to neutrophils which promotes its systemic spread in the human host. The
cytokine IL-12 is known for inducing the differentiation of naïve T-cells to TH1 cells.
Following dendritic cell maturation, T cell priming takes place. Co-culturing CD4+ T-cells
with dendritic cells that are infected with O. tsutsugamushi result in T-cell activation and
an abundance of IFN-γ secretion from these T-cells.85 IFN-γ is essential for defending
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against intracellular pathogens by promoting the generation of reactive oxygen species
in macrophages to promote their destruction.92

As it is confirmed that O. tsutsugamushi activates CD4+ T-cells, CD8+ T-cells are
necessary for removal of the pathogen in the human host. CD8+ T-cells are essential in
defending against pathogens that reside in the host cell cytoplasm. Scrub typhus patients
show un upregulation of lymphocyte derived granzymes that suggest that CD8+ T-cells
are used in attempt to eliminate the bacteria.93 Depletion of CD8+ T-cells in mice results
in uncontrolled spread of the bacteria resulting in death. The host cannot solely depend
on CD8+ T-cells to rid the infection. Restoring CD8+ T-cells from O. tsutsugamushi
infected mice into CD8+ depleted mice via adoptive transfer results only in a partial rescue
of mortality.94 Knocking out the function of CD8+ T-cells in what appear to be healthy
mice 84 days post-infection results in restoration of bacterial burden suggesting that
CD8+ T-cells are necessary to suppress persistent scrub typhus symptoms. To further
support the necessity of a CD8+ T cell response for fighting scrub typhus, knocking out
the β2m gene, a component of the MHC-I complex, results in a 100-fold higher bacteremia
in late infection. Knockout of this gene also results in 80-fold higher concentration of IFNγ in mice sera. This confirms that although IFN-γ is a cornerstone of activating
macrophages to destroy intracellular pathogens, it is not sufficient to provide protection.
It has been documented that CD8+ T-cells are the cause of the hepatic lesions caused
by systemic O. tsutsugamushi, which also results in elevated serum levels of alanine
aminotransferase, a common sign in scrub typhus patients.94
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NF-κB proinflammatory transcription factor family background
The NF-κB transcription factor family is comprised of five proteins, p65 (RelA), RelB, cRel, p105 (p50), and p100 (p52), which form as homo- or heterodimers to either promote
or repress gene transcription.95 When first discovered, it was described as a nuclear factor
that bound to the enhancer element of immunoglobulin kappa light-chain of activated B
cells, hence its abbreviation NF-κB.96 These five proteins function by forming homo- or
heterodimers by means of a motif known as the Rel homology domain (RHD). The RHD
is not only necessary for dimerization but also for binding to their proper DNA
sequences.97 During cellular quiescence, NF-κB molecules remain inactive in the cytosol
by a family of inhibitors known as the IκB family, IκBα, IκBβ, IκBε, IκBζ and BCL-3. These
inhibitors possess ankyrin repeat motifs that are used for facilitating protein-protein
interactions with NF-κB that allow it to be removed from DNA, exported to the cytosol by
exportin-1, and remain bound to NF-κB’s nuclear localization signal (NLS) making it
inactive. Other inhibitors of NF-κB are the p105 and p100 precursors themselves also
called IκBns. Prior to becoming cleaved into the mature p52 and p50, the C-terminal
region of each possesses seven ankyrin repeats that are utilized as internal NF-κB
inhibitors.

Activation of p65:p50 NF-κB
The heterodimer that is essential and activated within minutes during the innate immune
response is the p65:p50 (commonly called NF-κB). The activation of NF-κB is dependent
on numerous factors. It can be activated by genotoxic stress such as ultraviolet light, γ-
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radiation, and reactive oxygen species.98 For the most part, NF-κB is activated during the
innate immune response by many mechanisms such as the interaction of pathogenassociated molecular patterns (PAMPs (LPS and dsRNA)) to toll-like receptors (TLRs), T
and B cell receptor interactions, and proinflammatory cytokines like TNF-α and IL-1β.98,
99

Since O. tsutsugamushi infection induces TNF-α and IL-1β production in scrub typhus

patients but lacks LPS, it most likely these bacteria stimulate NF-κB activation by means
of the TNF-α and IL-1β pathway.86, 100 How this pathway works has been thoroughly
defined. As TNF-α is secreted from activated professional phagocytes, the cytokine binds
to its respective receptor, TNF-α receptor (TNFR), performing a conformational change
in the cytoplasmic tail. The cytoplasmic tail of the receptor recruits adaptor proteins
TRADD by its death domain (DD). TRADD (TNFR-associated protein with a DD) is then
able to recruit TNF-α associated factor 2 (TRAF2) which partners with cIAP2 which are
considered to act as an E3 ubiquitin ligase for receptor-interacting protein 1 (RIP1).101, 102
This subsequently leads to the lysine-63 polyubiquitination linkage of RIP1 by the E2
Ubc13 complex which then permits RIP1 to recruit the NF-κB essential modulator
(NEMO), one of the three proteins that build the IκBα kinase (IKK).103 As NEMO is
recruited to RIP1:TRADD, the other two IKK subunits, IKKα and IKKβ, are then brought
together where the NEMO:IKKα:IKKβ complex complete the IKK enzyme. 102 This kinase
can then phosphorylate NF-κB inhibitor IκBα on serine 32 and 36 which will allow the
attachment of the SCFβTRCP E3 ubiquitin ligase complex.104 The ubiquitin ligase utilizes
the UbcH5 E2 conjugating enzyme to result a lysine-48 polyubiquitination of IκBα which
promotes its 26S proteasome degradation (Figure 5).102, 105 After IκBα is degraded, the
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Figure 5. TNF-α activation pathway of NF-κB. Modified from: Hayden, M.S. & Ghosh,
S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions.
Genes Dev 26, 203-34 (2012).
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NLS of p65 is revealed permitting nuclear import proteins, importin-α3-4 and importin-β1
to interact with NF-κB.106, 107

As there are numerous nuclear transport mechanisms in mammalian cells, the utilization
of the importin-β protein classifies this mechanism as the “classic nuclear protein import
cycle.”108 This begins by the adaptor protein importin-α recognizing a short basic NLS.109112

In the case of NF-κB, p65 uses a KRKR NLS at amino acids 301 to 304.113 The carrier

protein, importin-β, then binds to importin-α to traffic to the nuclear pore complex and
facilitate the entry of the heterodimer complex and its cargo. Once in the nucleus, the
complex RanGTP binds to importin-β resulting in dissociation of the complex allowing the
cargo to be liberated in the nucleus. Importin-α interacts with the nuclear export factor
CAS and RanGTP where both importin-α and β shuttle back to the cytoplasm. To return
the importin proteins to their functioning state, a RanGAP (GTPase activating protein)
hydrolyzes RanGTP to GDP thus releasing RanGDP from both importin proteins where
they can be recycled for another round of nuclear import.108

Once NF-κB is released in the nucleus from the importin complex, it now has the ability
to bind κB DNA sites (5’-GGGRNWYYCC-3’ where N is any base, R is a purine, W is an
adenine or a thymine, and Y is a pyrimidine) where it will promote gene transcription. One
of these is the IκBα gene itself which promotes a negative regulatory feed-back loop of
NF-κB function. IκBα utilizes its second ankyrin repeat to traffic to the nucleus in an
importin-independent manner, where it then removes NF-κB from the DNA, interacts with
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exportin-1 by its N-terminal nuclear export signal (NES), and finally escorts NF-κB back
to the cytoplasm to remain inactive until further stimuli arise.114, 115

The ability for exportin-1 to remove proteins from the nucleus has been linked to a nuclear
export signal (NES) that is defined to be rich in leucine rich amino acids such as that in
IκBα amino acids 45-54.115, 116 Exportin-1 interacts with the cargo NES by a hydrophobic
groove and removes the cargo by means of a RanGTP:RanGDP gradient as RanGTP is
100 times more abundant in the nucleus than the cytoplasm. The RanGTP increases the
binding of exportin-1 to interact with its cargo 500 to 1,000 fold.117 The exportin complex
is made up of exportin-1:RanGTP:cargo in the nucleus where it exits the nuclear pore
channel and interacts with RanGAP to promote hydrolysis of RanGTP to RanGDP thus
allowing the complex to dissociate in the cytoplasm.

NF-κB function during pathogen invasion
NF-κB plays a heavy role during pathogen infiltration in a human host. It promotes antiapoptotic control, pro-inflammation, and recruitment of lymphocytes. Following activation,
NF-κB transcribes cellular FLICE (FADD-like IL-1β-converting enzyme)-inhibitory protein
(c-FLIP) which then binds to FADD (Fas-associated DD protein), caspase-8 and/or
caspase-10, and TNF-related apoptosis-inducing ligand (TRAIL) 5 (DR5) which overall
creates an apoptosis inhibitory complex. Active caspase-8 and -10 are responsible for
cleaving pro-apoptotic protein Bid to tBid which is induces cytochrome c release from the
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mitochondria.118 Thus inhibiting these two caspases’ function, cytochrome c remains
intact.

From the proinflammatory standpoint, NF-κB induces the expression of proinflammatory
cytokines such as TNF-α, IL-1, and IFN-γ. These cytokines can induce fever, tissue
destruction, swelling, artery dilation, and increased capillary permeability. 119 Increasing
the vascular diameter and permeability allows for lymphocytes to become quickly
recruited to the site of infection. NF-κB upregulates IL-8 which is vital for recruiting and
activating neutrophils as these cells are the first responders during pathogen-host
entry.120 Expression of NF-κB dependent adhesion molecules such as endothelialleukocyte adhesion molecule-1 (ELAM-1), vascular cell adhesion molecule-1 (VCAM-1),
and intracellular adhesion molecule-1 (ICAM-1) allow for the ability of lymphocytes to
target breached area where the leukocyte integrins will interact with their respective
adhesion molecule which promotes the leukocyte’s transmigration into tissues.121

1.7 Ankyrin repeat-containing proteins
An ankyrin repeat-containing protein (Ank) is defined as a protein that possesses two or
more ankyrin repeats motifs. Each of these motifs is approximately 30-34 amino acids
that begin with a β-turn that is prior to two antiparallel α-helices and terminates with a loop
that feeds into the next ankyrin repeat, commonly called α-helix-β-turn-α-helix domain, in
which its sole function is to mediate protein-protein interactions.59, 122 The β-turn region of
this motif is the region that performs the direct contact with its protein interacting partner. 63
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Next to immunoglobulins, repeat proteins (Ank, leucine-rich repeat, and armadillo repeat
proteins) are the second most prevalent protein family that perform protein-protein
functions.123, 124 Anks are confirmed to perform a myriad of functions such as transcription
regulation, cytoskeletal organization, modulation of cell cycle progression, and cell
differentiation. IκBα is a prime example of an Ank that modulates transcription regulation
of NF-κB.

The tertiary structure of Anks and their ability to bind to their unique interacting partner is
dependent on five main elements. The first is the number of ankyrin repeat motifs the
protein contains. Functional Anks have been documented to contain as few as two but as
many as twenty-nine ankyrin repeats.122 Second is the presence of non-ankyrin repeat
domains that facilitate spacing between individual ankyrin motifs. An example of this is
the yeast ribosomal binding protein Yar-1. While it has three and a half ankyrin repeats it
also encodes a calmodulin-binding domain at its C-terminal region.125 Third is the
positioning of the motifs in the protein. Ankyrin motifs positioned directly at the end of the
protein, C- or N- terminal, allows the Ank to be more solvent assessable as they better
shield the hydrophobic core of the Ank compared to Anks that possess the ankyrin motif
within the protein itself. Fourth is the variance of the β-loops themselves. Although Anks
traditionally have the α-helix-β-loop-α helix motif, in certain proteins these β-loops are
extremely long and can exhibit more convoluted formations than a β-sheet.122 The Swi6
yeast Ank possesses an approximate 40 amino acid region between its two α-helices as
opposed to the traditional four to six amino acids.126, 127 IκBα has a similar situation in
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which it forms an additional helical region within the loop of an ankyrin repeat (Figure
6).128, 129

Anks were previously thought to be only associated with eukaryotic organisms after its
discovery in yeast and mammals but recent evidence has shown that prokaryotes encode
genes for Ank expression just as much. A recent study performed in silico analyses with
1,912 bacterial strains (992 species) that encompassed bacteria of different lifestyles,
including free living, facultative host-associated, and obligate intracellular, revealed that
51% of the bacterial strains encoded at least one Ank. Out of the three bacterial lifestyles,
obligate intracellulars have the highest fraction of proteomes containing Anks. Bearing in
mind both the abundance of proteins with Ank repeats and the small genome in obligate
intracellulars, obligate intracellular bacteria have a remarkably high composition of Anks
that is comparable to that of eukaryotes.59

Ank effectors in pathogens
Bacterial species in the order Rickettsiales are notorious for their ability to secrete Ank
effectors by a type 1 secretion system (T1SS) or a type 4 secretion system (T4SS).
Anaplasma phagocytophilum secretes AnkA by a T4SS, which then traffics predominantly
to the host nucleus where it modulates host cell transcription by binding to AT-rich DNA
regions and recruiting histone deacetylase 1 to silence gene expression. This Ank is
confirmed to halt transcription of antimicrobial defense genes such as the CYBB
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Figure 6. Examples of ankyrin repeat-containing proteins in nature. The red arrow
denotes the non-canonical β-loop region of ankyrin repeats in Swi6 and IκBα Anks (f and
g). Modified from: Li, J., Mahajan, A. & Tsai, M.D. Ankyrin repeat: a unique motif mediating
protein-protein interactions. Biochemistry 45, 15168-78 (2006).
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component of the NADPH oxidase defense mechanism.130 Ehrlichia chaffeensis secretes
Ank200 (p200) by the T1SS where it too localizes to the host nucleus to interact with AluSx promoter elements. It was confirmed that this effector’s primary target promoters were
those involved in nuclear structural proteins, ATPase activity, and regulation of
transcription, and apoptosis. Delaying apoptosis in the host cell promotes survival of this
pathogen’s niche in the host. A facultative intracellular pathogen known as Legionella
pneumophila secretes LegAU13 (Ankyrin B) by a Dot/Icm T4SS where it is thoroughly
incorporated into the Legionella containing vacuole. LegAU13 possesses an F-box
domain which is used to recruit the SCF ubiquitin ligase complex where it can
polyubiquitinate host proteins resulting in their proteasomal degradation thus supplying
the bacteria with an ample amount of amino acids for growth. A previous member of the
order Rickettsiales, C. burnetii, secretes AnkG by the T4SS to interact with host p32 and
importin-α1 to allow AnkG’s translocation into the nucleus. Once in the nucleus, this
effector, by an unknown mechanism, inhibits cellular apoptosis thus promoting survival of
the pathogen by allowing it to continue to reside in its host cell niche.131

Viral Anks are for the most part, but not exclusively, limited to poxviruses.59 Poxviral Anks
range from 400 to 800 amino acids in length and frequently possess a PRANC (Pox
protein Repeats of ANkyrin C-terminal) domain, which has high sequence homology to
the F-box domain.132, 133 Numerous species of Poxviridae Anks have been confirmed to
interact with the SCF complex to promote polyubiquitination of an array of host
proteins.134-137 These Anks are essential to these viruses in that majority of them alter or
inhibit NF-κB innate immune response by mimicking the IκBα protein. Some of these
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effectors are the CP77 (cowpox virus), K1 (vaccinia virus), MNF (myxoma virus), and
A238L (African swine fever virus).138-141 The necessity of these NF-κB inhibitory Anks can
be observed that when knocking out the MNF Ank in myxoma virus, it transforms this
virus from lethal to non-pathogenic.140 To date, there are no bacterial Anks that inhibit
NF-κB function in a host.

Similar to these listed pathogen Anks, O. tsutsugamushi too encodes Anks that interact
with the SCF1 ubiquitin ligase complex via PRANC domains. 60, 61 In the Boryong strain,
six Anks have been confirmed to interact with SCF components as well as elongation
factor 1 α (EF1α) in which one, Ank1U5, decreases the host cell EF1α protein levels. It is
hypothesized that Ank1U5 polyubiquitinates EF1α to be degraded by the 26S
proteasome. The reason for the degradation is not understood yet as EF1α constitutes
approximately 1-2% of the human cell’s total proteins and is utilized for a wide array of
functions such as protein nuclear export, cytoskeleton regulation, apoptosis regulation,
and protein translation.61 The O. tsutsugamushi Ikeda strain encodes 29 Anks that have
a PRANC domain making it one of the largest repertoires among bacteria. When
subtracting the paralogs from the 29 Anks it results in a total of 16 out of 20 unique Anks
that are confirmed to interact with Skp1, a component of the SCF complex. Removing the
PRANC domain from an Ank results in abrogation of Skp1 interaction. Unlike the Boryong
strain, none of these Anks were seen to promote degradation of the EF1α host protein,
suggesting that although these two strains are of the same species they may utilize their
Anks for different purposes.60 Ikeda strain Ank9 has a sophisticated mechanism in which
it uses a Golgi localization signal to traffic to this respective organelle where it interacts
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with a COPI subunit known as COPB2. COPI is method of intracellular retrograde
trafficking from the Golgi to the endoplasmic reticulum (ER). Once in the ER, it facilitates
an unfolded protein response (UPR) causing significant ER stress which was linked to
abrogate host cell protein secretion.142 During mammalian cell infection, O.
tsutsugamushi transcribes mRNA for all 20 unique Anks confirmed by Dr. Lauren
VieBrock of the Carlyon laboratory.143

1.8 Bacterial secretion systems: T1SS and T4SS
T1SS background
To date, bacteria have been documented to encode nine different secretion systems to
facilitate transport of macromolecules from the bacterial cell to its extracellular
environment. Individual bacterial species do not encode all nine and will depend on a
limited amount of secretion systems to perform their necessary secretion functions. For
example, only heavy lapidated bacteria such as Mycobacterium and Corynebacterium
spp. encode a Type 7 secretion system.144, 145 One that is well understood and commonly
reported in Gram negative bacteria is the T1SS. This system is similar to a large family
of ATP-binding cassette (ABC) transporters, which are utilized for pumping out small
molecules such as antibiotics and toxins out of a bacterial cell.146 The T1SS is known for
its function in secretion of digestive enzymes (lipases and proteases), adhesins, and
pathogenic toxins/effectors.147 How this system works is only dependent on three
proteins: an ABC transporter protein, a membrane fusion protein (MFP), and an outer
membrane protein (OMP).148 T1SS substrates possess a non-cleavable C-terminal
secretion signal that is recognized by both the ABC transporter and possibly N-terminal
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region of the MFP.149, 150 A hallmark example is the pathogenic Escherichia coli HlyB,
HlyD, TolC T1SS secretion system and its function in secreting the erythrocyte lysing
enzyme, hemolysin A (HlyA). E. coli encodes an operon known as the HlyCABD operon
which encodes two thirds of the T1SS itself. HlyB acts as the inner membrane ABC
transporter and HlyD as the periplasmic MFP. HlyC functions as an acyl-transferase to
perform acylation of HlyA at lysine-540 and lysine-648, which is essential for HlyA function
but not its secretion.148, 151 The TolC OMP gene is located on another region of the E. coli
chromosome, as this protein is used for multiple purposes aside from the T1SS. 152 HlyA
depends on its C-terminal secretion signal, which is located in the last 48 to 60 amino
acids and is recognized by HlyB.153-155 The classical secretion signal for the T1SS is
described to be a C-terminus (approximately 50-60 amino acids) rich in the amino acids
LDAVTSIF, having an acidic pI, and low in KHPMWC amino acids.156 As the secretion
signal docks with HlyB, it recruits HlyD and TolC, which then allows HlyB to hydrolyze
ATP as an energy source to push the unfolded substrate through HlyD and TolC in onestep (Figure 7).157

Two members of the order Rickettsiales have confirmed T1SS dependent Ank
secretion.62,

156

It is extremely challenging to generate obligate intracellular knock-out

mutants alongside keeping the bacterial viable when a complete secretion system is
removed, which is most likely necessary for bacterial survival. To complement this,
heterologous systems that use T1SSs are used. In the case of the Rickettsia typhi,
Rickettsia ankyrin repeat protein 1 (RARP-1) was documented to be TolC dependent for
secretion in an E. coli heterologous T1SS assay. Strikingly, abrogation of RARP-1
39

Figure 7. General T1SS model and mechanism for T1SS substrate secretion. The
T1SS is composed of the three proteins ABC protein, MFP, and the OMP. The substrate
C-terminal secretion signal (Cter) is recognized by the ABC inner-membrane protein
which then recruits the MFP. The MFP acts as a medium to connect the ABC protein to
the OMP where then ATP is hydrolyzed by the ABC protein providing energy to pass the
T1SS substrate to the extracellular environment. Modified from: Delepelaire, P. Type I
secretion in gram-negative bacteria. Biochimica et biophysica acta 1694, 149-61 (2004)
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secretion occurred when deleting the N-terminal signal peptide region or the C-terminal
ankyrin repeats.62 Ank200 of E. chaffeensis secretion was also confirmed using an E. coli
heterologous T1SS assay. The secretion of Ank200 in E. coli was reduced when TolC
expression was absent. Alongside testing the TolC dependence, this was also confirmed
by HlyBD dependence in which an Ank200 mutant that only expressed the last 112 amino
acids was secreted only when HlyBD membrane proteins were present. This confirmed
that Ank200 possesses a T1SS signal in its C-terminus and uses the T1SS apparatus to
escape the bacterial cell.158 O. tsutsugamushi encodes T1SS genes annotated alkaline
protease secretion ATP-binding protein (AprD; ABC protein), alkaline protease secretion
protein (AprE; MFP), and TolC. These three genes have been confirmed to be expressed
during O. tsutsugamushi infection of mammalians cells by Dr. Lauren VieBrock of the
Carlyon laboratory (Figure 8A).143

T4SS background
The mechanism and the assembly of the T4SS is more convoluted and sophisticated than
that of the T1SS. This secretion system can be used for two main purposes. The first is
the conjugation system which mediates interbacterial transfer of genetic elements
(plasmids and chromosomal DNA). The second is the secretion of virulence protein
effectors.159 This system is present in nearly all bacterial and archael species. 160-165 This
secretion of DNA or effectors is dependent upon cell-to-cell contact by means of a
bacterial pilus.166 One of the best characterized T4SS to date is the VirB/VirD4 system of
the plant pathogen Agrobacterium tumefaciens. The species forms its secretion
apparatus by assembling the VirB1-11 and VirD4 subunits that form a channel from the
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A.

B.

Figure 8. O. tsutsugamushi transcriptionally expresses T1SS and T4SS
components during infection of mammalian host cells. RT-PCR using primers
targeting genes encoding (A) T1SS components and (B) T4SS components. O.
tsutsugamushi genomic DNA and water served as positive (+) and negative (-) controls,
respectively. Results are representative of two experiments with similar results. Modified
from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin repeat-containing
protein family members are Type 1 secretion system substrates that traffic to the host cell
endoplasmic reticulum. Front Cell Infect Microbiol, 2014.
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inner membrane to the outer membrane thus making secreted effectors bypass the
periplasm (Figure 9).167 Gram negative bacteria encode four functional units to allow the
entire T4SS apparatus to function. The first is a Type 4 coupling protein (T4CP, (VirD4))
which forms a hexameric structure that recognizes the secreted substrate and hydrolyzes
ATP as an energy source for secretion.168-170 The second unit is an inner membrane
complex (VirB3, -4, -6, -8 and -11 units) which is responsible for substrate transfer through
the inner membrane where VirB4 and VirB11 also perform ATPase function.159 The third
unit is the outer membrane core complex (VirB7, -9, and -10) which allows the substrate
to travel from the inner membrane, bypass the periplasm, to the outer membrane
directly.167, 171 The last conserved unit is the conjugative pilus, the organelle responsible
for creating contact with target cells. This organelle is highly composed of the pilin subunit
VirB2 and the pilus-tip adhesin VirB5.172, 173 T4SS substrates are recognized by the T4CP
by a hydrophobic or positively charged secretion signal in the substrate itself. Most often
the secreted effectors depend on chaperone adaptor proteins to be shuttled to the
T4CP.159

It has been confirmed that O. tsutsugamushi encodes and expresses 15 vir T4SS genes
(1 virB3, 2 virB4, 5 virB6, 2 virB8, 2 virB9, 1 virB10, 1 virB11, and 1 virD4). Interestingly,
the O. tsutsugamushi genome does not encode orthologues of A. tumefaciens virB2 or
virB5, the genes required for pilus assembly. The hypothesis behind this reason is that
due to its obligate intracellular, freely-cytoplasmic lifestyle, it does not require a pilus to
secrete its effectors and simply relies on only the inner membrane and core

43

Figure 9. T4SS model. The T4SS is composed of 11 different VirB proteins derived from
the virB operon and inner membrane VirD4 subunits. Modified from: Gillespie, J.J. et al.
Phylogenomics reveals a diverse Rickettsiales type IV secretion system. Infect Immun
78, 1809-23 (2010).
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components.53, 174 The expression of these effectors has been confirmed by Dr. Lauren
VieBrock of the Carlyon laboratory (Figure 8B).143

1.9 Research objective
Regardless of the risk of scrub typhus to approximately one billion people, there is still no
vaccine, reports of antibiotic resistance, concerns of diagnostic accuracy, and little known
regarding O. tsutsugamushi pathogenesis. One arm of pathogenicity that we chose to
address is how this pathogen averts its destruction by the host innate immune response.
It begs the question how host cells that are programmed to eliminate pathogens
(macrophages and dendritic cells) are destined to be the establishment of O.
tsutsugamushi survival and replication during infection. As we have recently confirmed
that O. tsutsugamushi transcriptionally expresses all unique Anks during infection, our
first objective was to address whether these Anks are in fact able to be secreted from the
bacterium into the host cell cytoplasm to perform their effector functions. As O.
tsutsugamushi encodes a T1SS and a T4SS and the previous documentations of Ank
secretion in obligate intracellulars, we chose to study these two systems for Ank
secretion. Our second goal was to determine if any of these Anks are capable of inhibiting
a cornerstone of the innate immune response: the p50:p65 NF-κB pathway. We have
confirmed that of these Anks, Ank1 and Ank6 are able to inhibit NF-κB nuclear
accumulation even in the presence of an NF-κB activating cytokine. It is confirmed here
that Ank1 and Ank6 are parallel in their function as we have confirmed that both Anks
interact with three host proteins: the nuclear traffic directing protein importin-β1, p65 NFκB subunit, and exportin-1. Our final goal was to understand the phenotype of NF-κB
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during O. tsutsugamushi infection by its observing its subcellular locale and its ability to
function as a transcription factor. These data will elucidate the mechanism to which O.
tsutsugamushi undergoes to avoid its elimination by the human innate immune response
and thus promote its survival.
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Chapter 2

Materials and Methods
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Cultivation of uninfected and O. tsutsugamushi infected host cells
HeLa human cervical epithelial cells (CCL-2; ATCC) were maintained in Roswell Park
Memorial Institute (RPMI)-1640 (Gibco, Grand Island, NY) medium supplemented with
10% FBS at 37°C in a humidified incubator with 5% CO2. HeLa cells stably transfected to
contain four NF-κB promoters upstream of the Firefly Luciferase gene (HeLa NF-κB
luciferase cells) were purchased from Signosis (Santa Clara, CA) and maintained in
Dulbecco’s modified Eagle’s medium (DMEM) with L-Glutamine, 4.5 g/l D-Glucose and
100 mg/l sodium pyruvate (Thermo Fisher Scientific, Waltham, MA) supplemented with
10% fetal bovine serum (FBS; Gemini Bio-Products, Sacramento, CA, USA). L929 cells
were cultured in Earle’s balanced salts with L-glutamine minimum essential medium
(EMEM; Quality Biological, Gaithersburg, MD) with 2.5% FBS to create L929 conditioned
media. Bone marrow-derived macrophages (BMDMs) were generated by cultivating bone
marrow cells obtained from the femurs of 6-8-week old C57BL/6 mice in DMEM
containing 30% L929 conditioned media, 3.3% FBS, and 1x Anti-Anti (Life Technologies,
Grand Island, NY) (BMDM differentiating medium) at 37°C in 5% CO2 for 6 days. The
BMDM differentiating medium was changed every 3 days. Macrophage differentiation
was confirmed by direct immunofluorescent microscopy using FITC conjugated CD11b
antibody (Biolegend, San Diego, CA). O. tsutsugamushi str. Ikeda was originally isolated
from a patient in Japan.175 To maintain O. tsutsugamushi, HeLa cells were infected and
passaged every 3-4 days. Infected cells were incubated in DMEM supplemented in 1%
FBS and 1x Anti-Anti at 35°C in 5% CO2. To obtain O. tsutsugamushi for experimental
use, infected HeLa cells were mechanically disrupted using glass beads followed by
differential centrifugation at 200 x g for 4 min to remove intact cells and cellular debris.
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The resulting supernatant was centrifuged at 2,000 x g for 10 min to obtain O.
tsutsugamushi organisms for use in infection studies.

C. burnetii cultivation and infection
A modified form of Acidified Citrate Cysteine Medium (ACCM) called ACCM-2, in which
1% FBS is replaced with 1 mg/ml methyl-β-cyclodextrin (Mβ-CD), was developed. C.
burnetii was cultivated in T-75 cell culture flasks or 0.2-μm-pore-size-filter-capped 125-ml
Erlenmeyer flasks containing 20 ml of medium, T-25 flasks containing 5 ml of medium, or
6-well tissue culture plates containing 3 ml of medium per well. Cultures were incubated
at 37°C in a 2.5% O2 and 5% CO2 environment using a CO-170 incubator (New
Brunswick Scientific, NJ). Oxygen was displaced by nitrogen gas. Where indicated,
Erlenmeyer flasks were shaken at 75 rpm. C. burnetii replication was measured by optical
density at 600 nm (OD600) or quantitative PCR (Q-PCR) of genome equivalents using
a dotA probe.

C. burnetii colonies were established using a modified soft agarose overlay method in
which bacteria are grown in the top medium layer. A 0.25% ACCM-2 agarose base in
100- by 20-mm petri dishes was created by mixing 10 ml of filter-sterilized 2× ACCM-2
with 10 ml of 0.5% (wt/vol in water) melted UltraPure agarose (Invitrogen). The bacterial
inoculum was mixed with 2.5 ml of 0.1% melted ACCM-2 agarose equilibrated to 37°C,
which was prepared by mixing together 1.25 ml of 2× ACCM-2, 0.75 ml of water, and 0.5
ml of 0.5% melted agarose. This solution was poured on top of the solidified ACCM-2
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agarose base. Plates were refrigerated (4°C) for 30 min to aid solidification of the top
agarose and then placed in a laminar airflow biosafety cabinet with lids ajar for 20 min to
remove condensation. Plates were incubated for 6 days as described above for ACCM-2
to allow colony development.176 THP-1 human monocytic leukemia cells (TIB-202; ATCC)
were maintained in RPMI-1640 medium containing 10% FBS at 37° C and 5% CO2. THP1 monocytes were differentiated into macrophage-like cells by overnight treatment with
200 nM phorbol-12-myristate-13-acetate (PMA) followed by two washes with phosphatebuffered saline (PBS; 1.05 mM KH2PO4, 155 mM NaCl, 2.96 mM Na2HPO4, pH 7.2) prior
to infection. These procedures were kindly performed by Charles L. Larson of the Robert
A. Heinzen laboratory (University of Wyoming).

In silico analyses of O. tsutsugamushi Anks
The O. tsutsugamushi Ank sequences were searched against the non-redundant protein
sequences database using Protein BLAST (Basic Local Alignment Search Tool)
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). The SMART (Simple Modular Architecture
Research Tool) algorithm (http://smart.embl-heidelberg.de/) was used to identify the
amino acids of each individual ankyrin repeat within each Ank. Analysis of the C-terminal
60 amino acids of each Ank was performed manually to determine the percentage of
amino acids characteristic of a T1SS signal sequence (LDAVTSIF) as well as those that
are commonly absent (KHPMWC). The pI of each protein and that of each C-terminus
was calculated using the protein calculator algorithm (http://protcalc.sourceforge.net/).
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Plasmids for Subcellular Localization Studies and T1SS Assays
pBMH constructs carrying O. tsutsugamushi ank genes that were codon optimized for
expression in mammalian cells were synthesized by Biomatik (Wilmington, DE; Table 3)
with an EcoRI restriction site and a single nucleotide that restored the reading frame
upstream of the gene and a SalI restriction site downstream of the gene. pBMH vectors
containing the ank genes and the recipient vectors, p3XFLAG-CMV-7.1 (Sigma-Aldrich,
St. Louis, MO) and pEGFP-C1 (donated by Dr. Marci Scidmore, Cornell University,
Ithaca, NY), were double-digested with 0.8 U each of SalI and EcoRI (New England
Biolabs, Ipswich, MA) for 2 h at 37°C in EcoRI buffer (New England Biolabs), and gelpurified using the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA). The restriction
fragments carrying each codon-optimized ank were ligated into the digested plasmids
with T4 DNA ligase (New England Biolabs) according to the manufacturer’s instructions.
Biomatik synthesized ank10_01 and ank14 as mammalian codon-optimized sequences
and cloned them into pEGFP-C1 to generate pEGFP-Ank10 and pEGFP-Ank14,
respectively.

To generate constructs for expressing N-terminal His-tagged chimeric HlyA proteins in
which the final 60 C-terminal amino acids of HlyA were replaced with the final 60 Cterminal amino acids of each O. tsutsugamushi Ank, we utilized the In-Fusion HD Cloning
Plus kit (Clontech, Mountain View, CA) following the manufacturer’s protocol to PCR
amplify and clone hlyA-ank fusion PCR products into the pET19-b vector (Novagen,
Madison, WI). Primers for this purpose were designed using Clontech’s online Primer
Design Tool for In-Fusion Cloning (www.clontech.com) (Table 4). Each mammalian
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Table 3. Plasmids for cloning and mammalian expression of O. tsutsugamushi
Anks

Gene

pBMH1

pEGFPC12

p3XFLAGCMV-73

ank1_02

pBMH-Ank1_02

pEGFP-Ank1_02

pFLAGAnk1_02

ank2

pBMH-Ank2

pEGFP-Ank2

pFLAG-Ank2

ank3_08

pBMH-Ank3_08

pEGFP-Ank3_08

pFLAGAnk3_08

ank4_01

pBMH-Ank4_01

pEGFP-Ank4_01

pFLAGAnk4_01

pEGFP-Ank4∆Fbox

pFLAGAnk4∆F-box

ank4∆Fbox
ank5_01

pBMH-Ank5_01

pEGFP-Ank5_01

pFLAGAnk5_01

ank6_02

pBMH-Ank6_02

pEGFP-Ank6_02

pFLAGAnk6_02

ank7_02

pBMH-Ank7_02

pEGFP-Ank7_02

pFLAGAnk7_02

ank8

pBMH-Ank8

pEGFP-Ank8

pFLAG-Ank8

ank9

pBMH-Ank9

pEGFP-Ank9

pFLAG-Ank9

ank10_01 pBMH-Ank10_01 pEGFPAnk10_01
ank11

pBMH-Ank11

pEGFP-Ank11

pFLAG-Ank11

ank12_01 pBMH-Ank12_01 pEGFPAnk12_01

pFLAGAnk12_01

ank13

pBMH-Ank13

pEGFP-Ank13

pFLAG-Ank13

ank14

pBMH-Ank14

pEGFP-Ank14

ank15

pBMH-Ank15

pEGFP-Ank15

pFLAG-Ank15

ank16

pBMH-Ank16

pEGFP-Ank16

pFLAG-Ank16
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p3XFLAGCMV-144

pAnk4_01FLAG

pAnk9-FLAG

ank17

pBMH-Ank17

pEGFP-Ank17

pFLAG-Ank17

ank18

pBMH-Ank18

pEGFP-Ank18

pFLAG-Ank18

ank19

pBMH-Ank19

pEGFP-Ank19

pFLAG-Ank19

ank20

pBMH-Ank20

pEGFP-Ank20

pFLAG-Ank20

pAnk17FLAG

1pBMH

constructs carried the ank genes that were codon-optimized for expression in
mammalian cells and served as templates for cloning the codon-optimized genes into
the other constructs used in this study with the exception of pEGFP-Ank10 and pEGFPAnk14.
2pEGFP

constructs were used to express the codon-optimized Anks N-terminally fused
to eGFP.
3p3xFLAG7

constructs were used to express the Anks with N-terminal triplicate FLAG

tags.
4p3xFLAG14

constructs were used to express the Anks with C-terminal triplicate FLAG

tags.
Modified from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin repeatcontaining protein family members are Type 1 secretion system substrates that traffic to
the host cell endoplasmic reticulum. Front Cell Infect Microbiol, 2014. 4: p. 186.
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Table 4. Oligonucleotides used for cloning HlyA and chimeric HlyA fusion coding
sequences into pET19b
Designation

Sequence (5’ to 3’)1

pET19b-hlyA-4F

ACGACGACAAGCATATGCCAACAATAACCACTGCACAAA

pET19b-hlyA3075R

GGATCCTCGAGCATATGTTATGCTGATGCTGTCAAAGTTATT

pET19b-hlyA2892R

GGATCCTCGAGCATATGTTATGCATCATTCCCATACACA
TAA CTT

hlyA-1731F

TAAATGGACGGTGAAGGGGGT

hlyA-2892-ank1822R

GGCATCCTGGTTGCT4TGCATCATTCCCATACACATAACTT

ank1-808F

AGCAACCAGGATGCCAAC

pET19b-ank1990R

GGATCCTCGAGCATATGTTACTCTTCCTCGTAGATGGCG

hlyA-2892R-ank2867R

GCTTTCGAAGATCTCTGCATCATTCCCATACACATAACTT

ank2-853F

GAGATCTTCGAAAGCAACCAC

pET19b-ank21035R

GGATCCTCGAGCATATGTTACTCGCCCTCGTACAG

hlyA-2892R-ank3540R

GATGTCGGCGCCATATGCATCATTCCCATACACATAACTT

ank3-526F

TATGGCGCCGACATCGAC

pET19b-ank3702R

GGATCCTCGAGCATATGTTAACAGGAGGAGAACAGCTG

hlyA-2892-ank41011R

CGGCTTCAGGATCTGTGCATCATTCCCATACACATAACTT

ank4-997F

CAGATCCTGAAGCCGGAC

pET19b-ank41179R

GGATCCTCGAGCATATGTTAAGAGTTGGTGTTTTCACCTTT
C

hlyA-2892-ank5870R

CGCGTCTTGGTTAGATGCATCATTCCCATACACATAACTT

ank5-856F

TCTAACCAAGACGCGAACC
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pET19b-ank52892R

GGATCCTCGAGCATATGTTACTCGCCCTCGTAGATAGC

hlyA-2892-ank6846R

TTGGGACTTCTGGCTTGCATCATTCCCATACACATAACTT

ank6-832F

AGCCAGAAGTCCCAAACC

pET19b-ank61108R

GGATCCTCGAGCATATGTTACTCCTCTTCGTATATTGCGTG

hlyA-2892-ank71089R

GATCTCGTCCTGGGTTGCATCATTCCCATACACATAACTT

ank7-1075F

ACCCAGGACGAGATCGC

pET19b-ank71233R

GGATCCTCGAGCATATGTTAGTTGTTTGTGTAATTTTGGGC
C

hlyA-2892-ank81002R

GATGCTCTCGACGGCTGCATCATTCCCATACACATAACTT

ank8-988F

GCCGTCGAGAGCATCGAC

pET19b-ank81170R

GGATCCTCGAGCATATGTTAGCTTTCTTTGTGCATGACG

hlyA-2892-ank91101R

GACGGTCTCGGCCAGTGCATCATTCCCATACACATAACTT

ank9-1087F

CTGGCCGAGACCGTCACA

pET19b-ank91269R

GGATCCTCGAGCATATGTTAGTCGCAGATGGCGTAGCC

hlyA-2892-ank10
1488R

GCTCTTGTGGCTCTCTGCATCATTCCCATACACATAACTT

ank10-1474F

GAGAGCCACAAGAGCATTA

pET19b-ank10
1656R

GGATCCTCGAGCATATGTTAGGTCTCAATGTTCACCACC

hlyA-2892-ank11522R

CATCCTGCAGATGCATGCATCATTCCCATACACATAACTT

ank11-508F

TGCATCTGCAGGATGGCC

pET19b-ank11690R

GGATCCTCGAGCATATGTTACAGGCCGATGTTCTTTC
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hlyA-2892-ank12
1320R

TGGTTGTTCCTTGCATGCATCATTCCCATACACATAACTT

ank12-1306F

TGCAAGGAACAACCAAAGG

pET19b-ank12
1488R

GGATCCTCGAGCATATGTTAGATGCACCTGTGGCC

hlyA-2892-ank131308R

GTCGTCGATAGATTTTGCATCATTCCCATACACATAACTT

ank13-1294F

AAATCTATCGACGACGTGTGC

pET19b-ank13
1476R

GGATCCTCGAGCATATGTTAGATGCCGAGACTTGAAG

hlyA-2892-ank141089R

CTCGTTAATGTTGGTTGCATCATTCCCATACACATAACTT

ank14-1075F

ACCAACATTAACGAGCAAGC

pET19b-ank141257R

GGATCCTCGAGCATATGTTAGTTCTCCCCCATGGC

hlyA-2892-ank15762R

AATGTTGTCCTTCTCTGCATCATTCCCATACACATAACTT

ank15-748F

GAGAAGGACAACATTCAGCCAC

pET19b-ank15930R

GGATCCTCGAGCATATGTTACTCATTATTGGTGGTGTTTTG
GC

hlyA-2892-ank16633R

CTCGCTGTCGGGCTTTGCATCATTCCCATACACATAACTT

ank16-619F

AAGCCCGACAGCGAGAAG

pET19b-ank16
801R

GGATCCTCGAGCATATGTTAGATCATGCCGTGGATGC

hlyA--2892-ank17561R

CAGTTTGGATTCCTTTGCATCATTCCCATACACATAACTT

ank17-547F

AAGGAATCCAAACTGTTCGG

pET19b-ank17729R

GGATCCTCGAGCATATGTTAGGCGTTGTTGTCGTCG

hlyA-2892-ank1851R

GTAGGCCTTGTACAGTGCATCATTCCCATACACATAACTT
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ank18-37F

CTGTACAAGGCCTACTTCAGC

pET19b-ank18219R

GGATCCTCGAGCATATGTTAGATGATGTTGCAGCCGGTG

hlyA-2892-ank19327R

CATGTCCGCGCCGTGTGCATCATTCCCATACACATAACTT

ank19-313F

CACGGCGCGGACATGAAC

pET19b-ank19
495R

GGATCCTCGAGCATATGTTAACACTTCACGTTGGCG

hlyA-2892-ank201362R

CGGCAGATACTGGAATGCATCATTCCCATACACATAACTT

ank20-1348F

TTCCAGTATCTGCCGAACG

pET19b-ank201530R

GGATCCTCGAGCATATGTTACACGCTGCTCTCGTTT

hlyA-2892-ompA447R

AGCCCTCTTTTTCCCTGCATCATTCCCATACACAT

ompA-433F

GGGAAAAAGAGGGCTGATG

pET19b-ompA615R

GGATCCTCGAGCATATGTTATGCTATATTACTTTTAATAATT

hlyA-2892-lktA2664R

GATTTTACCGTTACCTGCATCATTCCCATACACATAACTT

lktA-2650F

GGTAACGGTAAAATCACCCAGG

pET19b-lktA2862R

GGATCCTCGAGCATATGTTACGCCGCACGCGCGAA

1Underlined

nucleotides correspond to pET19b vector sequence; unformatted text
corresponds to hlyA sequence; double underlined nucleotides correspond to an added
stop codon; bold nucleotides correspond to ank gene coding sequence.
Modified from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin repeatcontaining protein family members are Type 1 secretion system substrates that traffic to
the host cell endoplasmic reticulum. Front Cell Infect Microbiol, 2014. 4: p. 186.
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codon-optimized ank was PCR amplified from its respective pBMH construct (Table 3)
using an ank gene-specific forward primer and a reverse primer that targeted the 3’ end
of its respective ank and had an additional 17-nucleotide sequence at its 5’ end that was
complementary to the insertion site of the pET19-b vector. E. coli strain A0 34/86 was
kindly provided by Peter Sebo (Institute of Microbiology, Institute of Biotechnology,
Academy of Sciences of the Czech Republic, Prague, Czech Republic). The hlyA gene
minus its final 180 nucleotides and stop codon was PCR amplified from DNA that had
been isolated from a boiled colony of E. coli strain A0 34/86 using hlyA-specific forward
and reverse primers that targeted nucleotides 4 to 2892 of hlyA and had an additional 15nucleotides at its 5’ end that were complementary to the first 15 nucleotides of the coding
sequence for each Ank’s putative Type 1 secretion signal (Table 4). PCR reactions were
performed using CloneAmp HiFi PCR Premix (Clontech) and the following thermal cycling
conditions: 98ºC for 2 min; followed by 35 cycles of 98ºC for 10 s, 55ºC for 15 s, and 72ºC
for 60 s. PCR products were resolved by gel electrophoresis, excised, purified using the
QIAquick Gel Extraction Kit (Qiagen), eluted, and assayed spectrophotometrically for
DNA concentration. The pET19-b vector was digested with 0.4 U of NdeI at 37ºC for 1 h
and purified using the PCR Extract Mini Kit (5 Prime). The InFusion cloning reaction was
performed according to the manufacturer’s protocol and the resulting recombinant
constructs were transformed into Stellar E. coli cells (Clontech). The transformants were
plated on Luria-Bertani (LB) agar plates containing 100 μg/ml ampicillin and incubated at
37º C overnight. Colonies were screened via colony PCR using the hlyA-1731F forward
primer (Table 4) and T7 terminator reverse primer (Integrated DNA Technologies,
Coralville, IA), MyTaq Red polymerase and buffer (Bioline, Taunton, MA), and thermal
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cycling conditions described above. All constructs described in this section were isolated
using the PerfectPrep Spin Mini Kit (5 Prime, Gaithersburg, MD) and sequenced to verify
insert integrity (Genewiz, South Plainfield, NJ). The resulting plasmids that encode each
HlyA-Ank chimeric protein consisting of HlyA lacking its final C-terminal 60 amino acids
fused to the final 60 amino acids of each respective O. tsutsugamushi Ank are listed in
Table 5.

To generate pFLAG-p65, cDNA was generated from HL-60 cells as previously described
(Troese et al., 2011). Human p65 was PCR amplified from the cDNA template using
CloneAmp HiFi PCR Premix (Clontech, Mountain View, CA) and p65-targeting primers
5’-ATAGATCTGATATCGGTACCAATGGACGAACTGTTCCCC-3’
AGTCAGCCCGGGATCCGGAGCTGATCTGACTCAGCAG-3’

and

(boldface

5’indicates

nucleotides that are complementary to the sequences in the p3XFLAG-CMV-7.1; KpnI
and BamHI restriction sites are underlined) as described previously. The amplicon was
ligated into p3XFLAG-CMV-7.1 plasmid that had been digested with KpnI and BamHI by
InFusion (Clontech) cloning. Plasmid encoding FLAG-tagged IκBα super repressor
(pFLAG-IκBα SR), which contains the human IκBα gene having alanine substitutions at
serine 32 and serine 36 to prevent its phosphorylation and thus its degradation (Brockman
et al., 1995), was a kind gift from Dean W. Ballard (Vanderbilt University, Nashville, TN).
pFLAG-BAP, which encodes FLAG-tagged BAP was purchased from Sigma-Aldrich.
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Table 5. Plasmids used for T1SS analyses
Gene
E. coli hlyA
E. coli hlyA
nucleotides 1-2892
E. coli hlyBD

Plasmid
pHlyA
pHlyA∆96510241
pLG5752

hlyA-lktA

pHlyA-LktA3

hlyA-ank1_02

pHlyAAnk1_024
pHlyA-Ank2
pHlyA-Ank3_08
pHlyA-Ank4_01
pHlyA-Ank5_01
pHlyA-Ank6_02

hlyA-ank2
hlyA-ank3_08
hlyA-ank4_01
hlyA-ank5_01
hlyA-ank6_02

Purpose
T1SS positive control substrate
T1SS negative control substrate
Used to reconstitute the fully functional
T1SS in E. coli BL21 (DE3)
T1SS chimeric substrate positive
control
Evaluate Ank1_02 C-terminus for T1SS

Evaluate Ank2 C-terminus for T1SS
Evaluate Ank3_08 C-terminus for T1SS
Evaluate Ank4_01 C-terminus for T1SS
Evaluate Ank5_01 C-terminus for T1SS
Evaluate Ank6_02 C-terminus for
T1SS
hlyA-ank7_02
pHlyA-Ank7_02 Evaluate Ank7_02 C-terminus for T1SS
hlyA-ank8
pHlyA-Ank8
Evaluate Ank8 C-terminus for T1SS
hlyA-ank9
pHlyA-Ank9
Evaluate Ank9 C-terminus for T1SS
hlyA-ank10_01
pHlyAEvaluate Ank10_01 C-terminus for
Ank10_01
T1SS
hlyA-ank11
pHlyA-Ank11
Evaluate Ank11 C-terminus for T1SS
hlyA-ank12_01
pHlyAEvaluate Ank12_01 C-terminus for
Ank12_01
T1SS
hlyA-ank13
pHlyA-Ank13
Evaluate Ank13 C-terminus for T1SS
hlyA-ank14
pHlyA-Ank14
Evaluate Ank14 C-terminus for T1SS
hlyA-ank15
pHlyA-Ank15
Evaluate Ank15 C-terminus for T1SS
hlyA-ank16
pHlyA-Ank16
Evaluate Ank16 C-terminus for T1SS
hlyA-ank17
pHlyA-Ank17
Evaluate Ank17 C-terminus for T1SS
hlyA-ank18
pHlyA-Ank18
Evaluate Ank18 C-terminus for T1SS
hlyA-ank19
pHlyA-Ank19
Evaluate Ank19 C-terminus for T1SS
hlyA-ank20
pHlyA-Ank20
Evaluate Ank20 C-terminus for T1SS
hlyA-ompA
pHlyA-OmpA
Evaluate OmpA C-terminus for T1SS
1HlyA∆965-1024 lacks its final C-terminal 60 amino acids that contain the type 1
secretion signal.
2Described in Mackman et al., 1985.
3HlyA-LktA is a chimeric protein consisting of HlyA lacking its final C-terminal 60 amino
acids fused to the final 70 amino acids of Mannheimia haemolytica leukotoxin A (LktA),
which contains the LktA type 1 secretion signal.
4Each HlyA-Ank or HlyA-OmpA protein is a chimeric protein consisting of HlyA∆965-1024
fused to the final 60 amino acids of each O. tsutsugamushi Ank or OmpA, respectively.
Modified from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin repeatcontaining protein family members are Type 1 secretion system substrates that traffic to
the host cell endoplasmic reticulum. Front Cell Infect Microbiol, 2014. 4: p. 186.
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CyaA translocation assay
Mammalian codon-optimized Ank coding sequences were amplified from the plasmids
listed in Table 3 using Accuprime Pfx (Invitrogen) and the oligonucleotides listed in Table
6. The PCR products were cloned into pJB-CAT-CyaA using the In-Fusion HD Cloning
Plus kit (Clontech) to generate plasmids encoding each Ank N-terminally fused to CyaA
(Table 7).176 THP-1 cells (1 × 105 per well) in 24-well plates were differentiated into
macrophage-like cells by incubation overnight in RPMI (Invitrogen) medium containing
10% (vol/vol) FBS and 200 nM PMA. Cells were washed once with RPMI plus 10% FBS,
infected with 1 × 106 C. burnetii harboring pJB-CAT-CyaA-CvpA or vector alone, and
incubated in RPMI plus 10% FBS for 48 h. The concentration of cAMP in lysates from
infected cells was determined using the cAMP enzyme immunoassay (GE Healthcare). 177
Briefly, PMA-differentiated THP-1 macrophages seeded in 24-well plates at a density of
5 × 105 cells per well were infected at a MOI of 50 with C. burnetii transformants
expressing each candidate protein N-terminally fused to CyaA. After 48 h, the cells were
washed with PBS and lysed with 200 μl of lysis buffer containing 50 mM HCl and 0.1%
Triton X-100. Samples were boiled for 5 min and 400 μl of 95% ethanol was added. The
samples were dried under vacuum and resuspended in 400 μl of assay buffer (0.5 M
sodium acetate [pH 6.0], 0.002% w/v bovine serum albumin (BSA)). The amount of cAMP
in the samples was determined with the cAMP Biotrak Enzymeimmunoassay (EIA)
System (GE Healthcare) according to the non-acetylation procedure. Samples were
measured in duplicate for each of three independent experiments. Values were reported
as fold change in cAMP concentration versus the empty vector control (CyaA only).
Proteins were deemed T4SS substrates if fold change in cAMP concentration was
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significantly greater (P > 0.05) than the CyaA only control using the one-way ANOVA
statistical test, part of the Prism 6.0 software package (GraphPad, La Jolla, CA). This
procedure was kindly performed by Charles L. Larson of the Robert A. Heinzen laboratory
(NIH: National Institute of Allergy and Infectious Diseases, Hamilton, MT).

T1SS assay and Western blot analyses of results
Plasmid pLG575, which constitutively expresses E. coli HlyB and HlyD, was kindly
provided by Peter Sebo (Institute of Microbiology, Institute of Biotechnology, Academy of
Sciences of the Czech Republic).178 On day one, E. coli BL21 (DE3) cells were
transformed with pET19-b plasmids carrying inserts that encoded His-tagged HlyA-Ank
fusion proteins (Table 5) in the presence or absence of pLG575. Transformants were
cultivated overnight in LB broth containing the appropriate antibiotics at 37°C with shaking
at 250 rpm to generate starter cultures. On day two, 1 ml of each culture was diluted
twenty-fold into fresh media and appropriate antibiotics, and the cultures were shaken at
250 rpm at 37° C. When the OD was between 0.6 and 1.0, 0.5 ml of each culture was
retained as a non-induced control. The cultures were chilled on ice for 10 min, after which
they were induced to express proteins of interest by the addition of isopropyl ß-D-1thiogalactopyranoside (IPTG) to a final concentration of 1.0 mM and shaking at 250 rpm
at 16°C overnight. On day three, a 0.5 ml aliquot of each induced culture was removed,
its OD determined to ensure that the E. coli had not lysed due to HlyA-Ank expression
and for subsequent normalization when loading on a SDS-PAGE gel. Aliquots were
pelleted at 11,000 x g for 10 min, and the supernatant discarded. This saved bacterial
pellet would enable us to verify that proteins of interest had been expressed. For
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Table 6. Oligonucleotides used for cloning Ank coding sequences into pJB-CATCyaA
Designation Sequence (5’ to 3’)1
cyaA-ank1_02-4F TTCCGGCTATGTCGACATGAACAACTACCTGAGA
CTGAG
cyaA-ank1_02-990R GCATGCCTCAGTCGACTCACTCTTCCTCGTAGAT
GGCGTAGGC
cyaA-ank2-4F TTCCGGCTATGTCGACATGGGCAACACAGCACTG
CATGAG
cyaA-ank2-1035R GCATGCCTCAGTCGACTCACTCGCCCTCGTACA
GGGCG
cyaA-ank3_08-4F TTCCGGCTATGTCGACATGATCCTGAAGAGCAAG
ACCAAATAC
cyaA-ank3_08-708R GCATGCCTCAGTCGACTCAACAGGAGGAGAACA
GCTGAT GG
cyaA-ank4-4F TTCCGGCTATGTCGACATGAACAACGGTAACCTG
CTGCACG
cyaA-ank4-1179R GCATGCCTCAGTCGACTCAAGAGTTGGTGTTTTC
ACCTTTCAGTG
cyaA-ank5-4F TTCCGGCTATGTCGACATGATGACAGTGCTTCAC
AAGGCCGCG
cyaA-ank5-1038R GCATGCCTCAGTCGACTCACTCGCCCTCGTAGA
TAGCGTAGG
cyaA-ank6_02-4F TTCCGGCTATGTCGACATGTACAAGGTTCTGCCA
CTCAGAG
cyaA-ank6_02-1011R GCATGCCTCAGTCGACTCACTCCTCTTCGTATAT
TGCGTGG
cyaA-ank7_02-4F TTCCGGCTATGTCGACATGGATAAGACCCTGAGG
CAGCAAG
cyaA-ank7_02-1257R GCATGCCTCAGTCGACTCAGTTGTTTGTGTAATT
TTGGGCCAGC
cyaA-ank8-4F TTCCGGCTATGTCGACATGTATAATACCGACCTG
CATGATG
cyaA-ank8-1170R GCATGCCTCAGTCGACTCAGCTTTCTTTGTGCAT
GACGTTTCCC
cyaA-ank9-4F TTCCGGCTATGTCGACATGGGGAGATTCACCAGA
CTGC
cyaA-ank9-1269R GCATGCCTCAGTCGACTCAGTCGCAGATGGCGT
AGCC
cyaA-ank10_01-4F TTCCGGCTATGTCGACATGAAGAACTGGCTGAGC
TGGC
cyaA-ank10_01- GCATGCCTCAGTCGACTCAGGTCTCAATGTTCAC
1656R CACCTCC
cyaA-ank11-4F TTCCGGCTATGTCGACATGAAGTCCAATAAGAGC
CCCAGG
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cyaA-ank11-687R GCATGCCTCAGTCGACTCACAGGCCGATGTTCTT
TCCGC
cyaA-ank12_01-4F TTCCGGCTATGTCGACATGATGAATACCGCTTTG
TCACTGG
cyaA-ank12_01- GCATGCCTCAGTCGACTCAGATGCACCTGTGGC
1485R CGCTG
cyaA-ank13-4F TTCCGGCTATGTCGACATGGCCCCTTTCTCTACC
AAAGACG
cyaA-ank13-1473R GCATGCCTCAGTCGACTCAGATGCCGAGACTTG
AAGATTTATTC
cyaA-ank14-4F TTCCGGCTATGTCGACATGAACTTCCAACTGCAT
AACGC
cyaA-ank14-1257R GCATGCCTCAGTCGACTCAGTTCTCCCCCATGG
CATGC
cyaA-ank15-4F TTCCGGCTATGTCGACATGAGCAGAGAGGAACT
GCTGC
cyaA-ank15-930R GCATGCCTCATCGACTCACTCATTATTGGTGGTG
TTTTGGC
cyaA-ank16-4F TTCCGGCTATGTCGACATGAATAACAACGACCTG
CTGAG
cyaA-ank16-801R GCATGCCTCAGTCGACTCAGATCATGCCGTGGA
TGCTG
cyaA-ank17-4F TTCCGGCTATGTCGACATGAACAAACTGAACCAA
CTGGATAAG
cyaA-ank17-729R GCATGCCTCAGTCGACTCAGGCGTTGTTGTCGT
CGATG
cyaA-ank18-4F TTCCGGCTATGTCGACATGGACGACGCCACCAG
C
cyaA-ank18-219R GCATGCCTCAGTCGACTCAGATGATGTTGCAGC
CGGTG
cyaA-ank19-4F TTCCGGCTATGTCGACATGAGGAACCCCTTCGCT
TACTGC
cyaA-ank19-492R GCATGCCTCAGTCGACTCAACACTTCACGTTGGC
GCCC
cyaA-ank20-4F TTCCGGCTATGTCGACATGGACCAGCTGCTGAG
GTATATC
cyaA-ank20-1527R GCATGCCTCAGTCGACTCACACGCTGCTCTCGTT
TCCC
1Bold nucleotides correspond to pJB-CAT-CyaA vector sequence; italicized nucleotides
correspond to SalI restriction site; underlined nucleotides correspond to added start
codon.
Modified from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin repeatcontaining protein family members are Type 1 secretion system substrates that traffic to
the host cell endoplasmic reticulum. Front Cell Infect Microbiol, 2014. 4: p. 186.
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Table 7. Plasmids used for T4SS analyses
Gene
Plasmid
Purpose
cyaA-ank1_02
pCyaA-Ank1_02
Evaluate Ank1_02 for T4SS
cyaA -ank2
pCyaA-Ank2
Evaluate Ank2 for T4SS
cyaA -ank3_08
pCyaA-Ank3_08
Evaluate Ank3_08 for T4SS
cyaA -ank4_01
pCyaA-Ank4_01
Evaluate Ank4_01 for T4SS
cyaA -ank5_01
pCyaA-Ank5_01
Evaluate Ank5_01 for T4SS
cyaA -ank6_02
pCyaA-Ank6_02
Evaluate Ank6_02 for T4SS
cyaA -ank7_02
pCyaA-Ank7_02
Evaluate Ank7_02 for T4SS
cyaA -ank8
pCyaA-Ank8
Evaluate Ank8 for T4SS
cyaA -ank9
pCyaA-Ank9
Evaluate Ank9 for T4SS
cyaA -ank10_01
pCyaA-Ank10_01
Evaluate Ank10_01 for T4SS
cyaA -ank11
pCyaA-Ank11
Evaluate Ank11 for T4SS
cyaA -ank12_01
pCyaA-Ank12_01
Evaluate Ank12_01 for T4SS
cyaA -ank13
pCyaA-Ank13
Evaluate Ank13 for T4SS
cyaA -ank14
pCyaA-Ank14
Evaluate Ank14 for T4SS
cyaA -ank15
pCyaA-Ank15
Evaluate Ank15 for T4SS
cyaA -ank16
pCyaA-Ank16
Evaluate Ank16 for T4SS
cyaA -ank17
pCyaA-Ank17
Evaluate Ank17 for T4SS
cyaA -ank18
pCyaA-Ank18
Evaluate Ank18 for T4SS
cyaA -ank19
pCyaA-Ank19
Evaluate Ank19 for T4SS
cyaA -ank20
pCyaA-Ank20
Evaluate Ank20 for T4SS
Modified from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin repeatcontaining protein family members are Type 1 secretion system substrates that traffic to
the host cell endoplasmic reticulum. Front Cell Infect Microbiol, 2014. 4: p. 186.
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supernatant samples, each culture was spun at 10,000 x g for 20 min at 4°C, after which
15 ml of the supernatant was syringe filter-sterilized through a 0.22 μm filter, mixed with
15 ml of ice-cold 40% (vol/vol) trichloroacetic acid (TCA) in acetone, and chilled at 4° C
for 1 h. The samples were spun at 13,000 x g for 15 min, the supernatant discarded, and
the pellets, which contained precipitated proteins, were each resuspended in 1 ml of icecold acetone and transferred to a 1.5 ml tube. The sample was spun at 15,000 x g for 5
min at 4°C and washed with ice-cold acetone two additional times. After pipetting to
remove most of the acetone, the tube containing precipitated proteins was heated at 70°C
for 5 min to evaporate residual acetone. Precipitated proteins were resuspended in 25 μl
of PBS.

Normalized amounts of the induced E. coli pellet samples and the entirety of the
supernatant samples were resolved by SDS-PAGE in 4 to 15% polyacrylamide gradient
gels at 115 V for 10 min followed by 200 V for 20 min. Proteins from the gels were
transferred to nitrocellulose membrane in Towbin buffer at 100 V for 30 min. The blots
were blocked in 5% (vol/vol) non-fat dry milk in tris-buffered saline plus 0.05% Tween-20
(TBS-T) for 1 h at room temperature. The blots were screened with mouse monoclonal
antibody G3 that was specific for HlyA residues 626 to 673 (a kind gift from Rodney
Welch, University of Wisconsin, Madison, WI) at a 1:5000 dilution, mouse anti-FLAG at a
1:1,000 dilution, rabbit anti-p65 at a 1:250 dilution, rabbit anti-IκBα (Santa Cruz) at a 1:250
dilution, mouse anti-GAPDH (Santa Cruz) at a 1:250 dilution, rabbit anti-importin-β1
(Santa Cruz) at a 1:250 dilution, rabbit anti-exportin-1 (EMD Millipore, Billerica, MA) at a
1:10,000 dilution, and mouse anti-β-actin (Santa Cruz) at a 1:2,500 dilution in 5% (vol/vol)
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non-fat dry milk in TBS-T overnight at 4° C with gentle rocking. The blots were washed
three times in TBS-T with vigorous agitation. They were incubated with horseradish
peroxidase-conjugated horse anti-mouse IgG (Cell Signaling Technology, Danvers, MA)
at a 1:10,000 dilution in 5% (vol/vol) non-fat dry milk in TBS-T for 1 h with rocking followed
by three washes in TBS-T. Blots were incubated with SuperSignal West Pico or
SuperSignal West Dura (Thermo Scientific, Rockford, IL) respectively, and exposed to
film (Chapter 3: T1SS study) or imaged using a ChemiDoc Touch Imaging System (BioRad, Hercules, CA) (Chapter 4: NF-κB study). Densitometry analysis was performed
using Bio-Rad Image Lab software (Chapter 4: NF-κB study).

NF-κB and FLAG-tagged protein nuclear translocation immunofluorescence assay.
HeLa cells were seeded onto glass coverslips in 24-well plates. For infection experiments,
cells were infected with O. tsutsugamushi at an MOI of 1 or 50 and incubated at 35°C for
a designated period of time. For mock infected controls, uninfected HeLa cells were
mechanically disrupted and differentially centrifuged exactly as described above for
Orientia infected cells. For the mock infection control, the resulting miniscule pellet of
uninfected HeLa cellular debris was resuspended in RPMI-1640 medium containing 10%
(vol/vol) FBS and the suspension was incubated with naïve HeLa cells for the same period
of time as host cell free bacteria. For studies involving ectopic expression of FLAG-tagged
proteins, HeLa cells were transfected with 0.4 μg of plasmid using Lipofectamine 2000
(Invitrogen, Carlsbad, CA) as directed by manufacturer. Cells were allowed to ectopically
express protein for 16 h before being processed. In some cases, cells were incubated
with media containing 25 ng/mL of TNF-α (Life Technologies, Grand Island, NY) or vehicle
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control (H2O) for 30 min at 37°C. Cells were then fixed and permeabilized with -20° C
methanol. The coverslips were washed with PBS twice and then blocked in 5% (vol/vol)
BSA in PBS for 1 h at room temperature. Samples were then incubated at room
temperature with antibody targeting endogenous p65 (rabbit C-20 or mouse F-6; Santa
Cruz, Dallas, TX) at a 1:250 dilution, rabbit anti-O. tsutsugamushi TSA56 at a 1:1,000
dilution142, and/or mouse anti-FLAG epitope (Sigma-Aldrich) at a 1:1,000 dilution in PBS
containing 5% (vol/vol) BSA for 1 h. The coverslips were washed three times in PBS and
incubated with Alexa Fluor 488-conjugated goat anti-mouse or anti-rabbit IgG (Invitrogen)
and Alexa Fluor 594-conjugated goat anti mouse or anti-rabbit IgG (Invitrogen) at a
1:1,000 dilution in 5% BSA for 1 h at room temperature. Samples were rinsed with PBS
three times and mounted using ProLong Gold Antifade plus 4’ 6-diamidino-2-phenylindole
(DAPI; Invitrogen). Coverslips were imaged with a Zeiss LSM 700 laser-scanning
confocal microscope. Cells were scored for NF-κB nuclear accumulation by counting 100
cells per coverslip, examining for the presence of immunolabeled p65 in the cytosol or
nucleus. In some cases, cells were scored for FLAG-tagged protein accumulation in the
nucleus. In some experiments, cells were treated with 20 nM leptomycin B (LMB) (SigmaAldrich) for 1 h prior to processing for immunofluorescence microscopy.

NF-κB luciferase assay. HeLa NF-κB luciferase cells were seeded at a density of 5 x
104 cells per well in a 96-well plate and cultivated overnight. For infection studies, cells
were infected with O. tsutsugamushi organisms at an MOI of 10, 50, or 100 (confirmed
by IFA) and incubated at 35°C for 24 h. MOIs were confirmed by immunofluorescent
microscopy examination of cells that had been infected in parallel. In some cases, the
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HeLa NF-κB luciferase cells were transfected with 0.1 μg of plasmid to express FLAGtagged protein for 16 h prior to being assayed. The media was replaced with fresh media
containing 25 ng/mL TNF-α or vehicle control and incubated for 8 h for infection studies
or 4 h for ectopic expression studies. The media was removed and the cells were rinsed
with 100 μL of PBS followed by a 15-min incubation in 20 μL of Passive lysis buffer
(Promega, Durham, NC). The samples were then vigorously pipetted with 100 μL of
Firefly Luciferase substrate (Signosis). Luminescence signal was quantitated using a
Perkin Elmer 1420 Multilabel Counter Victor3 for 10 s per well.

Cytosol and nuclear fractionation. HeLa cells were grown in a T-75 flask to 60%
confluency, which corresponds to approximately 5 x 106 cells, for infection studies and to
90% confluency, which corresponds to approximately 7.5 x 10 6 cells, for ectopic protein
expression studies. For infection experiments, cells were incubated with O.
tsutsugamushi bacteria at an MOI of 50 or with uninfected HeLa cell lysate for the mock
infection control and incubated for 4 or 72 h. For protein expression studies, cells were
transfected with 18 μg of plasmid DNA using Lipofectamine 2000 (Invitrogen) and
incubated for 16 h. Old media was removed and replaced with fresh media containing 25
ng TNF-α per mL or H2O as a vehicle control and incubated for 30 min. In an alternative
experiment, cells were treated with 50 μM importazole (Sigma-Aldrich) or DMSO vehicle
control for 3 h. Media was removed from the flasks. The cells were rinsed with PBS,
treated with 0.05% trypsin-EDTA (Invitrogen) for 5 min. Cells were harvested by
centrifugation at 200 x g for 4 min, washed with PBS, and subjected to a second round of
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centrifugation. Cytosol and nuclear fractions were acquired using the Nuclear Extraction
Kit (Abcam) and subjected to Western blot analysis.

Immunoprecipitation. HeLa cells were transfected as described above with pFLAGAnk1, pFLAG-Ank6, pFLAG-BAP, or pFLAG-p65 vectors and incubated for 16 h. Cells
were harvested and lysed in Tris buffer high saline (50 mM Tris HCl, 400 mM NaCl, 1 mM
EDTA, pH 7.4) with 0.05% Tween-20 (TBHS-T) containing protease inhibitor cocktail
(Roche Diagnostics GmBH, Mannheim, Germany) on ice for 30 min with s vortexing every
5 min. Agarose beads conjugated to mouse anti-FLAG or rabbit anti-p65 antibodies were
washed with TBHS-T buffer five times, centrifuged at 8,400 x g for 30 s, and added to
400 μg of cell lysate in final volume 500 μl. The samples were rotated with beads at 4°C
for 4 h followed by centrifugation at 8,400 x g for 30 s and washing with TBHS-T five
times. Beads were then resuspended in 40 μL of 2X Laemmli buffer and incubated at
100°C for 5 min to elute bound proteins. Inputs (50 µg of lysate) and eluates (entire 40
μL sample) were resolved by SDS-PAGE and screened by Western blotting.

Statistical Analyses
Statistical analyses were performed using the Prism 5.0 software package (Graphpad,
San Diego, CA). One-way analysis of variance (ANOVA) with Tukey's post hoc test was
used to test for a significant difference among groups. Statistical significance was set at
p <0.05.
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Chapter 3

Orientia tsutsugamushi Anks are secreted by a T1SS
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3.1 Introduction
In order for pathogens to modulate host cell functions such as immune evasion,
recruitment of bacterial cell components, and nutrient acquisition, it is essential that they
secrete pathogenic effectors to facilitate specific functions that will in turn promote survival
and adaptation to the pathogen’s environment. The mechanism for secreting effectors is
highly regulated by the pathogen in that it utilizes specific secretion systems, which
traverse proteins to pass the bacterial inner and outer membranes to its extracellular
environment.179 To date, there are nine different kinds of prokaryotic secretion systems
reported in which O. tsutsugamushi encodes and expresses the T1- and T4SS during
mammalian cell infection.143,

179

In addition, this pathogen also expresses a family of

eukaryotic-protein mimicking effectors known as Anks, which are thoroughly documented
to be key virulence factors of intracellular bacterial pathogens.59, 63, 180, 181 Anks were first
thought to be exclusive to eukaryotes and shown to be involved in a variety of processes
including

signal

transduction,

transcriptional regulation.59,

vesicular

63, 180

trafficking,

cytoskeleton

integrity,

and

However, many intracellular bacterial species

translocate Ank effectors into host cells, which traffic to distinct subcellular locales and
subvert eukaryotic processes beneficial to the pathogens.

182-195

Several Rickettsiales

effectors, including Anks, are deployed by their T1SS or T4SS.62, 158, 185, 196

In order for an effector to be secreted by either of these two secretion systems, it must
bear a proper secretion signal to be recognized by the secretion system inner membrane
components. While there is no consensus T1SS substrate signal sequence, it typically
comprises the C-terminal 60 residues, is rich in several amino acids (LDAVTSIF), poor in
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others (KHPMWC), and is not cleaved during translocation.156, 158, 192 Additionally, T1SS
effectors tend to have acidic pIs and contain few or no cysteine residues.

The T4SS is another substrate translocation channel that traverses Gram-negative
bacterial cell walls.193 T4SS effectors of several important human pathogens including
Coxiella burnetii, Legionella pneumophila, Helicobacter pylori, Brucella spp., and
Anaplasma phagocytophilum have been shown to modulate a wide range of host cell
processes.194 The VirB/VirD4 and Dot/Icm T4SSs have some discernible sequence
homologies to each other.196 They retain at least some degree of functional homology
because surrogate bacterial hosts that use the Dot/Icm system can secrete VirB/VirD4
substrates.196, 197 For both VirB/VirD4 and Dot/Icm substrates, the translocation signals
tend to be located in their unstructured C-termini and can include clusters of positively
charged arginine residues (VirB/D4), glutamate-rich stretches called E blocks (Dot/Icm),
and hydrophobic residues (Dot/Icm).198-200

Given the scarcity of information on O. tsutsugamushi effectors, the importance of the
T1SS and T4SS to rickettsial pathogens, and the potential of Anks to serve as virulence
factors, we investigated the secretion mechanism of O. tsutsugamushi Ikeda strain Anks.
Due to the obligate intracellular nature of O. tsutsugamushi, it is currently not feasible for
genetic knockout-complementation studies to be performed to test which secretion
system is responsible for secreting these Anks. As an alternative method, surrogate
bacterial models are used to address this issue. It is confirmed here that C. burnetii could
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not secrete heterologously expressed Anks in a T4SS-dependent manner. On the
contrary, substituting the E. coli T1SS effector HlyA C-terminal secretion signal (the final
60 amino acids) with the C-termini of O. tsutsugamushi Anks secretes the chimeric
proteins in an HlyBD-dependent manner.
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3.2 Results
3.2.1 The O. tsutsugamushi genome encodes Anks that display characteristics of
T1SS substrates
The O. tsutsugamushi Ikeda strain genome (NCBI accession number NC_010793.1)
encodes 38 ank ORFs and 9 ank pseudogenes
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that are distributed throughout the

chromosome. SMART (Simple Modular Architecture Research Tool) analysis revealed
that each carries up to 9 ankyrin repeats (Table 8). Eighteen of the 38 ank ORFs exist as
multiple identical or near-identical paralogs and 12 occur as single copy genes. Ank18,
carries no ankyrin repeats but is homologous to the non-ankyrin repeat portion of Boryong
Ank1u7 (OTBS_1195), which does contain an ankyrin repeat domain

53,

and was

therefore included in this study. We selected a subset of the 38 full-length Anks that were
substantially diverse in sequence such that they could be differentiated from each other
by PCR. We chose all of the single copy Anks and one representative member of each
multi-copy Ank group to arrive at a total of 20 Anks (Table 9). The selected Anks displayed
characteristics of T1SS effectors, especially those encoded by other rickettsial pathogens
(Table 10)

62, 156, 158, 200,

but not T4SS substrates. In silico analyses of the O.

tsutsugamushi T1SS components OTT_0076 (TolC), OTT_1107 (AprE), and OTT_1108
(AprD) revealed that they had 22%, 27%, and 41% amino acid identity to E. coli TolC,
HlyD, and HlyB, respectively. The percentage of LDAVTSIF residues occurring within the
60 C-terminal amino acids of each Ank ranged from 37 to 63%. The pIs of 13 of the 20
full-length Anks were acidic, ranging between 4.6 and 6.3. Ank7_02, Ank10_01, and
Ank15 had overall pIs of 7.3, 6.85, and 7.2, but had C-termini with pIs of 4.3, 5.0, and 4.2
respectively. All of the Anks had relatively few cysteines. Thus, O. tsutsugamushi Anks
might be T1SS substrates.
75

Table 8. Orientia tsutsugamushi Ikeda strain Anks

Ank

Gene

Ank1_01

OTT_0036

Ank1_02

OTT_0753

Ank2

OTT_0049

Ank3_01

OTT_0153

Ank3_023

OTT_0236

Ank3_033

OTT_0237

Ank3_04

OTT_0288

Ank3_05

OTT_0316

Ank3_06

OTT_0982

Ank3_073

OTT_1032

Ank3_08

OTT_1112

Ank3_09

OTT_1118

Ank3_103

OTT_1236

Ank3_11

OTT_1453

Ank3_123

OTT_1465

Ank3_13

OTT_1696

Ank3_143

OTT_1730

Ank3_15

OTT_1852

Ank4_01

OTT_0210

Number
Chromosomal
of
Coordinates1 ankyrin
repeats
(+) 4440202
44929
(-) 7802903
781279
(-) 548304
55864
(-) 1442576
144901
(-) 2237183
224077
(-) 2243102
224588
(-) 2896506
290294
(+) 3290275
329575
(+) 10324335
1032981
(-) 10726594
1073159
(-) 11463645
1147071
(+) 11524715
1153019
(-) 12713580
1271513
(-) 14856546
1486298
(+) 14977824
1498282
(-) 17218776
1722521
(-) 17511814
1751648
(-) 18832486
1883895
(-) 200588201766

7

76

Amino acid locations of
individual ankyrin repeats of
Ank protein

23-52, 56-85, 89-118
1-30, 38-67, 71-100, 104-134
6-36, 40-69, 73-115, 119-149,
153-182, 186-213
5-47, 51-81, 85-114
12-42, 46-75
6-36, 40-69, 73-115, 119-149,
153-182, 186-213
8-37, 41-83, 87-117, 121-150,
154-181
8-37, 41-83, 87-117, 121-150,
154-181
25-67, 71-101, 105-134, 138165
6-36, 40-69, 73-115, 119-149,
153-182
8-37, 41-83, 87-117, 121-150,
154-181

6-36, 40-69, 73-115, 119-149,
153-182, 186-213
25-67, 71-101, 105-134, 138165
6-36, 40-69, 73-115, 119-149,
153-182, 186-213
14-56, 60-90, 94-123, 127-154
7-37, 41-70, 74-116, 120-150,
1540183, 187-214
50-79, 83-112, 116-147, 151180, 184-214, 218-279, 283315

(+) 19514981952676

7

50-79, 83-112, 116-147, 151180, 184-214, 218-279, 283315

4

2-29, 36-65, 69-99, 103-132

4

2-29, 36-65, 69-99, 103-132

4

2-29, 36-65, 69-99, 103-132

4

23-52, 56-85, 89-118, 122-158

4

23-52, 56-85, 89-118, 122-158

4

23-52, 56-85, 89-118, 122-158

4

23-52, 56-85, 89-118, 122-158

2

35-64, 100-130

3

35-64, 68-96, 100-129

3

35-64, 68-96, 100-129

Ank4_02

OTT_1916

Ank5_01

OTT_0214

Ank5_02

OTT_0412

Ank5_03

OTT_0487

Ank6_01

OTT_0226

Ank6_02

OTT_1149

Ank6_03

OTT_1496

Ank6_04

OTT_1912

Ank7_013

OTT_0250

Ank7_02

OTT_1509

Ank7_03

OTT_1936

Ank8

OTT_0257

Ank9

OTT_0298

Ank10_01

OTT_0398

(-) 416849418504

9

Ank10_02

OTT_0875

(+) 918456920111

9

Ank10_033

OTT_1089

Ank10_043

OTT_1090

Ank11

OTT_0459

(+) 205067206104
(+) 432777433814
(-) 505323506360
(-) 215330216340
(+) 11807831181793
(+) 15251581526168
(-) 19474921948502
(-) 241933242373
(-) 15351301536386
(-) 19695411970797
(-) 252600253769
(+) 307356308624

5
7

(-) 11220061122263
(-) 11223021122703
(-) 482167482853

Ank12_01

OTT_0602

(-) 621330622814

Ank12_02

OTT_1300

(-) 13188921320379

1-31, 35-64, 68-98, 111-140,
144-173
21-51, 55-84, 88-117, 121-150,
154-188, 192-221, 225-256
20-50, 54-83, 87-117, 121-150,
154-184, 188-217, 222-252,
256-285, 290-319
20-50, 54-83, 87-117, 121-150,
154-184, 188-217, 222-252,
256-285, 290-319

0
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2

14-43, 48-78

2

10-39, 132-161

7

8

35-64, 68-97, 102-144, 148178, 182-211, 215-246, 250281
1-30, 35-64, 68-97, 102-144,
148-178, 182-211, 215-246,
250-281

Ank13

OTT_0852

Ank14

OTT_1019

Ank15

OTT_1232

Ank16

OTT_1271

Ank17

OTT_1478

Ank184

OTT_1518

Ank19

OTT_1519

(-) 899766901238

8

(+) 10639421065198
(+) 12681081269037
(+) 12962551297055
(+) 15053501506078
(-) 15489141549132
(-) 15493611549852

5

18-48, 52-81, 85-114, 118-147,
151-182, 186-215, 219-254,
258-285
33-62, 66-95, 99-128, 132-161,
162-193

1

105-134

3

5-34, 41-93, 97-125

4

37-66, 69-98, 102-129, 133163

0
4

4-33, 37-75, 79-110, 114-163

32-62, 66-96, 101-130, 135164, 165-194, 200-233, 237267, 271-300, 304-335
1(+) and (-) refer to the sense and antisense DNA strands, respectively.
Ank20

2Ank1_01
3These

OTT_1575

(+) 16034871605013

9

is homologous to the non-ankyrin repeat-containing portions of Ank1_02.

ORFs are annotated as probable pseudogenes by Nakayama et al., 2008.

4

Ank18 carries no ankyrin repeats, but exhibits homology to the non-ankyrin repeat portion of its
homolog in the O. tsutsugamushi Boryong strain, Ank1u7 (OTBS_1195; Cho et al., 2007).
Modified from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin repeat-containing
protein family members are Type 1 secretion system substrates that traffic to the host cell
endoplasmic reticulum. Front Cell Infect Microbiol, 2014. 4: p. 186.
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Table 9. Representative O. tsutsugamushi Anks
Ank

% identity with paralog(s)1

Ank1_02

Ank1_01 (43.2%)

Ank2

Single copy

Ank3_08

Ank3_01 (83.4%), Ank3_04 (84.7%), Ank3_05 (69.8%), Ank3_06
(69.8%), Ank3_09 (69.8%), Ank3_11 (81.3%), Ank3_13 (84.7%),
Ank3_15 (80.9%)

Ank4_01

Ank4_02 (100%)

Ank5_01

Ank5_02 (100%), Ank5_03 (100%)

Ank6_02

Ank6_01 (99.1%), Ank6_03 (100%), Ank6_04 (100%)

Ank7_02

Ank7_03 (100%)

Ank8

Single copy

Ank9

Single copy

Ank10_01

Ank10_02 (100%)

Ank11

Single copy

Ank12_01

12_02 (76.4%)

Ank13

Single copy

Ank14

Single copy

Ank15

Single copy

Ank16

Single copy

Ank17

Single copy

Ank18

Single copy

Ank19

Single copy

Ank20

Single copy

1Annotated

pseudogenes were excluded.
Modified from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin repeatcontaining protein family members are Type 1 secretion system substrates that traffic to
the host cell endoplasmic reticulum. Front Cell Infect Microbiol, 2014. 4: p. 186.
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Table 10. O. tsutsugamushi Ank C-termini features
pI
Protein1

Final 60 C-terminal amino acids2

LDAVTSIF3

(entire/
C-term4)

Ank1_02

SNQDANQKSQISWLHLPLEVRMMILENLSN
TDLTKLQHNDTAEADAEAELEGAYAIYEEE

30/60 =
50%

5.1/4.2

Ank2

EIFESNHDASQEGHTSWLYLPPELKLMILEN
LSTNDLIKLQQFDEAEALLKGAYALYEGE

30/60 =
50%

5.3/4.3

Ank3_08

YGADIDAKDDNGMTTIDYAAKSGNSDLSVA
PPIFKGLSYKLFADKAYISKALFHQLFSSC

38/60 =
63%

5.5/5.9

Ank4_01

QILKPDSEKNDADKFLEKWLELDIGITKQIVE
ALQDDDLGTFQQLYEEYKVALKGENTNS

31/60 =
52%

5.5/4.4

Ank5_01

SNQDANQESQISWLHLPPEVRMMILENLSN
TDLTKLQHNDTAEAEAEAELEGAYAIYEGE

28/60 =
47%

6.3/4.1

Ank6_02

SQKSQTSWSHLPPEVRFMILENLDNDDLTKI
QRTDVAEAGEAGAEVEAEVGGAHAIYEEE

30/60 =
50%

5.3/4.3

Ank7_02

TQDEIAIYDTAKCLIESNSRLETENMLSLRLD
KSTKLLEQFLLPDESDYVQLLAQNYTNN

33/60 =
55%

7.3/4.3

Ank8

AVESIDEIFEPNQDDSTSWLHLPLEMKFMVL
EYCSKDDLTKLQHHEEVEIAGGNVMHKES

29/60 =
48%

6.1/4.5

Ank9

LAETVTLFPDDHVASTPSWNNLPYEVQHMI
LGHLSNNELRKFQPDDEEEAEITGGYAICD

30/60 =
50%

5.8/4.3

Ank10_01 ESHKSITFSQLNNYDTHKIYEYLDNPVLKEL
QHEYKTIDVNDKKCFFCSLSGEEVVNIET

29/60 =
48%

6.9/5.0

Ank11

26/60 =
43%

8.6/8.0

Ank12_01 CKEQPKEHSTERKVGWDTIPPEVKFNILKHL
SNEDLSKIQQNKTSEAKKKDPQPSGHRCI

22/60 =
37%

7.0/8.9

Ank13

KSIDDVCKNKDNTPRNYWNVIPQELKENILK
YLNNTDLSNIQQDNKKKDVNKNKSSSLGI

26/60 =
43%

8.4/9.1

Ank14

TNINEQAYLYQLYLYIVGAQNEGQVDLNNSN
IQVECESYTNETQQEESENNTYVHAMGEN

22/60 =
37%

4.8/3.6

CICRMAKRYSNPYLDSEERNAIQNIMNILRE
NGADYNITNNSGQSATSFLDMKSGKNIGL
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Ank15

EKDNIQPLTQKVSSNVILVDFSIRYNAILEELP
VDYFMQKPYISVEEDVYLLGQNTTNNE

31/60 =
52%

7.2/4.2

Ank16

KPDSEKTDADKFLENWRELARLGLDEQILD
TLQDDYLGTFQQLNEERKVALGEDSIHGMI

31/60 =
52%

5.7/4.5

Ank17

KESKLFGLNTYALEEILKHLNFNDLQSLIEAC
TVKLYTESNYNTDMPAMGGEFSIDDNNA

31/60 =
52%

5.0/4.4

Ank18

LYKAYFSTLTSQSDLAAEYQNVNNTSYAED
YGLMDHNETEFGLSGKVHSNVKSYTGCNII

31/60 =
52%

4.6/4.8

Ank19

HGADMNKQDKKGNTILHNVVKKYKCSEDVI
YIVGLSKKDYKFEYSNYIELLLKLGANVKC

26/60 =
43%

9.1/9.0

Ank20

FQYLPNEIRYKIFSYLGLRELEALQLLADDLN
SSNVSSLQFNNEVDLNTQPIGVGNESSV

33/60 =
55%

5.9/4.2

1Only

the C-termini of Anks selected for codon optimization were analyzed.

2Red

amino acids denote LDAVTSIF residues that are commonly found in the C-terminal
secretion signals of T1SS substrates.
3The

total number of LDAVTSIF residues per Ank was divided by 60 and multiplied by
100 to determine the percentage of LDAVTSIF residues in the final C-terminal 60 amino
acids.
4C-term.,

C-terminus

Modified from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin repeatcontaining protein family members are Type 1 secretion system substrates that traffic to
the host cell endoplasmic reticulum. Front Cell Infect Microbiol, 2014. 4: p. 186.
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3.2.2 Assay for evaluating HlyBD-dependent secretion of potential T1SS
substrates
We next sought to determine how O. tsutsugamushi Anks are potentially translocated.
However, due to its obligatory intracellular nature, no knock out-complementation system
exists to directly assess the mechanism by which they are secreted. The Anks share
features with T1SS substrates, including the presence of T1SS-like secretion signals in
their C-termini. Accordingly, we evaluated O. tsutsugamushi Anks as putative T1SS
effectors using the approach that previously verified E. coli strains K-12 or C600 could
secrete recombinant forms of full-length E. chaffeensis or R. typhi T1SS candidate
substrates in a TolC-dependent manner, respectively.62, 158 However, when full-length O.
tsutsugamushi Anks were tested, they were toxic to E. coli C600, as the bacteria grew
poorly or lysed regardless of inducer concentration, length of induction time, or induction
temperature (data not shown). Also, for those E. coli C600 transformants that did not lyse,
the Ank proteins were detected in the supernatants of both C600 and the C600 TolCdeficient mutant, which implied leaky secretion (data not shown). Thus, the TolCdependent method using E. coli C600 was unsuitable for assessing O. tsutsugamushi
Anks as potential T1SS substrates.

As an alternative, we developed an assay in which the C-terminal 60 amino acids of HlyA
containing the T1SS secretion signal were replaced with the 60 C-terminal residues of O.
tsutsugamushi Anks and tested for secretion in an HlyBD-dependent manner. This
approach is outlined in Figure 10 and was based on a report that the C-terminus of
Mannheimia haemolytica (formerly Pasteurella hemolytica) leukotoxin A (LktA), a T1SS
effector, would functionally replace the T1SS secretion signal of E. coli HlyA.201-203
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Figure 10. Experimental approach for assaying E. coli secretion of HlyA chimeric
proteins bearing the C-termini of putative T1SS substrates in an HlyBD-dependent
manner. E. coli BL21 (DE3) cells, which express TolC but not HlyB or HlyD, were
transformed with pLG575 to constitutively express HlyB and HlyD and thereby functionally
reconstitute the T1SS. E. coli with or without pLG575 were transformed with plasmids
that express IPTG-inducible chimeric HlyA proteins having their 60 C-terminal residues
(amino acids 964-1024) replaced with the 60-70 C-terminal residues of each O.
tsutsugamushi Ank or control protein. The E. coli cultures were induced and centrifuged,
and the resulting cell pellets and filter-sterilized supernatants were analyzed by Western
blot using HlyA antibody to detect HlyA-fusion proteins that the bacteria expressed and
secreted into the medium. Modified from: VieBrock, L., Evans, S.E., et al. Orientia
tsutsugamushi ankyrin repeat-containing protein family members are Type 1 secretion
system substrates that traffic to the host cell endoplasmic reticulum. Front Cell Infect
Microbiol, 2014. 4: p. 186.
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Moreover, our approach avoided the leaky TolC-independent secretion observed for O.
tsutsugamushi Anks expressed in the C600/C600 TolC-deficient mutant system, as T1SS
substrates are not directed to the TolC outer membrane channel in the absence of HlyB
and HlyD.148 E. coli strain BL21 (DE3) carries a chromosomal copy of tolC, but lacks hlyB
and hlyD. This strain was complemented with plasmid pLG575 (Mackman et al., 1985) to
constitutively express HlyB and HlyD and thereby reconstitute the T1SS.

To validate the system, we tested the ability of E. coli BL21 (DE3) to secrete HlyA and a
chimeric HlyA protein with its C-terminal 60 amino acids replaced with the LktA C-terminal
secretion signal (HlyA-LktA) in an HlyBD-dependent manner.201 E. coli expressing HlyA
lacking the C-terminal secretion signal (HlyA∆965-1024) served as a negative control.
Following IPTG induction of HlyA protein expression, the supernatants were Westernblotted and screened with HlyA antibody for the presence of secreted HlyA proteins.204
HlyA is a 107-kDa protein with a short half-life of 15 minutes that degrades into a series
of fragments that migrate with apparent molecular weights of ~70 to 100 kDa. 205 Bands
corresponding to the expected sizes for full-length HlyA and its breakdown products,
HlyA∆965-1024, and HlyA-LktA were detected in the E. coli cell pellets (Figure 11, A and
B), thereby confirming their expression in an IPTG-inducible manner, as they were absent
from non-induced samples (data not shown). Consistent with it lacking a T1SS secretion
signal, HlyA∆965-1024 was not detected in the supernatant from E. coli that also
expressed HlyB and HlyD (Figure 11A). Full-length HlyA and chimeric HlyA-LktA bands
were only detected in supernatants of E. coli that expressed HlyB and HlyD (Figure 11A
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Figure 11. Validation of the T1SS assay: E. coli secretion of HlyA and a chimeric
HlyA-LktA protein depends on the substrates’ C-terminal T1SS recognition signals.
E. coli BL21 (DE3) cells constitutively expressing HlyB and HlyD (+ HlyBD), or not (HlyBD) were transformed with plasmids encoding full-length HlyA (A), HlyA lacking its 60
C-terminal amino acids (HlyA∆965-1024) (A), or a chimeric HlyA-LktA protein
corresponding to HlyA∆965-1024 fused to the 70 C-terminal amino acids of M.
haemolytica LktA (B). Following IPTG induction of HlyA or HlyA chimeric protein
expression, the cultures were centrifuged. The resulting E. coli cell pellets and filtersterilized supernatants (SN) were analyzed by Western blot using HlyA antibody for the
presence of HlyA proteins that had been expressed (Pellet) and secreted into the medium
by the bacteria (SN), respectively. Arrows denote bands corresponding to the expected
sizes for full-length and naturally occurring break down products of HlyA, HlyA∆965-1024,
and HlyA-LktA. Results are representative of at least three independent experiments.
Modified from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin repeatcontaining protein family members are Type 1 secretion system substrates that traffic to
the host cell endoplasmic reticulum. Front Cell Infect Microbiol, 2014. 4: p. 186.
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and B), validating that E. coli BL21 (DE3) having a functionally reconstituted T1SS can
be used as a tool to screen T1SS candidates.

3.2.3 E. coli secretes chimeric HlyA proteins bearing the C-termini of O.
tsutsugamushi Anks in an HlyBD-dependent manner
To evaluate the 20 Anks of interest as potential T1SS substrates, we assessed if
swapping the final 60 amino acids of HlyA with the 60 C-terminal residues of each Ank
would permit secretion of HlyA-Ank chimeras in an HlyBD-dependent manner. For these
assays, HlyA and HlyA∆965-1024 served as positive and negative controls, respectively.
As an additional negative control to ensure that any secretion observed for HlyA-Ank
proteins was specific to the inclusion of a T1SS-compatible sequence, we assayed a
chimeric protein in which the HlyA C-terminal sequence was replaced with the 60 Cterminal amino acids of O. tsutsugamushi outer membrane protein A (HlyA-OmpA). The
OmpA C-terminus is similar in LDAVTSIF composition (51.7%) to the C-termini of O.
tsutsugamushi Anks and rickettsial effectors (Table 10), but is a cell envelope protein and,
as such, should not be secreted. Following induction, all HlyA-Ank proteins and HlyAOmpA were expressed, as HlyA antibody detected bands of the expected sizes for HlyA
and/or its cleavage products in the E. coli cell pellets (Figure 12). With the exception of
HlyA-Ank16 and HlyA-OmpA, all chimeric HlyA proteins were secreted in an HlyBDdependent manner. The signals for secreted HlyA-Ank7_02, -Ank8, -Ank11, -Ank12_01,
-Ank14, and -Ank19 were not as robust as for the other secreted HlyA-Anks. These data
demonstrate that nearly all of the O. tsutsugamushi Anks bear C-terminal sequences that
mediate heterologous recognition and secretion by the E. coli T1SS.
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Figure 12. Extracellular secretion of HlyA-Ank proteins from E. coli in an HlyBDdependent manner. E. coli BL21 (DE3) constitutively expressing HlyB and HlyD (+
HlyBD), or not (- HlyBD) were transformed with plasmids encoding the indicated chimeric
HlyA-Ank protein or the negative control chimera, HlyA-OmpA. Following IPTG induction
of HlyA chimeric protein expression, the cultures were centrifuged. The resulting E. coli
cell pellets and filter-sterilized supernatants (SN) were analyzed by Western blot using
HlyA antibody for the presence of HlyA chimeric proteins that had been expressed (pellet)
and secreted into the medium by the bacteria (SN), respectively. Results per each HlyAchimeric protein are representative of at least three independent experiments. Modified
from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin repeat-containing
protein family members are Type 1 secretion system substrates that traffic to the host cell
endoplasmic reticulum. Front Cell Infect Microbiol, 2014. 4: p. 186.
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3.2.4

The

C.

burnetii

Dot/Icm

T4SS

cannot

heterologously secrete

O.

tsutsugamushi Anks
Based on the HlyA-Ank secretion assay results and because of their C-terminal sequence
characteristics, we rationalized that the O. tsutsugamushi Anks are not T4SS effectors.
To validate this hypothesis, each of the 20 Anks of interest was N-terminally fused to the
enzymatic reporter, Bordetella pertussis adenylate cyclase (CyaA) and expressed in the
surrogate host, C. burnetii, which uses its Dot/Icm secretory apparatus to translocate
T4SS substrates.176,

206

Surrogate hosts that use the Dot/Icm system will secrete

heterologously expressed VirB/VirD4 effectors, including the Rickettsiales effector, A.
phagocytophilum AnkA.197 THP-1 cells that had been differentiated into macrophage-like
cells were infected with C. burnetii transformants expressing CyaA-fusions of O.
tsutsugamushi Anks, CyaA-CvpA (Coxiella vacuolar protein A; bona fide Dot/Icm effector;
positive control), or CyaA alone (negative control) and changes in host cAMP levels were
quantified.177 Expression of each CyaA-fusion protein in infected host cells was confirmed
by Western blot analysis (data not shown). cAMP levels were considerably elevated
relative to that in C. burnetii expressing CyaA alone when host cells were infected with C.
burnetii expressing CyaA-CvpA, but not any CyaA-Ank (Figure 13). As expected, cAMP
levels were low for host cells infected with transformants of a C. burnetii T4SS-defective
DotA mutant. Thus, heterologously expressed O. tsutsugamushi Anks cannot be
translocated by the C. burnetii Dot/Icm T4SS.
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Figure 13. The C. burnetii Dot/Icm T4SS cannot secrete O. tsutsugamushi Anks.
THP-1 macrophage-like cells were infected with C. burnetii transformants expressing
CyaA-tagged O. tsutsugamushi Anks, CvpA (+), or CyaA alone (-). Bars represent the
fold change in intracellular cAMP concentration for host cells infected with wild type C.
burnetii transformants expressing CyaA-fusions relative to control cells infected with
transformants expressing CyaA alone. Results are representative of two independent
experiments. This experiment was kindly performed by Charles L. Larson of the Robert A.
Heinzen laboratory (NIH: National Institute of Allergy and Infectious Diseases, Hamilton,
MT). Modified from: VieBrock, L., Evans, S.E., et al. Orientia tsutsugamushi ankyrin
repeat-containing protein family members are Type 1 secretion system substrates that
traffic to the host cell endoplasmic reticulum. Front Cell Infect Microbiol, 2014. 4: p. 186.
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3.3 Discussion
As an intracellular pathogen, O. tsutsugamushi has evolved to modulate eukaryotic host
cell functions to facilitate its intracellular survival. Yet, the virulence factors that enable it
to accomplish this feat are poorly defined or understood. In this study, we inferred the
importance of the T1SS and family of Ank effectors to O. tsutsugamushi pathogenesis.
The O. tsutsugamushi Ikeda strain expresses all T1SS component genes and all 20
distinguishable ank genes during infection of L929 cells, which implies the relevance of
the encoded products.143 A recent transcriptional analysis of 9 of the 50 ank genes
encoded by the O. tsutsugamushi Boryong strain revealed that all nine are transcribed
during infection of mammalian host cells.61 Thus, both O. tsutsugamushi strains express
multiple ank genes during infection. Also, pooled scrub typhus patient sera was shown to
weakly recognize recombinant forms of three of the nine Boryong Anks, indicating that
some Anks are potentially expressed during human infection and may elicit a weak
humoral immune response.61 Moreover, several lines of evidence argue for the likelihood
that O. tsutsugamushi translocates Anks into host cells: (1) the O. tsutsugamushi Anks
strongly resemble T1SS effectors; (2) the O. tsutsugamushi genome has retained genes
encoding one of the largest Ank repertoires of any organism and the T1SS over the
course of its reductive evolution

51, 59;

and (3) Anks that have been examined for

translocation by genetically tractable organisms

using knock out-complementation

approaches have proven to be bona fide effectors.189, 207-209

The T1SS translocates substrates directly into the extracellular milieu or, in the case of
an intracellular bacterium such as O. tsutsugamushi, directly into the host cell cytosol
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where the secreted effectors would have direct access to their host cell targets. T1SS
secretion signals are not highly conserved, but known T1SS effectors share trends in their
primary sequences.148 In silico analyses of the Ikeda Anks identified them as potential
T1SS effectors, as 37 to 63% of the residues in their final 60 amino acids consisted of
LDAVTSIF residues, most had overall acidic pIs or had acidic C-termini, and most had
very few cysteines. These sequence characteristics are similar to those of E. chaffeensis
tandem repeat protein (TRP) 32, TRP47, TRP120, and Ank200, and R. typhi RARP-1,
the latter two of which are Anks. These rickettsial proteins were proven to be T1SS
substrates using a heterologous E. coli C600 or K-12 as a heterologous host to secrete
them in a TolC-dependent manner.62, 158 However, O. tsutsugamushi Anks were toxic to
E. coli C600 and thus were incompatible. To circumvent this issue, we evaluated the
ability of E. coli BL21 (DE3) to secrete chimeric HlyA-Ank proteins in an HlyBD-dependent
manner, which (1) eliminated the toxicity associated with full-length Anks; (2) avoided
leaky secretion because T1SS substrates cannot be translocated from the cytosol in the
absence of HlyB and HlyD148; and (3) enabled us to directly assess the compatibility of
each Ank protein’s C-terminal 60 amino acids to recognition by heterologous T1SS
machinery. This approach identified 19 of the 20 distinguishable Anks as possible T1SS
substrates. Only HlyA-Ank16 was not secreted. Ank16 displays characteristics that are
comparable with the other T1SS-positive Anks: 52% of its C-terminal 60 residues are
LDAVTSIF amino acids, it has a pI of 5.7, and only 1.9% of its residues are cysteines.
Yet, these primary sequence characteristics alone are not enough for Ank16 to be
recognized and translocated by a functionally reconstituted T1SS. Consistent with this
observation, even though the final 60 amino acids of OmpA share primary sequence
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characteristics with O. tsutsugamushi Anks and other T1SS effectors, E. coli cannot
secrete HlyA-OmpA in an HlyBD-dependent manner.

Heterologously expressed Anks could not be secreted by C. burnetii in a Dot/Icmdependent manner. While it cannot be absolutely ruled out that this result is simply due
to incompatibility of the Dot/Icm apparatus with VirB/VirD4 translocation signals, we view
this possibility as being highly unlikely for three reasons. First, O. tsutsugamushi Ank Ctermini more closely resemble translocation signals of T1SS versus T4SS substrates.
Second, all but one of the Ank sequences tested were compatible with a T1SS apparatus
and, to our knowledge, bacterial effectors are specific for a particular secretion system.
Third, Dot/Icm systems have already been proven to secrete VirB/VirD4 substrates.196, 197

In concluding this chapter, this study adds to the growing appreciation for the T1SS as an
important translocation system for Rickettsial pathogen effectors and reveals the potential
that the O. tsutsugamushi has to manipulate mammalian host cells by its large Ank family.
Moving forward, it will be important to elucidate the functional benefits that these virulence
factors afford this understudied pathogen.
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Chapter 4

O. tsutsugamushi Ank1 and Ank6 traffic to the nucleus by hijacking importin-β1 to
remove NF-κB by an exportin-1 dependent mechanism
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4.1 Introduction
The ability of O. tsutsugamushi to replicate in the cytosol of diverse host cell types,
including professional phagocytes, suggests that it likely evolved to modulate processes
that occur in response to intracellular infection. Yet, despite its impact on global health,
whether it does and, if so, the bacterial factors involved, are poorly understood. Of 1,912
bacterial genomes examined, the O. tsutsugamushi Ikeda strain, ranks fifth (top 0.3%) in
terms of the number of genes encoding ankyrin repeat-containing proteins (Anks).59
Evidence for the importance of these T1SS effectors to Orientia pathobiology continues
to mount, as the bacterium transcriptionally expresses its entire Ank repertoire during
infection of mammalian host cells, and select Anks have been demonstrated to co-opt or
modulate SCF1 ubiquitin ligase complex assembly, endoplasmic reticulum (ER)-to-Golgi
retrograde trafficking, ER stress, and protein secretion. 60, 61, 142, 143 O. tsutsugamushi Ank
manipulation of the host immune response has yet to be demonstrated.

Activation of the transcription factor, NF-κB is the central initiating cellular event in the
antimicrobial response.210 The mammalian NF-κB family consists of five proteins that
function by forming homo- or heterodimers.97 Of these, ubiquitously expressed p50:p65
is the most studied and well understood. p50:p65 is held inactive in the cytosol by binding
IκBα to the NLS of p65. Signaling cascades initiated by stimuli, such as exposure to
pathogen-associated molecular patterns or TNF-α, activate the IKK complex. Next, IKKβ
phosphorylates IκBα, targeting IκBα for ubiquitination and proteasomal degradation. With
the p65 NLS no longer occluded by IκBα, p50/p65 translocates into the nucleus where it
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binds to DNA κB sites to activate hundreds of antimicrobial and pro-inflammatory
genes.210

The NF-κB response during Orientia infection is poorly understood. An electrophoretic
mobility shift assay indicated NF-κB activation in O. tsutsugamushi infected J774.1
macrophage-like cells at two h.211 Other time points were not examined. A similar study
performed using immortalized human microvascular endothelial cells evidenced NF-κB
activation during the first four h of infection but not at eight h

212,

suggesting that the

bacterium might modulate NF-κB. Despite these interesting preliminary leads made
between 2000 and 2002, questions as to whether Orientia inhibits NF-κB, if it does so in
a primary target host cell, in the presence of an activating stimulus (TNF-α, IL-1β, or LPS),
and the responsible bacterial factors have since remained unanswered.

It has been recently confirmed that 10 out of 20 O. tsutsugamushi str. Ikeda Anks bear a
canonical PRANC domain, which is utilized to recruit the SCF E3 ubiquitin ligase
complex.60, 61 It was first thought that this domain was only limited to poxviral Anks but
recent discoveries have confirmed that it is also found in intracellular bacterial Anks. 180 A
common function for these poxviral Anks is to inhibit the NF-κB innate immune response
which prevent its viral recognition by the host immune system.133 This led us to pursue
whether or not certain O. tsutsugamushi Anks are responsible for the phenomenon seen
during infection.
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In this chapter, we confirm a mechanism that O. tsutsugamushi undergoes to inhibit NFκB nuclear accumulation. We show that two nucleotropic Anks, Ank1 and Ank6, hijack
host importin-β1 to traffic to the nucleus to interact with p65 where they then export p65
to the cytosol by exploiting the host exportin-1 pathway. These data reveal a novel
mechanism by which O. tsutsugamushi inhibits the NF-κB response. To our knowledge,
Ank1 and Ank6 are the first documented bacterial Anks that inhibit NF-κB function and
moreover, the first microbial Anks that do so by exploiting both importin-1 and exportin1 activity.

4.2 Results
4.2.1 O. tsutsugamushi inhibits p65 accumulation in the nucleus
For NF-κB to activate antimicrobial gene transcription, it must translocate into the nucleus
210.

To determine if NF-κB accumulation in the nucleus is altered over the course of O.

tsutsugamushi infection, HeLa cells, which are useful for studying Orientia cellular
microbiology

60, 213,

or murine BMDMs were infected and examined by confocal

microscopy. In infected HeLa cells, p65 was detected in 42.7% of nuclei by 4 h, but only
17.7% by 8 h, 7.7% at 12 h, and 7.0% at 24 h (Figure 14, A and B). A similar trend was
observed for infected BMDMs except that the percentage of infected cells in which
nuclear p65 was detectable peaked at 8 h and the reduction observed at 12 and 24 h was
not as pronounced as that for HeLa cells (Figure 14, C and D). p65 was absent from the
nuclei of both host cell types harboring as few as three bacteria (Figure 14, A and C).
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Figure 14. O. tsutsugamushi inhibits p65 nuclear accumulation. HeLa cells (A and
B) or BMDM (C and D) were infected with O. tsutsugamushi at an MOI of 1. At 2, 4, 8, 12,
or 24 h, the cells were fixed and screened with antibodies against O. tsutsugamushi
TSA56 (Ot) and p65 prior to examination by confocal microscopy. (A and C)
Representative fluorescence images of cells viewed for Ot, p65, and merged images plus
DAPI, which stains the nucleus, are presented. White arrows denote representative
individual O. tsutsugamushi bacteria. (B and D) The mean percentage + SD of cells
exhibiting p65 in the nucleus was determined at each time point. Triplicate samples of
100 cells each were counted per time point. Results are representative of three separate
experiments.
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These data suggest that O. tsutsugamushi inhibits p65 accumulation in the nucleus within
the initial hours following host cell invasion.

TNF-α, a cytokine that is present in the sera of scrub typhus patients and mice
experimentally infected with O. tsutsugamushi, activates NF-Κb.86, 210, 214-217 Therefore, it
was examined if the bacterium is capable of inhibiting p65 accumulation in the nucleus
following host cell exposure to TNF-α. HeLa cells and BMDMs were incubated with O.
tsutsugamushi organisms at multiplicities of infection (MOIs) of 50 and 10, respectively,
for 24, 48, or 72 h followed by incubation in the presence of TNF-α for 30 min. In the
absence of TNF-α, p65 was detected in the nuclei of only a small percentage of infected
cells compared to mock infected controls (Figure 15), indicating that the lack of a strong
NF-κB response observed during the first 24 h continues at 48 and 72 h. p65
pronouncedly accumulated in the nuclei of mock infected cells exposed to TNF-α. In
contrast, O. tsutsugamushi infection reduced the percentages of TNF-α-stimulated HeLa
cells and BMDMs in which p65 could be detected in the nucleus. The robustness of this
inhibition increased over the duration of infection. Thus, O. tsutsugamushi inhibits TNFα-stimulated p65 accumulation in the nucleus and its ability to do so increases as infection
proceeds.

4.2.2 p65 levels are unchanged in O. tsutsugamushi infected cells
The reduction in p65 accumulation in the nuclei of O. tsutsugamushi infected cells
following TNF-α stimulation could be due to the bacterium promoting degradation of p65,
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Figure 15. O. tsutsugamushi inhibits TNF-α-stimulated p65 nuclear accumulation.
HeLa cells (A and B) or BMDMs (C and D) were infected with O. tsutsugamushi at an
MOI of 50 or 10, respectively. At 24, 48, or 72 h, the cells were treated with TNF-α or
vehicle control (Mock) for 30 min after which they were fixed, screened with antibodies
against O. tsutsugamushi TSA56 (Ot) and p65, and visualized by confocal microscopy.
(A and C) Representative fluorescence images of cells viewed for Ot, p65, and merged
images plus DAPI, which stains the nucleus, are presented. (B and D) The mean
percentage + SD of cells exhibiting p65 in the nucleus were determined at each time
point. Triplicate samples of 100 cells each were counted per time point. Statistically
significant (*P < 0.05; **P < 0.001; ****P < 0.0001) values are indicated. n.s., not
significant. Data are representative of three independent experiments. Data are
representative of the averages of three independent experiments performed in triplicate.
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preventing degradation of IκBα as a means of keeping p65 sequestered in the cytosol in
its inactive state, or directly acting on p65 itself. To determine if the reduction of p65 in
the nuclei of O. tsutsugamushi infected cells was due to it being degraded, Raw 264.7
macrophages and HeLa cells were incubated with the bacteria at MOIs of 25 and 10,
respectively. Whole cell lysates recovered at 24, 48, and 72 h were subjected to Western
blot and densitometry analyses. Probing with GAPDH and -actin antibodies confirmed
that equal protein amounts per sample had been loaded (Figure 16, A and C). Antibody
against the O. tsutsugamushi immunodominant protein, TSA56

142, 218,

verified that the

appropriate samples were infected and that the bacterial load increased over the course
of infection. p65 levels were unchanged between respective mock infected and O.
tsutsugamushi infected controls at all time points for both host cell types (Figure 16).
These data demonstrate that regardless of the bacterial load or duration of infection O.
tsutsugamushi does not reduce cellular levels of p65.

4.2.3 O. tsutsugamushi modulates p65 nuclear accumulation without inhibiting
IκBα degradation
TNF-α induced degradation of IκBα liberates the p50:p65 heterodimer to translocate into
the nucleus

210.

To assess whether the Orientia-mediated inhibition of p65 accumulation

in the nucleus following TNF-α stimulation is due to a blockage of IκBα degradation, HeLa
cells were infected with O. tsutsugamushi at MOIs of 10 or 25. Mock infected cells served
as controls. At 4 and 72 h, the cells treated with TNF-α or vehicle for 30 min. IκBα levels
were pronouncedly reduced and to a similar degree in TNF-α-treated Orientia infected
and control cells at both time points (Figure 17, A and B). As a complementary approach,
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Figure 16. p65 levels are unchanged in O. tsutsugamushi infected cells. RAW 264.7
(A and B) or HeLa cells (C and D) were infected with O. tsutsugamushi at an MOI of 25
or 10, respectively. (A) Whole cell lysates were analyzed by Western blotting with
antibodies to O. tsutsugamushi TSA56 and p65. The blots were stripped and reprobed
with antibody against GAPDH or β-actin as a loading control. (B and D) Mean normalized
ratios + SD of p65:GAPDH (B) and p65:β-actin (D) from three separate experiments were
calculated using densitometry. Statistically significant (*P < 0.05) values are indicated.
ns, not significant.
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Figure 17. O. tsutsugamushi modulates p65 nuclear accumulation without
inhibiting IκBα degradation. HeLa cells were infected with O. tsutsugamushi or
incubated with mock control at an MOI of 10 (A and B) or 25 (C and D). At 4 or 72 h, the
cells were treated with TNF-α or vehicle control for 30 min followed by homogenization.
Whole cell lysates (A) or nuclear and cytosolic fraction (C) were analyzed by Western
blotting with antibodies to IκBα, O. tsutsugamushi TSA56, and β-actin (loading control)
(C) or p65, lamin B1, TSA56, and GADPH (loading control (D). (B and D) Mean
normalized ratios + SD of IκBα:β-actin (C) and p65:lamin B1 (D) were calculated from
three separate experiments performed in (A) and (B), respectively, using densitometry.
Statistically significant (*P < 0.05) values are indicated. ns, not significant.
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the experiment was repeated except that nuclear and cytosolic fractions were analyzed
following exposure to TNF-α or vehicle. Screening nuclear fractions with antibodies
against p65 and lamin B1 (nuclear fraction loading control) and cytosolic fractions with
antibodies targeting TSA56 and GAPDH (cytosolic fraction loading and purity control)
verified that p65 accumulation in the nuclear fraction is significantly inhibited in Orientia
infected cells (Figure 17, C and D).

4.2.4 O. tsutsugamushi inhibits NF-κB-dependent gene transcription
To determine if the Orientia-mediated inhibition of p65 in the nucleus results in a reduction
in NF-κB-dependent transcriptional activation, stably transfected HeLa cells bearing four
copies of the NF-κB promoter upstream of the firefly luciferase gene were incubated with
O. tsutsugamushi bacteria at MOIs of 10, 50, or 100 for 24 h. The cells were stimulated
with TNF-α followed by the addition of luciferase substrate and measurement of the
resulting luminescence signal. Compared to mock infected controls, O. tsutsugamushi
stimulated a significant but low level activation of luciferase expression (Figure 18). O.
tsutsugamushi significantly reduced TNF-α-stimulated luciferase production at all MOIs
and in a dose-dependent manner, thereby confirming that it is capable of inhibiting NFκB-dependent transcription.

4.2.5 O. tsutsugamushi Ank1 and Ank6 inhibit p65 nuclear accumulation
O. tsutsugamushi inhibits TNF-α-induced p65 accumulation in the nucleus to reduce NFκB-dependent transcription in a manner that involves neither degradation of p65 nor
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Figure 18. O. tsutsugamushi inhibits NF-κB-dependent gene transcription. Stably
transfected HeLa cells bearing four copies of the NF-κB promoter upstream of the firefly
luciferase gene seeded in a 96-well plate were incubated with O. tsutsugamushi MOI of
10, 50, or 100 or mock control for 24 h. The cells were treated with TNF-α or vehicle for
8 h to promote NF-κB-dependent gene transcription followed by the addition of lysis buffer
and luciferase substrate. The plate was read in a luminometer for 10 sec per well to
quantify luciferase activity. Data are presented as the mean percentage + SD of luciferase
activity normalized to the luciferase activity of mock control cells exposed to TNF-α from
triplicate samples. Statistically significant (***P < 0.001; ****P < 0.0001) values indicated.
Data are representative of three independent experiments.
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inhibition of IκBα degradation and is likely due to direct bacterial modulation of p65 itself.
As select Orientia Anks have been shown known to modulate diverse host cellular
processes and the bacterium expresses the entire complement of ank genes during
infection of mammalian host cells 60, 61, 142, 143, we rationalized that one or more Anks might
contribute to the pathogen’s ability to modulate p65. Knock out-complementation is not
possible for Orientia. Moreover, even if genetic manipulation for the bacterium was
possible, it would be difficult to apply to the anks because they exist as multiple, nearidentical copies dispersed over the chromosome 51, 53, 143. We therefore devised a screen
in which each of the 20 distinguishable O. tsutsugamushi str. Ikeda Anks were cloned to
express FLAG or green fluorescent protein (GFP) at their N-terminus143 and were
examined by confocal microscopy for the ability to inhibit TNF-α-induced p65
accumulation in the nucleus when ectopically expressed in HeLa cells. FLAG-BAP
(bacterial alkaline phosphatase) and GFP alone served as negative controls (Figure 19).
Of the 20 Anks examined, only Ank1 (Ank1_02; OTT_0036) 51, 143 and Ank6 (Ank6_02;
OTT_1149)51, 143 antagonized TNF-α-stimulated p65 nuclear accumulation to phenocopy
the phenomenon associated with O. tsutsugamushi infection. To quantify this p65 nuclear
inhibition, cells ectopically expressing FLAG-tagged BAP (negative control), Ank1, Ank6,
or IκBα super repressor (IκBα SR; positive control) were scored by IFA. IκBα SR is the
human IκBα gene, which has Ala substitutions for Ser32 and Ser36 preventing its
phosphorylation and abrogating its degradation serving as an excellent positive control
for p65 inhibition.219 In the absence of TNF-α, p65 was devoid from the nuclei of nearly
all transfected cells regardless of the construct (Figure 20), thus verifying that neither the
transfection procedure nor any of the ectopically expressed proteins stimulated the NF-
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Figure 19 continued on next page
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Figure 19. Only Ank1 and Ank6 inhibit p65
nuclear accumulation. HeLa cells were
transfected to express FLAG-tagged or GFPtagged (Ank10 and Ank14) protein of interest.
At 16 h, the cells were exposed to TNF-α or
vehicle control for 30 min, after which they
were fixed, screened with antibodies specific
for the FLAG/GFP epitope and p65, and
examined by confocal microscopy.
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Figure 20. Ank1 and Ank6 translocate into the nucleus and prevent p65 nuclear
accumulation. (A) HeLa cells were transfected to express FLAG-tagged BAP, Ank1,
Ank6, or IκBα SR. At 16 h, the cells were exposed to TNF-α or vehicle control for 30 min,
after which they were fixed, screened with antibodies specific for the FLAG epitope and
p65, and examined by confocal microscopy. (B) The mean percentage + SD of
transfected cells exhibiting p65 in the nucleus was determined. Triplicate samples of 100
cells each were counted per time point. Statistically significant (****P < 0.0001) values
indicated. Results are representative of three independent experiments.
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κB response. p65 was detected in the nuclei of more than 80% of cells expressing FLAGBAP and almost none of the cells expressing FLAG-Ank1, -Ank6, or -IκBα SR following
exposure to TNF-α (Figure 20).

Ank1 exists as two paralogs in the O. tsutsugamushi str. Ikeda genome, Ank1_01 and
Ank1_02, the former of which is truncated, lacks an ankyrin repeat domain, and is
homologous to the non-ankyrin repeat region of Ank1_02. Ank6 exists as four paralogs
that exhibit 99.1 to 100% amino acid identify with each other. The respective Ank1 and
Ank6 paralogs are not tandemly arranged, but are instead distributed over the
chromosome.51,

143

Ank1_02 and Ank6_02 are the representative Ank1 and Ank6

paralogs chosen for this study and are hereafter simply referred to as Ank1 and Ank6,
respectively.

4.2.6 Ank1 and Ank6 sequence attributes
Ank1 exists as two paralogs in the O. tsutsugamushi str. Ikeda genome, Ank1_01 and
Ank1_02, the former of which is truncated, lacks an ankyrin repeat domain, and is
homologous to the non-ankyrin repeat region of Ank1_02. Ank6 exists as four paralogs
that exhibit 99.1 to 100% amino acid identity with each other. The respective Ank1 and
Ank6 paralogs are not tandemly arranged, but are instead distributed over the Ikeda strain
chromosome 51, 143. Ank1 and Ank6 contain three and four ankyrin repeats, respectively,
and C-terminal F-box and PRANC (Pox proteins Repeat of ANkyrin, C-terminal; consists
of an F-box and flanking upstream amino acids 132) domains. Ank1 and Ank6 bear 58.6%
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identity over the entirety of their sequences, 61.9% identity in their N-termini, 37.2%
identity in their ankyrin repeat domains, 76.9% identity in their PRANC domains, 76.2%
identity in their F-boxes, and 55.6% identity in their C-termini (Figure 21 and Table 11).
Although these two Anks accumulate in the nucleus, in silico analyses did not detect a
canonical NLS in either protein. However, Ank6, but not Ank1, has a canonical NES at
amino acids 143 to 161 (Figure 21).

4.2.7 Ank1 and Ank6 translocate into the nucleus and inhibit the NF-κB-dependent
transcriptional activation
To complement the immunofluorescence screen, nuclear and cytosolic fractions of HeLa
cells transfected to express FLAG-tagged Ank1, Ank6, IκBα SR, or BAP were subjected
to Western blot and densitometry analyses. Consistent with the immunofluorescence
results (Figure 19), the amount of p65 present in the nuclear fractions was significantly
reduced in cells expressing FLAG-tagged Ank1, Ank6, and IκBα SR as compared to
FLAG-BAP, whether exposed to TNF-α or not (Figure 22, A and B). Whereas FLAG-BAP
and FLAG-IκBα SR were abundantly detected in the cytosolic fractions and absent from
the nuclear fractions, FLAG-tagged Ank1 and Ank6 were almost exclusively present in
the nuclear fractions (Figure 22A). FLAG-Ank1 and FLAG-Ank6 translocated into the
nucleus in the presence and absence of TNF-α (Figure 22, A and B). To determine if Ank1
and Ank6 inhibit NF-κB-dependent transcriptional activation, HeLa cells having four
copies of the NF-κB promoter upstream of the luciferase gene were transiently
transfected to express FLAG tagged Ank1, Ank6, IκBα SR, or BAP. Following 4 h of TNF-
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Figure 21. Ank1 and Ank6 are similar in amino acid sequences outside their ankyrin
repeat domains. Alignment of O. tsutsugamushi Ank1 and Ank6 where the ankyrin
repeat (AR) domains are highlighted in blue and the PRANC domains highlighted in red.
The underlined region of Ank6 is the sequence of a canonical NES.
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Table 11. Amino acid identities between regions of O. tsutsugamushi str. Ikeda
Ank1 and Ank6
Region of interest
Whole sequence

Amino acid positions
Ank1: 1-329
Ank6: 1-336
N-terminus
Ank1: 1-21
Ank6: 1-21
Ankyrin repeat domain
Ank1: 22-157
Ank6: 22-158
Region between the ankyrin repeat Ank1: 158-201
domain and PRANC domain
Ank6: 159-203
PRANC domain
Ank1: 202-307
Ank6: 204-309
F-box
Ank1: 285-305
Ank6: 287-307
C-terminus
Ank1: 308-329
Ank6: 310-336
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Percent identity
58.6%
61.9%
37.2%
84.1%
76.9%
76.2%
55.6%

Figure 22. Ank1 and Ank6 translocate into the nucleus and inhibit the NF-κBdependent transcriptional activation. (A) HeLa cells were transfected to express
FLAG-tagged BAP, Ank1, Ank6, or IκBα SR. At 16 h, they were treated with TNF-α or
vehicle control (Ctrl) for 30 min. Western blotted nuclear or cytosolic fractions were
screened with antibodies against p65, lamin B1, GAPDH, or the FLAG epitope. (B) Mean
normalized ratios + SD of p65:lamin B1 were calculated from three separate experiments
performed in (A). (C) Stably transfected HeLa cells bearing four copies of the NF-κB
promoter upstream of the firefly luciferase gene were transiently transfected to express
the indicated FLAG-tagged proteins for 16 h. The cells were treated with TNF-α or vehicle
for 4 h to promote NF-κB-dependent gene transcription followed by lysis and mixing with
luciferase substrate. Data are presented as the mean percentage + SD of luciferase
activity normalized to the luciferase activity of control cells expressing FLAG-BAP and
exposed to TNF-α from triplicate samples. Statistically significant values (*P < 0.05; **P
< 0.01; ***P < 0.005) are indicated. Data presented are representative of three separate
experiments.
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α stimulation, luciferase substrate was added and the luminescence signal was recorded.
Background luminescence levels in the absence of TNF-α were similar among all
samples, indicating that neither the transfection procedure nor protein overexpression
activated transcription from the NF-κB promoter (Figure 22C). Relative to FLAG-BAP,
cells expressing FLAG-tagged Ank1, Ank6, or IκBα SR each exhibited comparably
reduced luciferase activity. Together, these data demonstrate that Ank1 and Ank6
translocate into the nucleus and antagonize the NF-κB transcriptional response.

4.2.8 Ank1 and Ank6 interact with endogenous p65 but not IκBα
To determine if Ank1 or Ank6 is capable of interacting with p65, HeLa cells expressing
FLAG-Ank1, -Ank6, or -BAP were exposed to TNF-α or vehicle, lysed, and incubated with
FLAG affinity agarose beads. Immunoprecipitated FLAG-tagged proteins and any coimmunoprecipitated interacting partners were Western-blotted. Probing Western blots of
input lysates confirmed that all FLAG-tagged bait proteins were expressed (Figure 23A).
Screening FLAG-pulldown samples with p65 antibody revealed that FLAG-tagged Ank1
and Ank6 but not BAP co-immunoprecipitated endogenous p65. FLAG-Ank1 and FLAGAnk6 interacted with p65 whether TNF-α was present or not, but failed to precipitate
endogenous IκBα in either condition. FLAG-p65 co-immunoprecipitated IκBα, which
verified that conditions allowed for p65 and IκBα to interact. Ank1-p65 and Ank6-p65
interactions

were

confirmed

by

reciprocal

co-immunoprecipitation

in

which

immunoprecipitating endogenous p65 co-precipitated FLAG-Ank1 and FLAG-Ank6
(Figure 23B). These results suggest that Ank1 and Ank6 are capable of directly binding
p65, but neither directly nor indirectly interacts with IκBα.
114

Figure 23. Ank1 and Ank6 each interact with p65. (A) HeLa cells ectopically expressing
FLAG-tagged BAP, Ank1, or Ank6 and were treated with TNF-α or vehicle for 30 min.
Whole cell lysates were incubated with FLAG antibody-conjugated agarose beads to
immunoprecipitate FLAG-tagged proteins and their interacting proteins. Resulting
Western blots were probed with p65 antibody to determine if any FLAG-tagged protein
co-immunoprecipitated endogenous p65. As a control to ensure that the conditions
allowed by p65 and IκBα to interact, a parallel experiment was performed in which lysates
of TNF-α or vehicle stimulated FLAG-p65 expressing HeLa cells were incubated with the
FLAG antibody coated beads followed by Western blot analysis of the resulting eluate
with antibody against endogenous IκBα. Expression of each FLAG-tagged protein of
interest was confirmed by subjecting 50 μg of each input lysate to Western blotting using
FLAG antibody. (B) A reciprocal co-immunoprecipitation was performed in which whole
cell lysates of TNF-α or vehicle stimulated HeLa cells expressing FLAG-BAP, -Ank1, or Ank6 were were incubated with p65 antibody-conjugated agarose beads to
immunoprecipitate p65 and any interacting proteins. Western blots of the resulting eluates
were probed with FLAG-tag antibody. Data presented are representative of three
independent experiments.
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4.2.9 Ank1 and Ank6 bind importin-β1 and exportin-1
The mechanisms by which Ank1 and Ank6 translocate into the nucleus and prevent p65
nuclear accumulation are unknown. Importin-1 and exportin-1 are two proteins of the
karyopherin- family that regulate import and export of nuclear cargo, respectively,
including NF-κB.115, 116 In the classic nuclear import pathway, cargo bearing an NLS is
bound by an importin-α protein, which, in turn, is bound by an importin-β protein that is
essential for translocation of the ternary complex through the nuclear pore complex

108.

Importin-β1 is the most well characterized karyopherin-β protein and has a conserved
function in NLS-mediated cargo import into the nuclei of animals, plants, and eukaryotic
microbes.220 Because importin-β1 is capable of dimerizing with most of the six different
importin-α proteins

116,

the most direct means for assessing if Ank1 or Ank6 potentially

exploits the classic nuclear import pathway was to determine if they are capable of
interacting with importin-β1. Exportin-1, also known as CRM1 (chromosome region
maintenance 1), is a ubiquitous receptor protein that binds to nuclear export signals on a
variety of cargoes, to direct their translocation from the nucleus to the cytosol

116.

We

therefore also examined if Ank1 and Ank6 interact with exportin-1. HeLa cells transfected
to express FLAG-tagged Ank1, Ank6, or BAP subjected to immunoprecipitation using
FLAG affinity agarose resin. Probing Western blots of eluted immunoprecipitated
complexes with antibodies specific for importin-β1 and exportin-1 confirmed that both
proteins were co-immunoprecipitated by FLAG-Ank1 and FLAG-Ank6, but not FLAG-BAP
even though FLAG-BAP was expressed and recovered at a considerably higher
abundance (Figure 24A). To further confirm that interaction of Ank1 and Ank6 with
importin-β1, p65, and exportin were specific to these Anks, immunoprecipitations were
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Figure 24. Ank1 and Ank6 each interact with importin-β1 and exportin-1. (A) Whole
cell lysates of HeLa cells expressing FLAG-tagged BAP, Ank1, or Ank6 were incubated
with FLAG antibody-conjugated agarose beads to immunoprecipitate FLAG-tagged
proteins and their interacting proteins. Resulting Western blots were probed with
antibodies specific for FLAG, importin β1, exportin 1, and p65. Expression of each FLAGtagged protein of interest was confirmed by subjecting 50 μg of each input lysate to
Western blotting using FLAG antibody. (B) As a control to verify that the abilities to bind
importin-1 and exportin-1 were not due to a non-specific interaction that could be
mediated by another O. tsutsugamushi ankyrin repeat domain, the experiment was
repeated except that FLAG tagged Ank1, Ank6, and Ank9 (Golgi/ER tropic Ank) were
immunoprecipitated and Western blots of the resulting interacting complexes were
screened with antibodies against FLAG, importin-1, exportin-1, and p65. Data presented
are representative of three separate experiments.
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again performed except that Ank9 was in lieu of BAP. Ank9 served as an alternative nonnuclear trafficking negative control as this Ank traffics to the Golgi and ER to assure these
interactions were not based on ankyrin repeat motifs in general. Ank9 was unable to
interact with importin-β1, p65, or exportin-1 (Figure 24B) but Ank1 and Ank6 were
confirming that these interactions are specific to only Ank1 and Ank6 and not simply
based on only possessing ankyrin motifs.
4.2.10 Ank1 and Ank6 translocation into the nucleus is dependent on importin 1
activity
Since our data has shown that Ank1 and Ank6 heavily traffic to the nucleus in addition to
co-immunoprecipitating importin-β1, we sought to determine if these Anks depend on
importin-β1 for their nuclear trafficking abilities. To measure this, we treated cells
ectopically expressing FLAG tagged Ank1, Ank6, or Ank9 with importazole or vehicle
control for three hours, performed nuclear extractions, and measured the amount of
nuclear Ank by Western blot densitometry. Importazole is a cell permeable small molecule
inhibitor which prevents importin-β dependent nuclear trafficking.221 We used Ank9 as a
negative control since the Carlyon laboratory has confirmed this to be a Golgi/ER tropic
effector and does not traffic to the nucleus whatsoever.142 The results of this experiment
revealed that cells expressing Ank1 or Ank6 treated with importazole have a decrease in
Ank nuclear accumulation approximately 50% (Figure 25, A and B). This experiment
together with previous data confirm that Ank1 and Ank6 interact with importin-β1 to permit
their entry into the host nucleus.
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Figure 25. Ank1 and Ank6 traffic to the nucleus in an importin-β dependent manner.
(A) HeLa cells were transfected to express Flag-tagged Ank1, Ank6, or Ank9. At 16 h, the
cells were treated with importazole or vehicle for 3 h. Following lysis and nuclear
fractionation, Western blotted nuclear or cytosolic fractions were screened with antibodies
against the Flag epitope, lamin A/C, and GAPDH. (B) Mean ratios + SD of Flag:lamin A
densitometric signals from three separate experiments were normalized to Flag-Ank9 to
account for the low level background nuclear accumulation of the ectopically expressed
Anks. Statistically significant (*P < 0.05) values are indicated. n.s., not significant. Data
presented are representative of three independent experiments.
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4.2.11 The abilities of Ank1, Ank6, and O. tsutsugamushi to mediate p65 export
from the nucleus rely on exportin-1 function
The abilities of ectopically expressed Ank1 and Ank6 and O. tsutsugamushi to prevent
nuclear accumulation of p65 could either be due to inhibition of p65 import into or
promotion of p65 export from the nucleus. To resolve this discrepancy, it was examined
if Ank1/Ank6/Orientia-mediated inhibition of p65 nuclear accumulation is dependent on
exportin-1 activity. Exportin-1 directs NF-κB export from the nucleus by binding to a
nuclear export sequence (NES) on IκBα bound to NF-κB translocating the IκBα:NF-κB
complex to the cytosol.
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Leptomycin B (LMB) is a fungal metabolite that covalently

binds to exportin 1, irreversibly blocking its ability to bind the NES of IκBα (and other
nuclear proteins), to prevent export of the IκBα:NF-κB complex.115,

222

HeLa cells

expressing FLAG-tagged Ank1, Ank6, IκBα SR, or BAP were treated with LMB or control
followed by the addition of TNF-α or vehicle. The cells were examined for the presence
of p65 in the nucleus using confocal microscopy. As observed above (Figure 20), p65
nuclear accumulation was abrogated in cells expressing FLAG-Ank1, -Ank6, and -IκBα
SR even when stimulated with TNF-α. LMB eliminated the abilities of FLAG-tagged Ank1,
Ank6, and IKBα SR to inhibit this phenomenon (Figure 26, A and B). To determine if O.
tsutsugamushi mediated reduction of p65 in the nucleus is LMB sensitive, HeLa cells that
had been infected with an MOI of 10 for 24 or 72 h were treated with the inhibitor and
examined. In contrast to vehicle control treated cells, abundant immunolabeled p65 signal
was detected in the nuclei of LMB treated cells (Figure 27). These results indicate that
O. tsutsugamushi and ectopically expressed Ank1 and Ank6 prevent nuclear

120

A.

Figure 26 continued on next page
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Figure 26. Ank1 and Ank6 remove p65 from the nucleus in an exportin 1-dependent
manner. (A) HeLa cells expressed FLAG tagged BAP (negative control), Ank1, Ank6, or
IκBα super repressor positive control for 16 h. Cells were then treated with leptomycin B
(LMB) or mock vehicle control for 1 h. After 1 h incubation, media was replaced with media
containing TNF-α or mock vehicle control for 30 min. Cells were fixed and screened by
IFA for the FLAG epitope (green), endogenous p65 (red), and merged with nuclear DAPI
stain (blue). (B) 100 cells were scored by IFA for p65 nuclear accumulation. Statistically
significant values (*P < 0.05; **P < 0.01) are indicated. Scoring performed in
quadruplicate.
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Figure 27. O. tsutsugamushi is exportin 1 dependent for inhibition of NF-κB nuclear
accumulation. HeLa cells were infected with O. tsutsugamushi at an MOI of 10. At 24 or
72 h, the cells were treated with LMB or vehicle control for 1 h after which they were fixed,
screened with antibodies against O. tsutsugamushi TSA56 (O. tsutsugamushi) and p65,
and visualized by confocal microscopy. (A) Representative fluorescence images of cells
viewed for O. tsutsugamushi, p65, and merged images plus DAPI, which stains the
nucleus, are presented 24 h and 72 h post-infection. (B) The mean percentage + SD of
cells exhibiting p65 in the nucleus were determined at each time point. Each sample had
100 cells scored per time point. Data are representative of one experiment performed in
triplicate.
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accumulation of p65 by promoting its export from the nucleus into the cytosol in an
exportin-1-dependent manner.

4.3 Discussion
Localized dermal dendritic cells and macrophages are initially infected by O.
tsutsugamushi following the bite of an infected Leptotrombidium chigger.223 O.
tsutsugamushi has been documented to quickly escape the autophagosome by an
unknown mechanism where it can then proliferate in the cytoplasm without a vacuole.224
The ability for this organism to avoid its destruction by professional phagocytes and evade
the innate immune response is poorly understood. In this chapter, we demonstrate a
mechanism that O. tsutsugamushi utilizes to inhibit an essential arm of innate immunity
known as the NF-κB proinflammatory response. It was first confirmed by the Kim
laboratory that O. tsutsugamushi activates NF-κB for a brief period of time, but that this
is later suppressed by an unknown mechanism.212 The mechanism as to how it dampens
this response has not been studied until now. NF-κB is expressed in all cells and is a
cornerstone for promoting transcription of hundreds of antimicrobial response genes, 95,
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so it is logical that this pathogen evades this host line of defense. Here we show that

O. tsutsugamushi prevents accumulation of NF-κB in immortalized human HeLa cells and
primary murine BMDMs within the first several hours of infection. The data presented here
illustrate how O. tsutsugamushi uses two confirmed type I secreted effectors, Ank1 and
Ank6, as a mechanism for inhibiting the NF-κB innate immune response. Both are
expressed during infection and, when ectopically expressed, phenocopy inhibition of
TNF-α-stimulated p65 nuclear accumulation as seen in infected samples. It is proposed
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that O. tsutsugamushi Ank1 and Ank6 hijack importin-1 gain access to the nucleus
where they remove NF-κB from the nucleus by utilizing the host exportin-1 protein and
finally depart the nucleus as a p65:Ank:exportin-1 complex, which effectively reduces
nuclear levels of NF-κB and thus its ability to function as a transcription factor.

A vast amount of pathogens have been documented to alter NF-κB function at nearly
every stage of its activation pathway to promote the pathogen’s survival. Certain ones act
on the early stages of the NF-κB activation pathway such as the vaccinia virus protein
A46R which mimics a Toll-like-interluekin-1 resistance (TIR) domain to recruit host cell
TIR adaptor proteins, MyD88 and TRIF, which interferes with further signaling for NF-κB
activation.225 Shigella flexneri uses IpaH9.8 which facilitates polyubiquitination of the IKK
subunit NEMO that leads to its proteasomal degradation and resulting in a nonfunctional
IKK.226 Other pathogens act towards that later stages of NF-κB activation. Chlamydia
trachomatis secretes a protease known as CT441 which cleaves the p65 subunit making
it inoperable.229 The VP1686 protein of Vibrio parahaemolyticus directly interacts with p65
to suppress its ability to bind DNA.230 On the contrary, there are pathogens that promote
NF-κB activation to promote its anti-apoptotic function. Toxoplasma gondii encodes its
own version of IKK to promote IκBα phosphorylation and subsequently NF-κB
activation.227 The same is similar for L. pneumophila as this pathogen secretes a kinase
known as LegK1 that too phosphorylates IκBα to promote its degradation. 228 It is
confirmed in this chapter, that O. tsutsugamushi inhibits NF-κB activation to promote its
evasion from the host innate immune response.
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During the first 24 h of infection, O. tsutsugamushi growth is slow (~8 - 9 h per binary
fission event), but becomes logarithmic between 48 and 72 h.229 The bacterium reduces
p65 nuclear accumulation within the first 8 to 12 h, depending on the host cell type, at
MOIs as low as one. NF-κB can be activated by a variety of stimuli such as PAMPs (LPS,
DNA, and ss/dsRNA) and proinflammatory cytokines (IL-1β and TNF-α). For our
experiments we used recombinant TNF-α as a source of NF-κB activation because this
cytokine is documented to be high in the sera of scrub typhus patients whereas IL-1β is
low230-232 and also because this bacterium does not possess LPS on its membrane.
Treating HeLa cells that were infected for 24 h did not result in inhibition of NF-κB nuclear
aggregation, but at 48 h O. tsutsugamushi was significantly able to and even more so at
72 h. This originally suggested that this phenomenon might be bacterial dose-dependent
or temporal dependent. This was elucidated by performing an MOI dose variable NF-κB
luciferase experiment which showed a direct correlation of MOI to inhibition of NF-κB
dependent gene transcription confirming that this is an infection dose dependent event.

Some methods that pathogens facilitate to inhibit the NF-κB pathway are by degrading
p65, preventing either degradation of IκBα, or its dissociation from NF-κB. Although it is
documented that thus far only the Kato strain of O. tsutsugamushi cleaves p65 within the
first five hours of infection, this is neither seen in the Gilliam, Boryong, nor Ikeda strains
suggesting that the highly virulent Kato strain might have an additional mechanism for
NF-κB inhibition.233 O. tsutsugamushi str. Ikeda NF-κB modulation is different than that of
str. Kato because p65 levels are unchanged and IκBα degradation occurs the same in
the presence of TNF-α compared to non-infected cells. A common strategy employed by
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intracellular pathogens to favor its survival is to perform host cell protein mimicry. Since
O. tsutsugamushi inhibits NF-κB nuclear accumulation and function subsequent IκBα
degradation and also that IκBα is an Ank, we sought to determine if any of O.
tsutsugamushi Anks are capable of performing this inhibitory function. Ectopically
expressing all FLAG tagged Anks individually in HeLa cells with TNF-α treatment revealed
that only Ank1 and Ank6 were capable of keeping the nucleus void of NF-κB. Performing
NF-κB luciferase assays supported this data in that these two Anks are capable of
significantly inhibiting NF-κB dependent gene transcription.

Following confirmation that these two effectors indeed play a role in NF-κB suppression,
our next assessment was to understand their mechanisms. We assessed if these
effectors directly interact with p65. Co-immunoprecipitations confirmed that this is the
case and is specific to only FLAG tagged Ank1 and Ank6 but not another Ank, Ank9, or
E. coli BAP. This experiment also elucidated that IκBα degradation is not necessary for
these Anks to interact with p65 as these Anks precipitated a similar amount of p65
regardless of TNF-α treatment. This experiment also showed us that Ank1 and Ank6 do
not interact with IκBα, which confirms that Ank1 or Ank6 do not form an Ank:IκBα:p65
complex but rather these effectors are competing with IκBα for p65 interaction.

Our next assessment was focused on the specific subcellular localization of Ank1 and
Ank6. Immunofluorescent microscopic analysis of the subcellular trafficking of these two
Anks showed that they heavily localize to the cell nucleus. To our surprise, in silico
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analysis of each Ank showed they are absent for any canonical arginine-lysine-rich NLS
for potential interaction of an importin-α protein. However, it has been documented that
nuclear trafficking proteins can circumvent interacting with importin-α and directly interact
with the importin-β protein which is subsequently recognized by the nuclear pore to
facilitate cargo entry.234,

235

Performing co-immunoprecipitations of Ank1 and Ank6

confirmed that both interact with importin-β1 whereas the Ank9 or BAP could not.
Performing nuclear extractions with cells ectopically expressing Ank1, Ank6, or Ank9
treated with the importin-β1 inhibitor importazole confirmed that Ank1 and Ank6 depend
on interaction with importin-β1 to enter the nucleus. It is unclear if Ank1 or Ank6 directly
interact with importin-1 or indirectly via binding to an importin-α protein. If they were to
directly bind importin-α, it is unclear how they would do so because both lack a canonical
NLS. It is to be noted that it is not feasible to test whether Ank1 and Ank6 must interact
with importin-β1 to inhibit NF-κB nuclear accumulation as importazole also inhibits NF-κB
nuclear accumulation.

Our last item to address was the mechanism by which Ank1 and Ank6 promote NF-κB
cytosolic accumulation. Since we confirmed that these Anks utilize host importin-β1 to
enter the nucleus and interact with p65, we hypothesized that these Anks use a nuclear
export trafficking protein. The exportin-1 protein is reported to interact with a leucine-rich
NES on the cargo protein that facilitates trafficking from the nucleus to the cytoplasm. 236
Performing in silico analysis of Ank1 and Ank6 revealed that only Ank6 possessed a
canonical leucine rich NES between amino acids 143-161 (Figure 21). Performing coimmunoprecipitations of Ank1 and Ank6 with BAP or Ank9 negative controls revealed that
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only Ank1 and Ank6 were able to interact with exportin-1. To further prove this interaction
was valid, we treated cells that ectopically expressed Ank1 or Ank6 with the exportin-1
inhibitor LMB in the presence of TNF-α or mock vehicle control then visualized by IFA the
localization of p65. Results showed that Ank1 and Ank6 were no longer able to prevent
p65 nuclear accumulation when exportin-1 function was inhibited even in the absence of
TNF-α. Performing this test on HeLa cells that were infected with an MOI of 10 for 24 or
72 h reveal the same results confirming that O. tsutsugamushi and Ank1 and Ank6 are
dependent upon exportin-1 for NF-κB inhibition.

Other microbial proteins co-opt either an exportin or importin protein but not both, and
none of these examples directly impact NF-κB function. Hantaan virus N protein, which
binds importin-α1, importin-α2, and importin-α3 but neither p50 nor p65, is believed to
inhibit NF-κB nuclear import by sequestering the importins from interacting with
p50:p65.237 Salmonella enterica Typhimurium SpvD interacts with exportin Xpo2, which
mediates nuclear-cytosolic recycling of importins. This interaction has been proposed to
disrupt the normal recycling of importin-α from the nucleus to thereby indirectly inhibit p65
nuclear translocation. African swine fever virus protein A238L is hypothesized to inhibit
NF-κB DNA binding. This effector is confirmed to translocate out of the nucleus via the
exportin-1 pathway but does not mediate exportin-1-dependent p65 nuclear export.238
Yersinia enterocolitica YopM is an immunosuppressive effector which traffics to the
nucleus to phosphorylate ribosomal S6-kinase which alters gene transcription regulation
where YopM then interacts with the DEAD-box helicase 3:exportin-1 dimer to exit the
nucleus which in turn regulates YopM function.239 To our knowledge, Ank1 and Ank6 are
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the first examples of individual microbial proteins that exploit both importin and exportin
activities and do so to promote p65 nuclear export. Ehrlichia chaffeensis, also a member
of the order Rickettsiales, has a similar phenotype as it has been shown to inhibit the NFκB response in the presence of LPS at 24 and 48 h p.i. but not at 3 h p.i.240 Whether E.
chaffeensis, other Rickettsiales organisms, or other microbial pathogens utilize a
mechanism similar to that achieved by O. tsutsugamushi Ank1 and Ank6 is unknown.

Ank1 and Ank6 are both capable of interacting with three proteins along the NF-κB
pathway – p65, importin-1, and exportin-1. It can be concluded that such binding
activities are specific and not simply due to their having an ankyrin repeat domain or
FLAG epitope since neither FLAG-Ank9 nor FLAG-BAP co-immunoprecipitate any of the
three Ank1 and Ank6 interacting partners. Ten out of the 20 O. tsutsugamushi Anks carry
a C-terminal PRANC domain that is capable of binding SKP1 and recruiting the SCF1
complex, including Ank1 and Ank6.60 Thus, these two Anks can form interactions with at
least four different host cell proteins enabling them to exploit and modulate nuclear import
and export pathways, NF-κB transcriptional activation, and SCF1 complex assembly.
Ank1 and Ank6’s purpose for recruitment of the SCF1 complex is currently unknown as
this complex is responsible for promoting ubiquitination of specific substrates. As we have
shown, ectopically expressing Ank1 or Ank6 in abundance does not result in a decrease
in the amounts of cellular p65, importin-β1, or exportin-1. Also there was no evidence of
an increase or decrease in molecular weight shifts in these three interacting partners by
Western blotting to suggest any attachment of ubiquitin moieties. This suggests that either
the PRANC/F-box domains of these two Anks are vestigial or that there is an additional
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protein that Ank1 and Ank6 interact that is ubiquitinated by the SCF1 E3 ubiquitin ligase
complex.
Though Ank1 and Ank6 are functionally identical in terms of how they modulate NF-κB
and their interacting partners, they bear only 58.6% overall amino acid identity (Figure 21
and Table 11). Even more striking, the greatest difference in their sequence similarity
occurs within their ankyrin repeat region, which, given that the ankyrin repeat is the most
common protein-protein interaction motif in nature, is presumably what forms interactions
with p65, importin-1, and exportin-1. Further studies of performing ankyrin repeat
deletions of each of Ank1 and Ank6 is needed to fully understand how these interactions
occur in addition to creating crystallized structures of each Ank with their interacting
partner. Overall, this chapter documents the first ever set of bacterial Anks to modulate
NF-κB function as well as the first ever pathogen effectors that hijack importin and
exportin to perform this phenomenon.
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Chapter 5

Conclusions and Potential Future Directions

132

5.1 Conclusion
In order for an organism to be classified as pathogenic they must have the following
criteria met: 1. It must be able to colonize the host (establish a niche), 2. evade the host
immune response, 3. acquire nutrients from the host, 4. replicate, and 5. and finally
escape the host to infect again to repeat this cycle. 241 The data presented here in this
study addresses the criterion of immune evasion which proposes a potential mechanism
that O. tsutsugamushi undergoes to inhibit the NF-κB innate immune response by means
of T1SS Ank effectors. It has been confirmed that O. tsutsugamushi transcriptionally
expresses all Anks during mammalian cell infection as well as the components for a T1
and a T4SS.143 In order to confirm the function of these Anks we first had to address if
they exit the bacterium and enter the host cytosol where they can potentially modulate
host cell activities and thus promote O. tsutsugamushi’s survival and replication.

Currently there is no method for genetic knockout studies in O. tsutsugamushi. Even so,
knocking out an entire secretion system would most likely result in death of the bacterium
as it must secrete virulence effectors to favor its survival. To overcome this challenge, we
chose to address if these are Anks are secreted by a T1SS by using a heterologous E.
coli T1SS assay. Originally, expressing the full length Anks in E. coli resulted in death of
this surrogate host suggesting these Anks are toxic to this species. To avoid cell death,
fusion of the potential Ank secretion signals to an E. coli T1SS effector, HlyA, that no
longer encodes its secretion signal, was done to determine if the presumed Ank secretion
signal could in fact restore secretion of HlyA.
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A T1SS effector is characterized as possessing a C-terminal secretion signal that is
recognized by the inner membrane ABC component of the T1SS complex where it then
utilizes ATP as an energy source to secrete the effector.148 To date, there is no canonical
primary amino acid sequence that defines a T1 secretion signal but there are
characteristics gathered from confirmed T1SS effectors. They are highly flexible in
primary amino acid sequence, can range from 30 – 70 amino acids in length, and
commonly have a helical secondary structure.156, 202, 242, 243 In addition, they possess few
to no cysteines, are scarce in positively charged amino acids, and have an acidic pI.158
With this information, in silico analyses were performed on the final 60 amino acids of all
20 Anks which revealed strong characteristics of T1 secretion signals.

Substitution of other bacterial species T1SS substrates’ C-termini to HlyA lacking its
secretion signal has been confirmed to restore secretion of the chimeric protein.202, 244
Similar to previous studies, replacing the HlyA secretion signal with the C-terminus of
each individual Ank restored secretion of 19 of 20 O. tsutsugamushi of these chimeric
proteins.143

To further support that these Anks are T1SS effectors, performing a C. burnetii T4SS
assay resulted in absence of secretion of all Anks.143 These results confirm that O.
tsutsugamushi does not utilize these Anks for their own cellular functions but that they
likely secrete them into their extracellular environment to aid in pathogenesis.
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Following confirmation of Ank secretion, our next item to address was the function of
these effectors. Recently, the Carlyon laboratory confirmed that 10/20 Anks possess a
Poxviridae motif known as the PRANC domain.60 Published data of Poxviridae Anks have
shown that one of their many functions is to inhibit the NF-κB innate immune response.245
This led us to first examine the NF-κB sub-cellular localization during infection. A time
course of HeLa cells infected with O. tsutsugamushi with an MOI of one showed that there
is an initial period of NF-κB nuclear accumulation at four h p.i., but eventually diminishes
to become accumulated in the cytosol 8 h and later. A recent publication has shown that
the escape of O. tsutsugamushi from the endosome results in activation of the host
inflammasome which in turn leads to cleavage of the immature IL-1 to mature IL-1β, a
proinflammatory cytokine.100 This initial inflammasome activation may be one of the
causes for the early spike of nuclear NF-κB as NF-κB can be activated by IL-1β. We then
confirmed that as bacterial load and infection time increases, O. tsutsugamushi is better
able to prevent NF-κB nuclear accumulation and its dependent gene transcription even
in the presence of a TNF-α stimulus. This was documented in human HeLa cells and
BMDMs. The ability for O. tsutsugamushi to inhibit NF-κB dependent gene transcription
and nuclear accumulation at 72 h as opposed to 24 h, suggests that these bacteria are
secreting NF-κB inhibiting effectors that begin to accumulate. This accumulation is most
likely greater during higher MOIs and/or at later time points and thus increases the ability
for these effectors to inhibit NF-κB function during TNF-α stimulation.

To determine at what stage O. tsutsugamushi inhibits NF-κB, IκBα degradation was
assessed in early and late infection time points with and without TNF-α stimulus. Treating
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infected cells with TNF-α still resulted in the same amount of IκBα degradation as mock
infected cells confirming that O. tsutsugamushi inhibits NF-κB nuclear accumulation
subsequent IκBα degradation.

Following these infection studies, we continued on with the hypothesis that Ank effectors
were involved in this inhibitory phenomenon. Treating HeLa cells transfected to
individually express all FLAG tagged Ank constructs with TNF-α revealed that only Ank1
and Ank6 inhibit nuclear accumulation of NF-κB. This was phenomenon was further
quantified by Western blot densitometry assessment of nuclear extracts in HeLa cells
expressing these Anks. Additionally, these two Anks were confirmed to significantly inhibit
NF-κB dependent gene transcription.

To better understand how these Anks inhibit NF-κB function, we tested if they interact
with NF-κB itself. Performing co-immunoprecipitations of HeLa cells that ectopically
expressed FLAG tagged Ank1, Ank6, or BAP and screening for endogenous p65 as well
as IκBα confirmed that only Ank1 and Ank6 interact with the p65 subunit of NF-κB but not
with IκBα. This suggests that these two Anks are in competition with IκBα to interact with
NF-κB.

We next sought to determine how these effectors traffic to the nucleus. Neither Ank1 nor
Ank6 not bear any canonical NLSs that would suggest they interact with a member of the
importin-α protein family. However, it has been documented that some nuclear trafficking
proteins can bypass interaction with importin-α and directly interact with importin-β to
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permit nuclear entry. We performed a co-immunoprecipitation of either FLAG tagged
Ank1, Ank6, Ank9, or BAP and screened for importin-β1. Results confirmed that Ank1
and Ank6 interact with importin-β1. Furthermore, treating cells ectopically expressing
Ank1, Ank6, or Ank9 (Golgi localizing Ank)142 with the importin-β inhibitor, importazole,
resulted in a decrease in Ank1 and Ank6 nuclear accumulation compared to mock
treatment thus confirming that these Anks are transported to the nucleus in an importinβ1 manner.

As we had confirmed thus far that these Anks traffic to the nucleus by importin-β1
interaction as well as confirming their interaction with p65, we next hypothesized that
these effectors most likely export NF-κB from the nucleus to prevent its function. An
essential host protein that facilitates nuclear to cytosolic trafficking is exportin-1. Coimmunoprecipitations performed as before showed that Ank1 and Ank6 directly interact
with exportin-1. Treating cells ectopically expressing Ank1 or Ank6 with LMB resulted in
the Anks no longer able to prevent NF-κB nuclear accumulation. Treating 24 and 72 h
infected cells resulted in the same outcome confirming that overall O. tsutsugamushi and
specifically Ank1 and Ank6 are dependent upon on exportin-1 to facilitate export of NFκB from the nucleus.

With this gathered data, an intrinsic never before seen mechanism can be proposed for
these two bacterial effectors. It is hypothesized that during the first four hours of infection
O. tsutsugamushi PAMPs interact with NLRs and TLRs in the host cell resulting in the
initial NF-κB nuclear accumulation. As these bacteria establish their niche in the host cell,
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they secrete Ank1 and Ank6 by their T1SS to allow these effectors access to the host cell
environment. Once in the cytosol, these Anks directly interact with importin-β1 to promote
their nuclear transport. As they enter the nucleus, Ank1 and Ank6 interact with NF-κB and
subsequently interact with exportin-1. Now that these Anks have tethered NF-κB and
exportin-1 simultaneously, they are then able to promote nuclear export of NF-κB thus
resulting NF-κB functionally inactive as a transcription factor averting the NF-κB innate
immune response (Figure 28).

What can be gathered as a whole from the data presented here is that obligate
intracellular bacteria and the host cells they infect undergo an arms race with one another.
Although many of these intracellular bacteria like C. burnetii, L. pneumophila, and
Neisseria gonorrhoeae infect professional phagocytes,246-248 they are able to avert their
destruction by using sophisticated evolutionarily favored mechanisms to thwart the host
immune response. One essential mechanism that these microorganisms employ is the
utilization of secretion systems to deliver pathogenic effectors that will promote the
adaptation of these bacteria in the host cell and their survival. It is shown here that these
pathogens use a T1- or a T4SS to secrete Anks which are used to hijack host cell
components to tip the scales in favor of these bacteria.62, 158, 189, 207 Furthermore, the fact
that intracellular bacteria, pox viruses, and the eukaryotic species these pathogens infect
all encode Anks that possess a conserved F-box motif highly suggests that natural
selection has favored the current existence of these microbes by their ability to perform
host cell protein mimicry.60,

135, 249

Finally, a degree of correlation can be observed

between O. tsutsugamushi and poxviruses as Orientia too encodes a great amount of the
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Figure 28. Hypothesized O. tsutsugamushi Ank1 and Ank6 mechanism for
inhibiting p65 nuclear accumulation. 1. Ank1 and Ank6 are secreted by a T1SS into
the host cytosol. 2. The Anks interact with importin-β1, 3. allowing them to traffic to the
nucleus. 4. The Anks dissociate from importin-β1 to interact with p65 in the nucleus. 5.
The Anks interact with exportin-1 to finally 6. exit the nucleus.
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poxviral PRANC domains within their Anks and furthermore utilizes a fraction of its Anks
repertoire to suppress NF-κB function which would imply that genetic exchange events
have occurred such as transduction enhancing the pathogenesis of O. tsutsugamushi.60,
250

5.2 Potential future directions
There is still much to be addressed with future studies to further dissect this mechanism.
Crystallization structures of Ank1 and Ank6 interacting with these three host proteins
would be most beneficial. This would help determine the regions of these Anks that are
responsible for facilitating these interactions and ultimately accelerate amino acid
mutation studies. These two Anks bear a great amount of sequence homology aside from
the ankyrin repeats themselves which begs the question: are these two effectors
interacting with p65 at different sites? It is unknown whether these Anks, after exporting
p65 from the nucleus, are able to dissociate the Ank:p65:exportin-1 complex in the
cytoplasm to repeat the cycle of NF-κB nuclear to cytoplasmic escorting. One item that
would be essential to address, is whether or not O. tsutsugamushi or these two individual
Anks are capable of inhibiting NF-κB dependent gene transcription in the presence of
LMB. This would give better understanding as to whether or not the interaction of these
effectors with p65 is sufficient to inhibit NF-κB dependent gene transcription or if the
complex must be exported to the cytosol.

140

Literature Cited

1.

Mandell, G.L., Bennett, J.E. & Dolin, R. Mandell, Douglas, and Bennett's
principles and practice of infectious diseases (Churchill Livingstone/Elsevier,
Philadelphia, PA, 2010).

2.

Tamura, A., Ohashi, N., Urakami, H. & Miyamura, S. Classification of Rickettsia
tsutsugamushi in a new genus, Orientia gen. nov., as Orientia tsutsugamushi
comb. nov. Int J Syst Bacteriol 45, 589-91 (1995).

3.

Atwal, S., Giengkam, S., VanNieuwenhze, M. & Salje, J. Live imaging of the
genetically intractable obligate intracellular bacteria Orientia tsutsugamushi using
a panel of fluorescent dyes. J Microbiol Methods 130, 169-176 (2016).

4.

Kelly, D.J., Richards, A.L., Temenak, J., Strickman, D. & Dasch, G.A. The past
and present threat of rickettsial diseases to military medicine and international
public health. Clinical infectious diseases : an official publication of the Infectious
Diseases Society of America 34, S145-69 (2002).

5.

Hayashi, N. Etiology of tsutsugamushi disease. J. Parasitol. 7, 53-68 (1920).

6.

Sasa, M. A historical review on the progress in studies of tsutsugamushi in
Japan. Acta Med. Biol. 15, 9-16 (1967).

7.

Nagayo, M., Tamiya, T., Imamura, A., Sato, K., Miyagawa, Y., and Mitamura, T.
“Demonstration of the virus of tsutsugamushi disease,” in Scientific Reports from
the Government Institute for Infectious Diseases. The Tokyo Imperial University
3, 37-40 (1924).

8.

Balcells, M.E. et al. Endemic scrub typhus-like illness, Chile. Emerging infectious
diseases 17, 1659-63 (2011).

9.

Izzard, L. et al. Isolation of a novel Orientia species (O. chuto sp. nov.) from a
patient infected in Dubai. J Clin Microbiol 48, 4404-9 (2010).

10.

Tamura, A., Urakami, H. & Ohashi, N. A comparative view of Rickettsia
tsutsugamushi and the other groups of rickettsiae. Eur J Epidemiol 7, 259-69
(1991).
141

11.

Ewing, E.P., Jr., Takeuchi, A., Shirai, A. & Osterman, J.V. Experimental infection
of mouse peritoneal mesothelium with scrub typhus rickettsiae: an ultrastructural
study. Infect Immun 19, 1068-75 (1978).

12.

Amano, K. et al. Deficiency of peptidoglycan and lipopolysaccharide components
in Rickettsia tsutsugamushi. Infect Immun 55, 2290-2 (1987).

13.

Kim, S.W. et al. Microtubule- and dynein-mediated movement of Orientia
tsutsugamushi to the microtubule organizing center. Infect Immun 69, 494-500
(2001).

14.

Seong, S.Y., Choi, M.S. & Kim, I.S. Orientia tsutsugamushi infection: overview
and immune responses. Microbes Infect 3, 11-21 (2001).

15.

Kim, M.J., Kim, M.K. & Kang, J.S. Involvement of lipid rafts in the budding-like
exit of Orientia tsutsugamushi. Microb Pathog 63, 37-43 (2013).

16.

Lee, S.M., Kim, M.K., Kim, M.J. & Kang, J.S. Novel polysaccharide antigen of
Orientia tsutsugamushi revealed by a monoclonal antibody. FEMS microbiology
letters 297, 95-100 (2009).

17.

Walker, D.H. Scrub Typhus - Scientific Neglect, Ever-Widening Impact. N Engl J
Med 375, 913-5 (2016).

18.

Ree, H.I., Cho, M.K., Lee, I.Y. & Jeon, S.H. Comparative epidemiological studies
on vector/reservoir animals of tsutsugamushi disease between high and low
endemic areas in Korea. Korean J Parasitol 33, 27-36 (1995).

19.

Lin, P.R. et al. Field assessment of Orientia tsutsugamushi infection in small
mammals and its association with the occurrence of human scrub typhus in
Taiwan. Acta Trop 131, 117-23 (2014).

20.

Kelly, D.J., Fuerst, P.A., Ching, W.M. & Richards, A.L. Scrub typhus: the
geographic distribution of phenotypic and genotypic variants of Orientia
tsutsugamushi. Clinical infectious diseases : an official publication of the
Infectious Diseases Society of America 48 Suppl 3, S203-30 (2009).

21.

Yu, X.-j. & Walker, D.H. in Bergey's Manual of Systematics of Archaea and
Bacteria (John Wiley & Sons, Ltd, 2015).
142

22.

Mathai, E. et al. Outbreak of scrub typhus in southern India during the cooler
months. Annals of the New York Academy of Sciences 990, 359-64 (2003).

23.

Chang, W.H. Current status of tsutsugamushi disease in Korea. J Korean Med
Sci 10, 227-38 (1995).

24.

Huang, B. et al. Anaplasma phagocytophilum APH_1387 is expressed
throughout bacterial intracellular development and localizes to the pathogenoccupied vacuolar membrane. Infection and immunity 78, 1864-73 (2010).

25.

Jeong, Y.J. et al. Scrub typhus: clinical, pathologic, and imaging findings.
Radiographics 27, 161-72 (2007).

26.

Kadosaka, T. & Kimura, E. Electron microscopic observations of Orientia
tsutsugamushi in salivary gland cells of naturally Infected Leptotrombidium
pallidum larvae during feeding. Microbiol Immunol 47, 727-33 (2003).

27.

Urakami, H., Takahashi, M., Murata, M. & Tamura, A. Electron microscopic study
of the distribution and the vertical transmission of Rickettsia tsutsugamushi in
Leptotrombidium pallidum. Jpn J Med Sci Biol 47, 127-39 (1994).

28.

Sudhakar, M.K., and Amarabalan, R. Scrub typhus in adults - a case series from
a tertiary care hospital. Int. J. Med. Public health 1, 34-36 (2011).

29.

Kawamura, A.J., Tanaka, H., Tamura, A. J. Tsutsugamushi disease. University of
Tokyo press (1995).

30.

Sharma, A., Mahajan, S., Gupta, M.L., Kanga, A. & Sharma, V. Investigation of
an outbreak of scrub typhus in the himalayan region of India. Jpn J Infect Dis 58,
208-10 (2005).

31.

Ogawa, M. et al. Scrub typhus in Japan: epidemiology and clinical features of
cases reported in 1998. Am J Trop Med Hyg 67, 162-5 (2002).

32.

Watt, G. & Parola, P. Scrub typhus and tropical rickettsioses. Curr Opin Infect Dis
16, 429-36 (2003).

143

33.

Ebisawa, I.I. Current Epidemiology and Treatment of Tsutsugamushi Disease in
Japan. J Travel Med 2, 218-220 (1995).

34.

Taylor, A.J., Paris, D.H. & Newton, P.N. A Systematic Review of Mortality from
Untreated Scrub Typhus (Orientia tsutsugamushi). PLoS Negl Trop Dis 9,
e0003971 (2015).

35.

Shelite, T.R. et al. Hematogenously disseminated Orientia tsutsugamushiinfected murine model of scrub typhus [corrected]. PLoS Negl Trop Dis 8, e2966
(2014).

36.

Valbuena, G. & Walker, D.H. Approaches to vaccines against Orientia
tsutsugamushi. Front Cell Infect Microbiol 2, 170 (2012).

37.

Phongmany, S. et al. Rickettsial infections and fever, Vientiane, Laos. Emerg
Infect Dis 12, 256-62 (2006).

38.

Megaw, J.W. Scrub typhus is a war disease. Br. Med. J. 2, 109-112 (1945).

39.

Philip, C.B. Tsutsugamushi disease in World War II. J Parasitol 34, 169-91
(1948).

40.

Janardhanan, J., Trowbridge, P. & Varghese, G.M. Diagnosis of scrub typhus.
Expert Rev Anti Infect Ther 12, 1533-40 (2014).

41.

Furuya, Y., Yoshida, Y., Katayama, T., Yamamoto, S. & Kawamura, A., Jr.
Serotype-specific amplification of Rickettsia tsutsugamushi DNA by nested
polymerase chain reaction. J Clin Microbiol 31, 1637-40 (1993).

42.

Kim, D.M. et al. Clinical usefulness of eschar polymerase chain reaction for the
diagnosis of scrub typhus: a prospective study. Clin Infect Dis 43, 1296-300
(2006).

43.

Jiang, J. et al. Development of a quantitative real-time polymerase chain reaction
assay specific for Orientia tsutsugamushi. Am J Trop Med Hyg 70, 351-6 (2004).

44.

Paris, D.H., Aukkanit, N., Jenjaroen, K., Blacksell, S.D. & Day, N.P. A highly
sensitive quantitative real-time PCR assay based on the groEL gene of
144

contemporary Thai strains of Orientia tsutsugamushi. Clin Microbiol Infect 15,
488-95 (2009).
45.

Paris, D.H., Blacksell, S.D., Newton, P.N. & Day, N.P. Simple, rapid and
sensitive detection of Orientia tsutsugamushi by loop-isothermal DNA
amplification. Trans R Soc Trop Med Hyg 102, 1239-46 (2008).

46.

Panpanich, R. & Garner, P. Antibiotics for treating scrub typhus. Cochrane
Database Syst Rev, Cd002150 (2000).

47.

Watt, G., Kantipong, P., Jongsakul, K., Watcharapichat, P. & Phulsuksombati, D.
Azithromycin activities against Orientia tsutsugamushi strains isolated in cases of
scrub typhus in Northern Thailand. Antimicrob Agents Chemother 43, 2817-8
(1999).

48.

Tantibhedhyangkul, W. et al. Intrinsic fluoroquinolone resistance in Orientia
tsutsugamushi. Int J Antimicrob Agents 35, 338-41 (2010).

49.

Watt, G. et al. Scrub typhus infections poorly responsive to antibiotics in northern
Thailand. Lancet 348, 86-9 (1996).

50.

Ha, N.Y. et al. Immunization with an autotransporter protein of Orientia
tsutsugamushi provides protective immunity against scrub typhus. PLoS Negl
Trop Dis 9, e0003585 (2015).

51.

Nakayama, K. et al. The Whole-genome sequencing of the obligate intracellular
bacterium Orientia tsutsugamushi revealed massive gene amplification during
reductive genome evolution. DNA research : an international journal for rapid
publication of reports on genes and genomes 15, 185-99 (2008).

52.

Cho, N.H. et al. The Orientia tsutsugamushi genome reveals massive
proliferation of conjugative type IV secretion system and host-cell interaction
genes. Proc Natl Acad Sci U S A 104, 7981-6 (2007).

53.

Cho, N.H. et al. The Orientia tsutsugamushi genome reveals massive
proliferation of conjugative type IV secretion system and host-cell interaction
genes. Proceedings of the National Academy of Sciences of the United States of
America 104, 7981-6 (2007).

145

54.

Nakayama, K. et al. Genome comparison and phylogenetic analysis of Orientia
tsutsugamushi strains. DNA research : an international journal for rapid
publication of reports on genes and genomes 17, 281-91 (2010).

55.

Liao, H.M. et al. Genomic Sequencing of Orientia tsutsugamushi Strain Karp, an
Assembly Comparable to the Genome Size of the Strain Ikeda. Genome
Announc 4 (2016).

56.

.

57.

Min, C.K. et al. Genome-based construction of the metabolic pathways of
Orientia tsutsugamushi and comparative analysis within the Rickettsiales order.
Comp Funct Genomics, 623145 (2008).

58.

Fuxelius, H.H., Darby, A., Min, C.K., Cho, N.H. & Andersson, S.G. The genomic
and metabolic diversity of Rickettsia. Res Microbiol 158, 745-53 (2007).

59.

Jernigan, K.K. & Bordenstein, S.R. Ankyrin domains across the Tree of Life.
PeerJ 2, e264 (2014).

60.

Beyer, A.R. et al. Orientia tsutsugamushi Strain Ikeda Ankyrin Repeat-Containing
Proteins Recruit SCF1 Ubiquitin Ligase Machinery via Poxvirus-Like F-Box
Motifs. J Bacteriol 197, 3097-109 (2015).

61.

Min, C.K. et al. Multiple Orientia tsutsugamushi ankyrin repeat proteins interact
with SCF1 ubiquitin ligase complex and eukaryotic elongation factor 1 alpha.
PLoS One 9, e105652 (2014).

62.

Kaur, S.J. et al. TolC-dependent secretion of an ankyrin repeat-containing protein
of Rickettsia typhi. Journal of bacteriology 194, 4920-32 (2012).

63.

Voth, D.E. ThANKs for the repeat: Intracellular pathogens exploit a common
eukaryotic domain. Cellular logistics 1, 128-132 (2011).

64.

Moron, C.G., Popov, V.L., Feng, H.M., Wear, D. & Walker, D.H. Identification of
the target cells of Orientia tsutsugamushi in human cases of scrub typhus.
Modern pathology : an official journal of the United States and Canadian
Academy of Pathology, Inc 14, 752-9 (2001).

146

65.

Murata, M. et al. Proliferating sites of Rickettsia tsutsugamushi in mice by
different routes of inoculation evidenced with immunofluorescence. Jpn J Exp
Med 55, 193-9 (1985).

66.

Kim, H.R., Choi, M.S. & Kim, I.S. Role of Syndecan-4 in the cellular invasion of
Orientia tsutsugamushi. Microb Pathog 36, 219-25 (2004).

67.

Ha, N.Y., Cho, N.H., Kim, Y.S., Choi, M.S. & Kim, I.S. An autotransporter protein
from Orientia tsutsugamushi mediates adherence to nonphagocytic host cells.
Infect Immun 79, 1718-27 (2011).

68.

Henderson, I.R., Navarro-Garcia, F., Desvaux, M., Fernandez, R.C. &
Ala'Aldeen, D. Type V protein secretion pathway: the autotransporter story.
Microbiol Mol Biol Rev 68, 692-744 (2004).

69.

Blanc, G. et al. Molecular evolution of rickettsia surface antigens: evidence of
positive selection. Mol Biol Evol 22, 2073-83 (2005).

70.

Wells, T.J., Tree, J.J., Ulett, G.C. & Schembri, M.A. Autotransporter proteins:
novel targets at the bacterial cell surface. FEMS Microbiol Lett 274, 163-72
(2007).

71.

Pankov, R. & Yamada, K.M. Fibronectin at a glance. J Cell Sci 115, 3861-3
(2002).

72.

Ruoslahti, E. Fibronectin and its receptors. Annu Rev Biochem 57, 375-413
(1988).

73.

Lee, J.H. et al. Fibronectin facilitates the invasion of Orientia tsutsugamushi into
host cells through interaction with a 56-kDa type-specific antigen. J Infect Dis
198, 250-7 (2008).

74.

Martinez, J.J., Seveau, S., Veiga, E., Matsuyama, S. & Cossart, P. Ku70, a
component of DNA-dependent protein kinase, is a mammalian receptor for
Rickettsia conorii. Cell 123, 1013-23 (2005).

75.

Seong, S.Y. et al. Induction of neutralizing antibody in mice by immunization with
recombinant 56 kDa protein of Orientia tsutsugamushi. Vaccine 15, 1741-7
(1997).
147

76.

Cho, B.A., Cho, N.H., Seong, S.Y., Choi, M.S. & Kim, I.S. Intracellular invasion
by Orientia tsutsugamushi is mediated by integrin signaling and actin
cytoskeleton rearrangements. Infect Immun 78, 1915-23 (2010).

77.

Woods, A. & Couchman, J.R. Syndecan 4 heparan sulfate proteoglycan is a
selectively enriched and widespread focal adhesion component. Mol Biol Cell 5,
183-92 (1994).

78.

Roy, C.R. & van der Goot, F.G. Eukaryotic cells and microbial pathogens: a
familiar couple take centre stage. Nat Cell Biol 5, 16-9 (2003).

79.

Chu, H. et al. Exploitation of the endocytic pathway by Orientia tsutsugamushi in
nonprofessional phagocytes. Infection and immunity 74, 4246-53 (2006).

80.

Cho, B.A. et al. Global gene expression profile of Orientia tsutsugamushi.
Proteomics 10, 1699-715 (2010).

81.

Heinzen, R.A. Rickettsial actin-based motility: behavior and involvement of
cytoskeletal regulators. Ann N Y Acad Sci 990, 535-47 (2003).

82.

Rikihisa, Y. & Ito, S. Intracellular localization of Rickettsia tsutsugamushi in
polymorphonuclear leukocytes. J Exp Med 150, 703-8 (1979).

83.

Rikihisa, Y. & Ito, S. Effect of antibody on entry of Rickettsia tsutsugamushi into
polymorphonuclear leukocyte cytoplasm. Infect Immun 39, 928-38 (1983).

84.

Saunders, J.P., Brown, G.W., Shirai, A. & Huxsoll, D.L. The longevity of antibody
to Rickettsia tsutsugamushi in patients with confirmed scrub typhus. Trans R Soc
Trop Med Hyg 74, 253-7 (1980).

85.

Chu, H. et al. Orientia tsutsugamushi infection induces CD4+ T cell activation via
human dendritic cell activity. J Microbiol Biotechnol 23, 1159-66 (2013).

86.

Soong, L. et al. Strong type 1, but impaired type 2, immune responses contribute
to Orientia tsutsugamushi-induced pathology in mice. PLoS Negl Trop Dis 8,
e3191 (2014).

148

87.

Wu, C.Y. et al. A Novel Strategy for TNF-Alpha Production by 2-APB Induced
Downregulated SOCE and Upregulated HSP70 in O. tsutsugamushi-Infected
Human Macrophages. PLoS One 11, e0159299 (2016).

88.

Zhao, X. et al. TNF-alpha stimulates caspase-3 activation and apoptotic cell
death in primary septo-hippocampal cultures. J Neurosci Res 64, 121-31 (2001).

89.

Tsai, M.H. et al. Cross-Regulation of Proinflammatory Cytokines by Interleukin10 and miR-155 in Orientia tsutsugamushi-Infected Human Macrophages
Prevents Cytokine Storm. J Invest Dermatol 136, 1398-407 (2016).

90.

Kaplanski, G., Marin, V., Montero-Julian, F., Mantovani, A. & Farnarier, C. IL-6: a
regulator of the transition from neutrophil to monocyte recruitment during
inflammation. Trends Immunol 24, 25-9 (2003).

91.

Harada, A. et al. Essential involvement of interleukin-8 (IL-8) in acute
inflammation. J Leukoc Biol 56, 559-64 (1994).

92.

Metz, G., Carlier, Y. & Vray, B. Trypanosoma cruzi upregulates nitric oxide
release by IFN-gamma-preactivated macrophages, limiting cell infection
independently of the respiratory burst. Parasite Immunol 15, 693-9 (1993).

93.

de Fost, M. et al. Activation of cytotoxic lymphocytes in patients with scrub
typhus. Am J Trop Med Hyg 72, 465-7 (2005).

94.

Hauptmann, M. et al. Protective and Pathogenic Roles of CD8+ T Lymphocytes
in Murine Orientia tsutsugamushi Infection. PLoS Negl Trop Dis 10, e0004991
(2016).

95.

Caamano, J. & Hunter, C.A. NF-kappaB family of transcription factors: central
regulators of innate and adaptive immune functions. Clin Microbiol Rev 15, 41429 (2002).

96.

Sen, R. & Baltimore, D. Multiple nuclear factors interact with the immunoglobulin
enhancer sequences. Cell 46, 705-16 (1986).

97.

May, M.J. & Ghosh, S. Rel/NF-kappa B and I kappa B proteins: an overview.
Semin Cancer Biol 8, 63-73 (1997).

149

98.

Oeckinghaus, A. & Ghosh, S. The NF-kappaB family of transcription factors and
its regulation. Cold Spring Harb Perspect Biol 1, a000034 (2009).

99.

Malinin, N.L., Boldin, M.P., Kovalenko, A.V. & Wallach, D. MAP3K-related kinase
involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385, 540-4
(1997).

100.

Koo, J.E., Hong, H.J., Dearth, A., Kobayashi, K.S. & Koh, Y.S. Intracellular
invasion of Orientia tsutsugamushi activates inflammasome in asc-dependent
manner. PLoS One 7, e39042 (2012).

101.

Mahoney, D.J. et al. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NFkappaB activation. Proc Natl Acad Sci U S A 105, 11778-83 (2008).

102.

Hayden, M.S. & Ghosh, S. NF-kappaB, the first quarter-century: remarkable
progress and outstanding questions. Genes Dev 26, 203-34 (2012).

103.

Yamamoto, M. et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme
in immune receptor signaling. Nat Immunol 7, 962-70 (2006).

104.

Taylor, J.A. et al. Serine 32 and serine 36 of IkappaBalpha are directly
phosphorylated by protein kinase CKII in vitro. J Mol Biol 290, 839-50 (1999).

105.

Yaron, A. et al. Identification of the receptor component of the IkappaBalphaubiquitin ligase. Nature 396, 590-4 (1998).

106.

Fagerlund, R., Kinnunen, L., Kohler, M., Julkunen, I. & Melen, K. NF-{kappa}B is
transported into the nucleus by importin {alpha}3 and importin {alpha}4. J Biol
Chem 280, 15942-51 (2005).

107.

He, S. et al. Upregulation of nuclear transporter, Kpnbeta1, contributes to
accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAMDR) in diffuse large B-cell lymphoma. J Cancer Res Clin Oncol 142, 561-72
(2016).

108.

Stewart, M. Molecular mechanism of the nuclear protein import cycle. Nat Rev
Mol Cell Biol 8, 195-208 (2007).

150

109.

Gorlich, D. & Kutay, U. Transport between the cell nucleus and the cytoplasm.
Annu Rev Cell Dev Biol 15, 607-60 (1999).

110.

Macara, I.G. Transport into and out of the nucleus. Microbiol Mol Biol Rev 65,
570-94, table of contents (2001).

111.

Chook, Y.M. & Blobel, G. Karyopherins and nuclear import. Curr Opin Struct Biol
11, 703-15 (2001).

112.

Fahrenkrog, B. & Aebi, U. The nuclear pore complex: nucleocytoplasmic
transport and beyond. Nat Rev Mol Cell Biol 4, 757-66 (2003).

113.

Ganchi, P.A., Sun, S.C., Greene, W.C. & Ballard, D.W. I kappa B/MAD-3 masks
the nuclear localization signal of NF-kappa B p65 and requires the transactivation
domain to inhibit NF-kappa B p65 DNA binding. Mol Biol Cell 3, 1339-52 (1992).

114.

Sachdev, S., Hoffmann, A. & Hannink, M. Nuclear localization of IkappaB alpha
is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats
define a novel class of cis-acting nuclear import sequences. Mol Cell Biol 18,
2524-34 (1998).

115.

Huang, T.T., Kudo, N., Yoshida, M. & Miyamoto, S. A nuclear export signal in the
N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization
of inactive NF-kappaB/IkappaBalpha complexes. Proc Natl Acad Sci U S A 97,
1014-9 (2000).

116.

Mahipal, A. & Malafa, M. Importins and exportins as therapeutic targets in
cancer. Pharmacol Ther 164, 135-43 (2016).

117.

Bischoff, F.R. & Ponstingl, H. Catalysis of guanine nucleotide exchange of Ran
by RCC1 and stimulation of hydrolysis of Ran-bound GTP by Ran-GAP1.
Methods Enzymol 257, 135-44 (1995).

118.

Safa, A.R. c-FLIP, a master anti-apoptotic regulator. Exp Oncol 34, 176-84
(2012).

119.

Thomas, P.G. et al. The intracellular sensor NLRP3 mediates key innate and
healing responses to influenza A virus via the regulation of caspase-1. Immunity
30, 566-75 (2009).
151

120.

Elliott, C.L., Allport, V.C., Loudon, J.A., Wu, G.D. & Bennett, P.R. Nuclear factorkappa B is essential for up-regulation of interleukin-8 expression in human
amnion and cervical epithelial cells. Mol Hum Reprod 7, 787-90 (2001).

121.

Collins, T. et al. Transcriptional regulation of endothelial cell adhesion molecules:
NF-kappa B and cytokine-inducible enhancers. FASEB J 9, 899-909 (1995).

122.

Li, J., Mahajan, A. & Tsai, M.D. Ankyrin repeat: a unique motif mediating proteinprotein interactions. Biochemistry 45, 15168-78 (2006).

123.

Andrade, M.A., Perez-Iratxeta, C. & Ponting, C.P. Protein repeats: structures,
functions, and evolution. J Struct Biol 134, 117-31 (2001).

124.

Forrer, P., Stumpp, M.T., Binz, H.K. & Pluckthun, A. A novel strategy to design
binding molecules harnessing the modular nature of repeat proteins. FEBS Lett
539, 2-6 (2003).

125.

Lycan, D.E., Stafford, K.A., Bollinger, W. & Breeden, L.L. A new Saccharomyces
cerevisiae ankyrin repeat-encoding gene required for a normal rate of cell
proliferation. Gene 171, 33-40 (1996).

126.

Foord, R., Taylor, I.A., Sedgwick, S.G. & Smerdon, S.J. X-ray structural analysis
of the yeast cell cycle regulator Swi6 reveals variations of the ankyrin fold and
has implications for Swi6 function. Nat Struct Biol 6, 157-65 (1999).

127.

Mosavi, L.K., Minor, D.L., Jr. & Peng, Z.Y. Consensus-derived structural
determinants of the ankyrin repeat motif. Proc Natl Acad Sci U S A 99, 16029-34
(2002).

128.

Huxford, T., Huang, D.B., Malek, S. & Ghosh, G. The crystal structure of the
IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB
inactivation. Cell 95, 759-70 (1998).

129.

Jacobs, M.D. & Harrison, S.C. Structure of an IkappaBalpha/NF-kappaB
complex. Cell 95, 749-58 (1998).

130.

Rennoll-Bankert, K.E., Garcia-Garcia, J.C., Sinclair, S.H. & Dumler, J.S.
Chromatin-bound bacterial effector ankyrin A recruits histone deacetylase 1 and
modifies host gene expression. Cell Microbiol 17, 1640-52 (2015).
152

131.

Schafer, W. et al. Nuclear trafficking of the anti-apoptotic Coxiella burnetii
effector protein AnkG requires binding to p32 and Importin-alpha1. Cell Microbiol
19 (2017).

132.

Mercer, A.A., Fleming, S.B. & Ueda, N. F-box-like domains are present in most
poxvirus ankyrin repeat proteins. Virus genes 31, 127-33 (2005).

133.

Herbert, M.H., Squire, C.J. & Mercer, A.A. Poxviral ankyrin proteins. Viruses 7,
709-38 (2015).

134.

Noel, E.A., Kang, M., Adamec, J., Van Etten, J.L. & Oyler, G.A. Chlorovirus
Skp1-binding ankyrin repeat protein interplay and mimicry of cellular ubiquitin
ligase machinery. J Virol 88, 13798-810 (2014).

135.

Sonnberg, S., Seet, B.T., Pawson, T., Fleming, S.B. & Mercer, A.A. Poxvirus
ankyrin repeat proteins are a unique class of F-box proteins that associate with
cellular SCF1 ubiquitin ligase complexes. Proceedings of the National Academy
of Sciences of the United States of America 105, 10955-60 (2008).

136.

Blanie, S., Gelfi, J., Bertagnoli, S. & Camus-Bouclainville, C. MNF, an ankyrin
repeat protein of myxoma virus, is part of a native cellular SCF complex during
viral infection. Virol J 7, 56 (2010).

137.

van Buuren, N., Couturier, B., Xiong, Y. & Barry, M. Ectromelia virus encodes a
novel family of F-box proteins that interact with the SCF complex. J Virol 82,
9917-27 (2008).

138.

Chang, S.J. et al. Poxvirus host range protein CP77 contains an F-box-like
domain that is necessary to suppress NF-kappaB activation by tumor necrosis
factor alpha but is independent of its host range function. J Virol 83, 4140-52
(2009).

139.

Shisler, J.L. & Jin, X.L. The vaccinia virus K1L gene product inhibits host NFkappaB activation by preventing IkappaBalpha degradation. J Virol 78, 3553-60
(2004).

140.

Camus-Bouclainville, C. et al. A virulence factor of myxoma virus colocalizes with
NF-kappaB in the nucleus and interferes with inflammation. J Virol 78, 2510-6
(2004).
153

141.

Powell, P.P., Dixon, L.K. & Parkhouse, R.M. An IkappaB homolog encoded by
African swine fever virus provides a novel mechanism for downregulation of
proinflammatory cytokine responses in host macrophages. J Virol 70, 8527-33
(1996).

142.

Beyer, A.R. et al. Orientia tsutsugamushi Ank9 is a multifunctional effector that
utilizes a novel GRIP-like Golgi localization domain for Golgi-to-endoplasmic
reticulum trafficking and interacts with host COPB2. Cell Microbiol (2017).

143.

VieBrock, L. et al. Orientia tsutsugamushi ankyrin repeat-containing protein
family members are Type 1 secretion system substrates that traffic to the host
cell endoplasmic reticulum. Front Cell Infect Microbiol 4, 186 (2014).

144.

Houben, E.N., Korotkov, K.V. & Bitter, W. Take five - Type VII secretion systems
of Mycobacteria. Biochim Biophys Acta 1843, 1707-16 (2014).

145.

Ates, L.S., Houben, E.N. & Bitter, W. Type VII Secretion: A Highly Versatile
Secretion System. Microbiol Spectr 4 (2016).

146.

Symmons, M.F., Bokma, E., Koronakis, E., Hughes, C. & Koronakis, V. The
assembled structure of a complete tripartite bacterial multidrug efflux pump. Proc
Natl Acad Sci U S A 106, 7173-8 (2009).

147.

Green, E.R. & Mecsas, J. Bacterial Secretion Systems: An Overview. Microbiol
Spectr 4 (2016).

148.

Thomas, S., Holland, I.B. & Schmitt, L. The Type 1 secretion pathway - the
hemolysin system and beyond. Biochim Biophys Acta 1843, 1629-41 (2014).

149.

Pimenta, A.L., Young, J., Holland, I.B. & Blight, M.A. Antibody analysis of the
localisation, expression and stability of HlyD, the MFP component of the E. coli
haemolysin translocator. Mol Gen Genet 261, 122-32 (1999).

150.

Balakrishnan, L., Hughes, C. & Koronakis, V. Substrate-triggered recruitment of
the TolC channel-tunnel during type I export of hemolysin by Escherichia coli. J
Mol Biol 313, 501-10 (2001).

154

151.

Stanley, P., Packman, L.C., Koronakis, V. & Hughes, C. Fatty acylation of two
internal lysine residues required for the toxic activity of Escherichia coli
hemolysin. Science 266, 1992-6 (1994).

152.

Koronakis, V., Sharff, A., Koronakis, E., Luisi, B. & Hughes, C. Crystal structure
of the bacterial membrane protein TolC central to multidrug efflux and protein
export. Nature 405, 914-9 (2000).

153.

Gray, L. et al. A novel C-terminal signal sequence targets Escherichia coli
haemolysin directly to the medium. J Cell Sci Suppl 11, 45-57 (1989).

154.

Gray, L., Mackman, N., Nicaud, J.M. & Holland, I.B. The carboxy-terminal region
of haemolysin 2001 is required for secretion of the toxin from Escherichia coli.
Mol Gen Genet 205, 127-33 (1986).

155.

Kenny, B., Taylor, S. & Holland, I.B. Identification of individual amino acids
required for secretion within the haemolysin (HlyA) C-terminal targeting region.
Mol Microbiol 6, 1477-89 (1992).

156.

Delepelaire, P. Type I secretion in gram-negative bacteria. Biochimica et
biophysica acta 1694, 149-61 (2004).

157.

Thanabalu, T., Koronakis, E., Hughes, C. & Koronakis, V. Substrate-induced
assembly of a contiguous channel for protein export from E.coli: reversible
bridging of an inner-membrane translocase to an outer membrane exit pore.
EMBO J 17, 6487-96 (1998).

158.

Wakeel, A., den Dulk-Ras, A., Hooykaas, P.J. & McBride, J.W. Ehrlichia
chaffeensis Tandem Repeat Proteins and Ank200 are Type 1 Secretion System
Substrates Related to the Repeats-in-Toxin Exoprotein Family. Frontiers in
cellular and infection microbiology 1, 22 (2011).

159.

Christie, P.J., Whitaker, N. & Gonzalez-Rivera, C. Mechanism and structure of
the bacterial type IV secretion systems. Biochim Biophys Acta 1843, 1578-91
(2014).

160.

Alvarez-Martinez, C.E. & Christie, P.J. Biological diversity of prokaryotic type IV
secretion systems. Microbiol Mol Biol Rev 73, 775-808 (2009).

155

161.

Baron, C. From bioremediation to biowarfare: on the impact and mechanism of
type IV secretion systems. FEMS Microbiol Lett 253, 163-70 (2005).

162.

Backert, S. & Clyne, M. Pathogenesis of Helicobacter pylori infection.
Helicobacter 16 Suppl 1, 19-25 (2011).

163.

Nagai, H. & Kubori, T. Type IVB Secretion Systems of Legionella and Other
Gram-Negative Bacteria. Front Microbiol 2, 136 (2011).

164.

Fischer, W. Assembly and molecular mode of action of the Helicobacter pylori
Cag type IV secretion apparatus. FEBS J 278, 1203-12 (2011).

165.

Llosa, M., Roy, C. & Dehio, C. Bacterial type IV secretion systems in human
disease. Mol Microbiol 73, 141-51 (2009).

166.

Cascales, E. & Christie, P.J. The versatile bacterial type IV secretion systems.
Nat Rev Microbiol 1, 137-49 (2003).

167.

Christie, P.J., Atmakuri, K., Krishnamoorthy, V., Jakubowski, S. & Cascales, E.
Biogenesis, architecture, and function of bacterial type IV secretion systems.
Annu Rev Microbiol 59, 451-85 (2005).

168.

Tato, I., Zunzunegui, S., de la Cruz, F. & Cabezon, E. TrwB, the coupling protein
involved in DNA transport during bacterial conjugation, is a DNA-dependent
ATPase. Proc Natl Acad Sci U S A 102, 8156-61 (2005).

169.

Chen, Y. et al. Enterococcus faecalis PcfC, a spatially localized substrate
receptor for type IV secretion of the pCF10 transfer intermediate. J Bacteriol 190,
3632-45 (2008).

170.

Rangrez, A.Y., Abajy, M.Y., Keller, W., Shouche, Y. & Grohmann, E. Biochemical
characterization of three putative ATPases from a new type IV secretion system
of Aeromonas veronii plasmid pAC3249A. BMC Biochem 11, 10 (2010).

171.

Fronzes, R. et al. Structure of a type IV secretion system core complex. Science
323, 266-8 (2009).

156

172.

Lai, E.M. & Kado, C.I. Processed VirB2 is the major subunit of the promiscuous
pilus of Agrobacterium tumefaciens. J Bacteriol 180, 2711-7 (1998).

173.

Backert, S., Fronzes, R. & Waksman, G. VirB2 and VirB5 proteins: specialized
adhesins in bacterial type-IV secretion systems? Trends Microbiol 16, 409-13
(2008).

174.

Koo, J.E., and Koh, Y. S. Structural and transcriptional analysis of gene clusters
for a type IV secretion system in Orientia tsutsugamushi. World J Microbiol
Biotechnol 26, 753-759 (2010).

175.

Ohashi, N. et al. Demonstration of antigenic and genotypic variation in Orientia
tsutsugamushi which were isolated in Japan, and their classification into type and
subtype. Microbiol Immunol 40, 627-38 (1996).

176.

Voth, D.E. et al. The Coxiella burnetii cryptic plasmid is enriched in genes
encoding type IV secretion system substrates. Journal of bacteriology 193, 1493503 (2011).

177.

Larson, C.L., Beare, P.A., Howe, D. & Heinzen, R.A. Coxiella burnetii effector
protein subverts clathrin-mediated vesicular trafficking for pathogen vacuole
biogenesis. Proc Natl Acad Sci U S A 110, E4770-9 (2013).

178.

Mackman, N., Nicaud, J.M., Gray, L. & Holland, I.B. Genetical and functional
organisation of the Escherichia coli haemolysin determinant 2001. Mol Gen
Genet 201, 282-8 (1985).

179.

Vincent, M.S. et al. Characterization of the Porphyromonas gingivalis Type IX
Secretion Trans-envelope PorKLMNP Core Complex. J Biol Chem 292, 32523261 (2017).

180.

Al-Khodor, S., Price, C.T., Kalia, A. & Abu Kwaik, Y. Functional diversity of
ankyrin repeats in microbial proteins. Trends in microbiology 18, 132-9 (2010).

181.

Rikihisa, Y. & Lin, M. Anaplasma phagocytophilum and Ehrlichia chaffeensis type
IV secretion and Ank proteins. Current opinion in microbiology 13, 59-66 (2010).

157

182.

Campanacci, V., Mukherjee, S., Roy, C.R. & Cherfils, J. Structure of the
Legionella effector AnkX reveals the mechanism of phosphocholine transfer by
the FIC domain. The EMBO journal 32, 1469-77 (2013).

183.

Garcia-Garcia, J.C., Rennoll-Bankert, K.E., Pelly, S., Milstone, A.M. & Dumler,
J.S. Silencing of host cell CYBB gene expression by the nuclear effector AnkA of
the intracellular pathogen Anaplasma phagocytophilum. Infection and immunity
77, 2385-91 (2009).

184.

Ijdo, J.W., Carlson, A.C. & Kennedy, E.L. Anaplasma phagocytophilum AnkA is
tyrosine-phosphorylated at EPIYA motifs and recruits SHP-1 during early
infection. Cellular microbiology 9, 1284-96 (2007).

185.

Lin, M., den Dulk-Ras, A., Hooykaas, P.J. & Rikihisa, Y. Anaplasma
phagocytophilum AnkA secreted by type IV secretion system is tyrosine
phosphorylated by Abl-1 to facilitate infection. Cellular microbiology 9, 2644-57
(2007).

186.

Lomma, M. et al. The Legionella pneumophila F-box protein Lpp2082 (AnkB)
modulates ubiquitination of the host protein parvin B and promotes intracellular
replication. Cellular microbiology 12, 1272-91 (2010).

187.

Luhrmann, A., Nogueira, C.V., Carey, K.L. & Roy, C.R. Inhibition of pathogeninduced apoptosis by a Coxiella burnetii type IV effector protein. Proceedings of
the National Academy of Sciences of the United States of America 107, 189979001 (2010).

188.

Mukherjee, S. et al. Modulation of Rab GTPase function by a protein
phosphocholine transferase. Nature 477, 103-6 (2011).

189.

Pan, X., Luhrmann, A., Satoh, A., Laskowski-Arce, M.A. & Roy, C.R. Ankyrin
repeat proteins comprise a diverse family of bacterial type IV effectors. Science
320, 1651-4 (2008).

190.

Park, J., Kim, K.J., Choi, K.S., Grab, D.J. & Dumler, J.S. Anaplasma
phagocytophilum AnkA binds to granulocyte DNA and nuclear proteins. Cellular
microbiology 6, 743-51 (2004).

191.

Price, C.T., Al-Khodor, S., Al-Quadan, T. & Abu Kwaik, Y. Indispensable role for
the eukaryotic-like ankyrin domains of the ankyrin B effector of Legionella
158

pneumophila within macrophages and amoebae. Infection and immunity 78,
2079-88 (2010).
192.

Price, C.T. et al. Molecular mimicry by an F-box effector of Legionella
pneumophila hijacks a conserved polyubiquitination machinery within
macrophages and protozoa. PLoS pathogens 5, e1000704 (2009).

193.

Price, C.T., Al-Quadan, T., Santic, M., Jones, S.C. & Abu Kwaik, Y. Exploitation
of conserved eukaryotic host cell farnesylation machinery by an F-box effector of
Legionella pneumophila. The Journal of experimental medicine 207, 1713-26
(2010).

194.

Price, C.T., Al-Quadan, T., Santic, M., Rosenshine, I. & Abu Kwaik, Y. Host
proteasomal degradation generates amino acids essential for intracellular
bacterial growth. Science 334, 1553-7 (2011).

195.

Voth, D.E. et al. The Coxiella burnetii ankyrin repeat domain-containing protein
family is heterogeneous, with C-terminal truncations that influence Dot/Icmmediated secretion. Journal of bacteriology 191, 4232-42 (2009).

196.

Huang, B. et al. Anaplasma phagocytophilum APH_0032 is expressed late during
infection and localizes to the pathogen-occupied vacuolar membrane. Microbial
pathogenesis 49, 273-84 (2010).

197.

de Jong, M.F., Sun, Y.H., den Hartigh, A.B., van Dijl, J.M. & Tsolis, R.M.
Identification of VceA and VceC, two members of the VjbR regulon that are
translocated into macrophages by the Brucella type IV secretion system.
Molecular microbiology 70, 1378-96 (2008).

198.

Luo, T., Kuriakose, J.A., Zhu, B., Wakeel, A. & McBride, J.W. Ehrlichia
chaffeensis TRP120 interacts with a diverse array of eukaryotic proteins involved
in transcription, signaling, and cytoskeleton organization. Infection and immunity
79, 4382-91 (2011).

199.

Luo, T. & McBride, J.W. Ehrlichia chaffeensis TRP32 interacts with host cell
targets that influence intracellular survival. Infection and immunity 80, 2297-306
(2012).

159

200.

Thomas, S., Holland, I.B. & Schmitt, L. The Type 1 secretion pathway - the
hemolysin system and beyond. Biochimica et biophysica acta 1843, 1629-41
(2014).

201.

Zhang, F., Greig, D.I. & Ling, V. Functional replacement of the hemolysin A
transport signal by a different primary sequence. Proc Natl Acad Sci U S A 90,
4211-5 (1993).

202.

Zhang, F., Yin, Y., Arrowsmith, C.H. & Ling, V. Secretion and circular dichroism
analysis of the C-terminal signal peptides of HlyA and LktA. Biochemistry 34,
4193-201 (1995).

203.

Davies, R.L., Campbell, S. & Whittam, T.S. Mosaic structure and molecular
evolution of the leukotoxin operon (lktCABD) in Mannheimia (Pasteurella)
haemolytica, Mannheimia glucosida, and Pasteurella trehalosi. J Bacteriol 184,
266-77 (2002).

204.

Rowe, G.E., Pellett, S. & Welch, R.A. Analysis of toxinogenic functions
associated with the RTX repeat region and monoclonal antibody D12 epitope of
Escherichia coli hemolysin. Infect Immun 62, 579-88 (1994).

205.

Aldick, T. et al. Vesicular stabilization and activity augmentation of
enterohaemorrhagic Escherichia coli haemolysin. Mol Microbiol 71, 1496-508
(2009).

206.

Huang, L. et al. The E Block motif is associated with Legionella pneumophila
translocated substrates. Cell Microbiol 13, 227-45 (2011).

207.

Al-Khodor, S., Price, C.T., Habyarimana, F., Kalia, A. & Abu Kwaik, Y. A Dot/Icmtranslocated ankyrin protein of Legionella pneumophila is required for
intracellular proliferation within human macrophages and protozoa. Molecular
microbiology 70, 908-23 (2008).

208.

Habyarimana, F., Price, C.T., Santic, M., Al-Khodor, S. & Kwaik, Y.A. Molecular
characterization of the Dot/Icm-translocated AnkH and AnkJ eukaryotic-like
effectors of Legionella pneumophila. Infection and immunity 78, 1123-34 (2010).

209.

Luhrmann, A., Nogueira, C.V., Carey, K.L. & Roy, C.R. Inhibition of pathogeninduced apoptosis by a Coxiella burnetii type IV effector protein. Proc Natl Acad
Sci U S A 107, 18997-9001 (2010).
160

210.

Rahman, M.M. & McFadden, G. Modulation of NF-kappaB signalling by microbial
pathogens. Nat Rev Microbiol 9, 291-306 (2011).

211.

Cho, N.H. et al. Expression of chemokine genes in murine macrophages infected
with Orientia tsutsugamushi. Infect Immun 68, 594-602 (2000).

212.

Cho, N.H. et al. Induction of the gene encoding macrophage chemoattractant
protein 1 by Orientia tsutsugamushi in human endothelial cells involves activation
of transcription factor activator protein 1. Infect Immun 70, 4841-50 (2002).

213.

Ko, Y., Cho, N.H., Cho, B.A., Kim, I.S. & Choi, M.S. Involvement of Ca(2)+
signaling in intracellular invasion of non-phagocytic host cells by Orientia
tsutsugamushi. Microb Pathog 50, 326-30 (2011).

214.

Yun, J.H., Koo, J.E. & Koh, Y.S. Mitogen-activated protein kinases are involved
in tumor necrosis factor alpha production in macrophages infected with Orientia
tsutsugamushi. Microbiol Immunol 53, 349-55 (2009).

215.

Iwasaki, H. et al. Correlation between the concentrations of tumor necrosis
factor-alpha and the severity of disease in patients infected with Orientia
tsutsugamushi. Int J Infect Dis 14, e328-33 (2010).

216.

Yun, J.H. et al. Chemokine and cytokine production in susceptible C3H/HeN
mice and resistant BALB/c mice during Orientia tsutsugamushi infection.
Microbiol Immunol 49, 551-7 (2005).

217.

Soong, L. et al. An Intradermal Inoculation Mouse Model for Immunological
Investigations of Acute Scrub Typhus and Persistent Infection. PLoS Negl Trop
Dis 10, e0004884 (2016).

218.

Chen, H.W. et al. Kinetics and magnitude of antibody responses against the
conserved 47-kilodalton antigen and the variable 56-kilodalton antigen in scrub
typhus patients. Clin Vaccine Immunol 18, 1021-7 (2011).

219.

Brockman, J.A. et al. Coupling of a signal response domain in I kappa B alpha to
multiple pathways for NF-kappa B activation. Mol Cell Biol 15, 2809-18 (1995).

161

220.

Luo, Y., Wang, Z., Tian, L. & Li, X. The function of importin beta1 is conserved in
eukaryotes but the substrates may vary in organisms. Plant Signal Behav 8
(2013).

221.

Soderholm, J.F. et al. Importazole, a small molecule inhibitor of the transport
receptor importin-beta. ACS Chem Biol 6, 700-8 (2011).

222.

Walsh, M.D., Jr. et al. Exportin 1 inhibition attenuates nuclear factor-kappaBdependent gene expression. Shock 29, 160-6 (2008).

223.

Paris, D.H. et al. Orientia tsutsugamushi in human scrub typhus eschars shows
tropism for dendritic cells and monocytes rather than endothelium. PLoS
neglected tropical diseases 6, e1466 (2012).

224.

Choi, J.H. et al. Orientia tsutsugamushi subverts dendritic cell functions by
escaping from autophagy and impairing their migration. PLoS Negl Trop Dis 7,
e1981 (2013).

225.

Stack, J. et al. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1
receptor adaptors and contributes to virulence. J Exp Med 201, 1007-18 (2005).

226.

Ashida, H. et al. A bacterial E3 ubiquitin ligase IpaH9.8 targets
NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory
response. Nat Cell Biol 12, 66-73; sup pp 1-9 (2010).

227.

Molestina, R.E. & Sinai, A.P. Detection of a novel parasite kinase activity at the
Toxoplasma gondii parasitophorous vacuole membrane capable of
phosphorylating host IkappaBalpha. Cell Microbiol 7, 351-62 (2005).

228.

Ge, J. et al. A Legionella type IV effector activates the NF-kappaB pathway by
phosphorylating the IkappaB family of inhibitors. Proc Natl Acad Sci U S A 106,
13725-30 (2009).

229.

Giengkam, S. et al. Improved Quantification, Propagation, Purification and
Storage of the Obligate Intracellular Human Pathogen Orientia tsutsugamushi.
PLoS Negl Trop Dis 9, e0004009 (2015).

162

230.

Koh, Y.S., Yun, J.H., Seong, S.Y., Choi, M.S. & Kim, I.S. Chemokine and
cytokine production during Orientia tsutsugamushi infection in mice. Microb
Pathog 36, 51-7 (2004).

231.

Iwasaki, H., Takada, N., Nakamura, T. & Ueda, T. Increased levels of
macrophage colony-stimulating factor, gamma interferon, and tumor necrosis
factor alpha in sera of patients with Orientia tsutsugamushi infection. J Clin
Microbiol 35, 3320-2 (1997).

232.

Tantibhedhyangkul, W. et al. Orientia tsutsugamushi, the causative agent of
scrub typhus, induces an inflammatory program in human macrophages. Microb
Pathog 55, 55-63 (2013).

233.

Kim MJ, L.S., Kil SH, Kang JS. Cleavage of p65 Subunit of NF-kappaB by
Orientia tsutsugamushi. Journal of bacteriology and virology 40, 151-157 (2010).

234.

Lee, S.J. et al. The structure of importin-beta bound to SREBP-2: nuclear import
of a transcription factor. Science 302, 1571-5 (2003).

235.

Cingolani, G., Bednenko, J., Gillespie, M.T. & Gerace, L. Molecular basis for the
recognition of a nonclassical nuclear localization signal by importin beta. Mol Cell
10, 1345-53 (2002).

236.

Dong, X. et al. Structural basis for leucine-rich nuclear export signal recognition
by CRM1. Nature 458, 1136-41 (2009).

237.

Taylor, S.L., Frias-Staheli, N., Garcia-Sastre, A. & Schmaljohn, C.S. Hantaan
virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor
necrosis factor alpha-induced activation of nuclear factor kappa B. J Virol 83,
1271-9 (2009).

238.

Silk, R.N., Bowick, G.C., Abrams, C.C. & Dixon, L.K. African swine fever virus
A238L inhibitor of NF-kappaB and of calcineurin phosphatase is imported
actively into the nucleus and exported by a CRM1-mediated pathway. J Gen Virol
88, 411-9 (2007).

239.

Berneking, L. et al. Immunosuppressive Yersinia Effector YopM Binds DEAD Box
Helicase DDX3 to Control Ribosomal S6 Kinase in the Nucleus of Host Cells.
PLoS Pathog 12, e1005660 (2016).
163

240.

Lin, M. & Rikihisa, Y. Ehrlichia chaffeensis downregulates surface Toll-like
receptors 2/4, CD14 and transcription factors PU.1 and inhibits
lipopolysaccharide activation of NF-kappa B, ERK 1/2 and p38 MAPK in host
monocytes. Cell Microbiol 6, 175-86 (2004).

241.

Casadevall, A. & Pirofski, L.A. Host-pathogen interactions: basic concepts of
microbial commensalism, colonization, infection, and disease. Infect Immun 68,
6511-8 (2000).

242.

Wolff, N., Delepelaire, P., Ghigo, J.M. & Delepierre, M. Spectroscopic studies of
the C-terminal secretion signal of the Serratia marcescens haem acquisition
protein (HasA) in various membrane-mimetic environments. Eur J Biochem 243,
400-7 (1997).

243.

Filloux, A. Secretion signal and protein targeting in bacteria: a biological puzzle. J
Bacteriol 192, 3847-9 (2010).

244.

Letoffe, S. & Wandersman, C. Secretion of CyaA-PrtB and HlyA-PrtB fusion
proteins in Escherichia coli: involvement of the glycine-rich repeat domain of
Erwinia chrysanthemi protease B. J Bacteriol 174, 4920-7 (1992).

245.

Mohamed, M.R. & McFadden, G. NFkB inhibitors: strategies from poxviruses.
Cell Cycle 8, 3125-32 (2009).

246.

Copenhaver, A.M. et al. Alveolar macrophages and neutrophils are the primary
reservoirs for Legionella pneumophila and mediate cytosolic surveillance of type
IV secretion. Infect Immun 82, 4325-36 (2014).

247.

Chen, A. & Seifert, H.S. Neisseria gonorrhoeae-mediated inhibition of apoptotic
signalling in polymorphonuclear leukocytes. Infect Immun 79, 4447-58 (2011).

248.

van Schaik, E.J., Chen, C., Mertens, K., Weber, M.M. & Samuel, J.E. Molecular
pathogenesis of the obligate intracellular bacterium Coxiella burnetii. Nat Rev
Microbiol 11, 561-73 (2013).

249.

Jin, J. et al. Systematic analysis and nomenclature of mammalian F-box proteins.
Genes & development 18, 2573-80 (2004).

164

250.

Kim, G. et al. Diversification of Orientia tsutsugamushi genotypes by intragenic
recombination and their potential expansion in endemic areas. PLoS Negl Trop
Dis 11, e0005408 (2017).

165

Sean M. Evans
Virginia Commonwealth University, Medical College Campus
Home: 3328 North Ave. Richmond, VA 23222
(757) 272-8787 evanssm@vcu.edu
Education
Doctor of Philosophy in Microbiology and Immunology
May 2017
Virginia Commonwealth University (VCU) School of Medicine, Richmond, VA
 Dissertation: Orientia tsutsugamushi secretes two ankyrin repeat-containing



effectors via a type-1 secretion system to inhibit host NF-κB pro-inflammatory
response
Principal Investigator: Jason A. Carlyon, Ph. D.
Cumulative GPA: 3.333

Bachelor of Science in Premedical Biology

December 2010

Magna cum laude
Longwood University, Farmville, VA
 Cumulative GPA: 3.643, Major GPA: 3.820
Relevant Work Experience

Graduate Student Researcher

August 2012-May 2017

VCU Department of Microbiology and Immunology, Richmond, VA
PI: Jason A. Carlyon, Ph. D.
“Determine how Orientia tsutsugamushi 1) secretes ankyrin repeat-containing effectors and
2) how this pathogen alters NF-κB function in the host cell.”
 Created a novel type-1 secretion system assay for obligate intracellular bacteria
 Discovered the first bacterial ankyrin proteins that inhibit the human
proinflammatory response
 Biosafety Level-3 (BSL-3) laboratory work culturing and performing research on the
obligate intracellular pathogen O. tsutsugamushi
 Proficient in: GLP in BSL-3, multiplicity of infection calculation for obligate
intracellulars, SDS-PAGE, Western blot, culture mouse bone marrow-derived
macrophages, culture and transfect mammalian cells, luciferase assays, nuclear
extractions, trichloroacetic acid protein precipitation, ImageStream® flow
cytometry, ELISAs, immunofluorescence assay, confocal microscopy, coimmunoprecipitations, in silico protein analysis, RT-PCR, qPCR, PCR, cloning,
restriction enzyme digestion, plasmid isolation, making chemically competent E. coli,
E. coli transformation, protein induction and purification
 Graduate level coursework in biochemistry, immunology, microbiology, virology,
pathology, and research methodology
 Presented course work at conferences
 Mentored new students in laboratory methods and research
 Authored and edited manuscripts and grant proposals
166

Opsonophagocytic assay analyst
January 2011 – August 2012
Pharmaceutical Product Development, LLC. Richmond, VA.
 Performed clinical laboratory testing for the human Streptococcus pneumoniae
vaccine, Prevnar 13 ®, for Pfizer, Inc.
 Testing performed by opsonophagocytic assays with human sera
o Assays that mimicked human immune response to bacteria with compliment
proteins and HL-60 cells serving as phagocytes
Hospital laboratory intern
Centra Southside Community Hospital, Farmville, VA.
 Performed laboratory work on bodily fluids (blood, mucus, fecal matter, saliva, urine)
and tissue samples.
 Assisted in the emergency room with multiple procedures (vitals, applying casts and
splints, spine boarding). Internship for Summer 2009 and Fall 2010.
Peer-Reviewed Publications
Evans, S.M. and Carlyon, J.A. Orientia tsutsugamushi uses two ankyrin repeat-containing
effectors to inhibit NF-κB. Manuscript being submitted in April 2017 to PLOS Pathog.
VieBrock, L., Rodino, K.G., Ge, H., Evans, S.M., Tegels, B.K., Oliver, Jr., L.D., Marconi, R.T.,
Richards, A.L., and Carlyon, J.A. An obligate intracellular bacterial pathogen degrades
host Bat3 to modulate endoplasmic reticulum-associated degradation and benefit its
growth. Manuscript under review, PNAS.
Evans, S.M., VieBrock, L., Beyer, A.R., Ge, H., Singh S., Rodino, K., Richards, A.L., and Carlyon,
J.A. (2012) Orientia tsutsugamushi ankryin repeat-containing protein family
members are type 1 secretion system substrates that traffic to the host cell
endoplasmic reticulum. Front Cell Infect Microbiol. PubMed ID: 25692099
Wang, X., Shaw, D.K., Hammond, H.L., Sutterwala, F.S., Rayamajhi, M., Shirey, K.A., Perkins,
D.J., Bonventre, J.V., Velayutham, T.S., Evans, S.M., Rodino, K.G., VieBrock, L., Scanlon,
K. M., Carbonetti, N. H., Carlyon, J.A., Miao, E.A., McBride J.W., Kotsyfakis, M., and Pedra,
J.H. (2016) The Prostaglandin E2-EP3 Receptor Axis Regulates Anaplasma
phagocytophilum-Mediated NLRC4 Inflammasome Activation. PLOS Pathog. PubMed
ID: 27482714

Presentations at Scientific Meetings
Evans, S.M., and Carlyon, J.A. Orientia tsutsugamushi ankyrin repeat-containing proteins
Ank1 and Ank6 inhibit the host NF-κB proinflammatory pathway.
-Oral presentation at the American Society for Rickettsiology, June, 2016.
-Travel Award given

167

Evans, S.M., and Carlyon, J.A. The obligate intracellular pathogen, Orientia tsutsugamushi,
modulates NF-κB via secreted effectors, Ank1 and Ank6.
-Oral presentation at the 1st Annual Gordon Archer Research Day in Infectious
Diseases, Microbiology, and Immunology, Medical College of Virginia, November,
2015.
Evans, S.M., and Carlyon, J.A. The obligate intracellular pathogen Orientia tsutsugamushi
modulates NF-κB via Ank1 and Ank6.
-Oral presentation at the Virginia American Society for Microbiology, Richmond, VA,
November, 2015.
Evans, S.M., and Carlyon, J.A. Orientia tsutsugamushi inhibits NF-κB nuclear trafficking
during intracellular infection.
-Poster presentation at the American Society for Rickettsiology General Meeting, Lake
Tahoe, CA, June, 2015
Evans, S.M., and Carlyon, J.A. Orientia tsutsugamushi ankyrin repeat-containing proteins are
type 1 secretion system substrates with one that potentially alters NF-κB function.
-Oral presentation at the Mid-Atlantic Microbial Pathogenesis Meeting, Wintergreen,
VA, January, 2015.
Beyer, A.R., VieBrock, L., Evans, S.M., Singh, S., Ge, H., Richards, A.L., and Carlyon, J.A.
Characterizing the molecular choreography of Orientia tsutsugamushi ankyrin
repeat proteins.
-Poster presentation at the Cold Spring Harbor Asia Bacterial Infection and Host
Defense Meeting, Suzhou, China, November, 2013. Poster also presented at the 2014
IRACDA conference, Albuquerque, NM, June, 2014.
Evans, S.M., Beyer, A.R., VieBrock, L., and Carlyon, J.A. The Orientia tsutsugamushi Ankyrin
repeat-containing proteins, Ank8 and Ank15, traffic to the lumen of the host cell
endoplasmic reticulum.
-Poster presentation at American Society for Microbiology General Meeting, Boston,
MA, May, 2014.
VieBrock, L., Beyer, A.R., Evans, S.M., Singh, S., Ge, H., Richards, A. L. Orientia tsutsugamushi
ankyrin repeat-containing proteins (Anks) target the host secretory pathway.
-Poster presentation at American Society for Microbiology General Meeting, Boston,
MA, May, 2014.
Evans, S.M., Beyer, A.R., VieBrock, L., and Carlyon, J.A. Orientia tsutsugamushi ankyrin repeatcontaining proteins, Ank8 and Ank15, traffic to the lumen of the host cell endoplasmic
reticulum.
-Poster presentation at American Society for Microbiology Virginia Annual Meeting,
Charlottesville, VA, November, 2013.

168

Professional Memberships
American Society for Microbiology
American Society for Rickettsiology

2013-Present
2015-Present

169

